SEC Info  
    Home      Search      My Interests      Help      Sign In      Please Sign In

Alion Science & Technology Corp – ‘10-K’ for 9/30/05

On:  Tuesday, 1/31/06, at 5:31pm ET   ·   For:  9/30/05   ·   Accession #:  950133-6-416   ·   File #:  333-89756

Previous ‘10-K’:  ‘10-K’ on 12/28/04 for 9/30/04   ·   Next:  ‘10-K’ on 12/1/06 for 9/30/06   ·   Latest:  ‘10-K’ on 12/30/14 for 9/30/14   ·   6 References:   

Find Words in Filings emoji
 
  in    Show  and   Hints

  As Of                Filer                Filing    For·On·As Docs:Size              Issuer               Agent

 1/31/06  Alion Science & Technology Corp   10-K        9/30/05   10:1.5M                                   Bowne - DC/FA

Annual Report   —   Form 10-K
Filing Table of Contents

Document/Exhibit                   Description                      Pages   Size 

 1: 10-K        For, 10-K                                           HTML   1.29M 
 2: EX-3.2      Articles of Incorporation/Organization or By-Laws   HTML     53K 
 3: EX-4.11     Instrument Defining the Rights of Security Holders  HTML     32K 
 4: EX-4.12     Instrument Defining the Rights of Security Holders  HTML     13K 
 5: EX-23.1     Consent of Experts or Counsel                       HTML      8K 
 6: EX-23.2     Consent of Experts or Counsel                       HTML      8K 
 7: EX-31.1     Certification per Sarbanes-Oxley Act (Section 302)  HTML     15K 
 8: EX-31.2     Certification per Sarbanes-Oxley Act (Section 302)  HTML     15K 
 9: EX-32.1     Certification per Sarbanes-Oxley Act (Section 906)  HTML     10K 
10: EX-32.2     Certification per Sarbanes-Oxley Act (Section 906)  HTML     10K 


10-K   —   For, 10-K
Document Table of Contents

Page (sequential) | (alphabetic) Top
 
11st Page   -   Filing Submission
"Part I
"Item 1
"Business
"Item 2
"Properties
"Item 3
"Legal Proceedings
"Item 4
"Submission of Matters to a Vote of Security Holders
"Part Ii
"Item 5
"Market for Registrant's Common Equity, Related Stockholders Matters and Issuer Purchases of Equity Security
"Item 6
"Selected Financial Data
"Item 7
"Management's Discussion and Analysis of Financial Condition and Results of Operations
"Item 7a
"Quantitative and Qualitative Disclosures About Market Risk
"Item 8
"Financial Statements and Supplementary Data
"Report of Independent Registered Public Accounting Firm
"Consolidated Balance Sheets as of September 30, 2005 and 2004
"Consolidated Statements of Operations for the years ended September 30, 2005, 2004 and 2003
"Consolidated Statements of Shareholder's Equity (Deficit), Subject to Redemption, for the years ended September 30, 2005, 2004 and 2003
"Consolidated Statements of Cash Flows for the years ended September 30, 2005, 2004 and 2003
"Notes to Consolidated Financial Statements
"Schedule II -- Valuation and Qualifying Accounts
"Report of Independent Auditors' Report
"Consolidated Balance Sheets as of September 30, 2002 and 2001
"Consolidated Statements of Income for the years ended September 30, 2002, 2001, and 2000
"Consolidated Statements of Changes in Owner's Net Investment for the years ended September 30, 2002, 2001, and 2000
"Consolidated Statements of Cash Flows for the years ended September 30, 2002, 2001, and 2000
"Item 9
"Changes in and Disagreements with Accountants on Accounting and Financial Disclosure
"Item 9a
"Controls and Procedures
"Item 9b
"Other Information
"Part Iii
"Item 10
"Directors and Executive Officers of the Registrant
"Item 11
"Executive Compensation
"Item 12
"Security Ownership of Certain Beneficial Owners and Management and Related Stockholders Matters
"Item 13
"Certain Relationships and Related Transactions
"Item 14
"Principal Accountant Fees and Services
"Part Iv
"Item 15
"Exhibits and Financial Statement Schedules

This is an HTML Document rendered as filed.  [ Alternative Formats ]



  e10vk  

 

 
 
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
 
Form 10-K
     
    ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
 
    For the fiscal year ended September 30, 2005
 
(ALION SCIENCE AND TECHNOLOGY CORPORATION LOGO)
Alion Science and Technology Corporation
(Exact name of Registrant as Specified in its Charter)
         
Delaware
  333-89756   54-2061691
(State or Other Jurisdiction of
Incorporation or Organization)
  (Commission File Number)   (IRS Employer
Identification No.)
     
10 West 35th Street   1750 Tysons Boulevard
Chicago, IL 60616   Suite 1300
(312) 567-4000   McLean, VA 22102
(703) 918-4480
(Address, including Zip Code and Telephone Number, including
Area Code, of Principal Executive Offices)
 
Securities registered pursuant to Section 12(b) or 12(g) of the Act:
None
      Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.     o Yes          þ No
      Indicate by check mark if disclosure of delinquent filers pursuant to Item 405 of Regulation S-K is not contained herein, and will not be contained, to the best of registrant’s knowledge, in definitive proxy or information statements incorporated by reference in Part III of this Form 10-K or any amendment to this Form 10-K.     o Yes          þ No
      Indicate by check mark whether the registrant is an accelerated filer (as defined in Exchange Act Rule 12b-2).     o Yes          þ No
      Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).     o Yes          þ No
      Aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was last sold as of the last business day of the registrant’s most recently completed second fiscal quarter: None
      The number of shares outstanding of Alion Science and Technology common stock as of September 30, 2005 was 5,149,840.
Documents Incorporated by Reference:
None
 
 


 

EXPLANATORY NOTE
      As previously reported, the Company delayed the filing of its Annual Report for the fiscal year ended September 30, 2005 to allow for an independent investigation relating to an anonymous letter received by the Company shortly before the deadline for filing the Annual Report alleging, among other things, that one of the Company’s business units has engaged in illegal activities with respect to certain of its business operations. Consistent with the Company’s Ethics Compliance Program, the Corporate Governance and Compliance Committee of the Registrant’s Board of Directors, in consultation with the Audit and Finance Committee of the Registrant’s Board of Directors, supervised an investigation that was conducted by independent outside legal counsel into the allegations.
      The investigation was completed on January 31, 2006. The investigation team did not uncover any evidence of any inappropriate activities of a material nature, as alleged in the anonymous letter. The Audit and Finance Committee of the Board of Directors reviewed the results of the investigation, expressed satisfaction with the scope and thoroughness of the investigation and confirmed that there was no evidence of any inappropriate activities of a material nature, as alleged in the anonymous letter.


 

ALION SCIENCE AND TECHNOLOGY CORPORATION
FORM 10-K
TABLE OF CONTENTS
                 
 PART I
 Item 1.    Business     2  
 Item 2.    Properties     26  
 Item 3.    Legal Proceedings     27  
 Item 4.    Submission of Matters to a Vote of Security Holders     28  
 
 PART II
 Item 5.    Market for Registrant’s Common Equity, Related Stockholders Matters and Issuer Purchases of Equity Security     28  
 Item 6.    Selected Financial Data     29  
 Item 7.    Management’s Discussion and Analysis of Financial Condition and Results of Operations     34  
 Item 7a.    Quantitative and Qualitative Disclosures About Market Risk     61  
 Item 8.    Financial Statements and Supplementary Data     63  
 Item 9.    Changes in and Disagreements with Accountants on Accounting and Financial Disclosure     114  
 Item 9a.    Controls and Procedures     114  
 Item 9b.    Other Information     114  
 
 PART III
 Item 10.    Directors and Executive Officers of the Registrant     115  
 Item 11.    Executive Compensation     120  
 Item 12.    Security Ownership of Certain Beneficial Owners and Management and Related Stockholders Matters     132  
 Item 13.    Certain Relationships and Related Transactions     133  
 Item 14.    Principal Accountant Fees and Services     133  
 
 PART IV
 Item 15.    Exhibits and Financial Statement Schedules     135  

1



 

PART I
Item 1. Business
      Some of the statements under “Business,” “Management’s Discussion and Analysis of Financial Condition and Results of Operations,” and elsewhere in this Form 10-K constitute forward-looking statements, which involve known and unknown risks and uncertainties. These statements relate to our future plans, objectives, expectations and intentions and are for illustrative purposes only. These statements may be identified by the use of words such as “believe,” “expect,” “intend,” “plan,” “anticipate,” “likely,” “will,” “pro forma,” “forecast,” “projections,” “could,” “estimate,” “may,” “potential,” “should,” “would” and similar expressions.
      The factors that could cause actual results to differ materially from those anticipated include, but are not limited to, the following: changes to the ERISA laws related to the Company’s Employee Ownership, Savings and Investment Plan; changes to the tax laws relating to the treatment and deductibility of goodwill; the Company’s subchapter S status, or any change in the Company’s effective tax rate; additional costs associated with compliance with the Sarbanes-Oxley Act of 2002, including any changes in the SEC’s rules, and other corporate governance requirements; failure of government customers to exercise options under contracts; funding decisions relating to U.S. Government projects; government contract procurement (such as bid protest) and termination risks; competitive factors such as pricing pressures and/or competition to hire and retain employees; the results of current and/or future legal proceedings and government agency proceedings which may arise out of our operations (including our contracts with government agencies) and the attendant risks of fines, liabilities, penalties, suspension and/or debarment; undertaking acquisitions that could increase our costs or liabilities or be disruptive; taking on additional debt to fund acquisitions; failure to adequately integrate acquired businesses; material changes in laws or regulations applicable to the Company’s businesses; as well as other risk factors discussed elsewhere in this annual report.
      Readers are cautioned not to place undue reliance on these forward-looking statements, which reflect management’s view only as of January 31, 2006. We undertake no obligation to update any of these factors or to publicly announce any change to our forward-looking statements made herein, whether as a result of new information, future events, changes in expectations or otherwise.
Pro Forma Financial Data
      On December 20, 2002, Alion acquired Selected Operations of IIT Research Institute (“IITRI”) in a business combination accounted for using the purchase method (the “Transaction”). Prior to December 20, 2002, Alion was a shell company with limited operating activity. All operating data for the fiscal years ended September 30, 2003 and 2002 are pro forma as it relates to the Transaction described and presented in Item 6, “Selected Financial Data” and assume that this acquisition was completed on October 1, 2001. All pro forma information included in this annual report is based upon the assumptions described in Item 6.
Overview
      Alion Science and Technology Corporation (“Alion”, the Company, “we”, “our”) is an employee-owned company. We apply our scientific and engineering experience to research and develop technological solutions for problems relating to national defense, homeland security and energy and environmental analysis. We provide our research and development and engineering services primarily to agencies of the federal government, but also to departments of state and local government and foreign governments, as well as commercial customers both in the U.S. and abroad.
      Our revenue for fiscal year ended September 30, 2005 was $369.2 million, a 36.8% increase over the prior fiscal year. Federal government contracts accounted for approximately 96% of our revenues in the fiscal year ended September 30, 2005, of which approximately 88% came from the U.S. Department of Defense (DoD) alone. For the fiscal year ended September 30, 2004, federal government contracts accounted for approximately 98% of our revenues and approximately 91% came from the U.S. Department of Defense.

2



 

      We apply our expertise to a range of specialized fields, which we refer to as core business areas. The core business areas are further described below. The estimated percentage distribution of our annual revenues, by core business area, is provided in the table below.
Estimated Revenue by Fiscal Year*
                                                 
Core Business Area   2005   2004   2003
             
    (In millions)
- Defense Operations
  $ 131       36 %   $ 105       39 %   $ 84       39 %
- Wireless Communications
  $ 56       15 %   $ 38       14 %   $ 45       21 %
- Industrial Technology Solutions
  $ 52       14 %   $ 36       13 %   $ 28       13 %
- Naval Architecture/ Marine Engineering
  $ 51       14 %   $ 1       0 %   $ 0       0 %
- Modeling and Simulation
  $ 35       9 %   $ 22       8 %   $ 13       6 %
- Chemical, Biological, Nuclear, and Environmental Sciences
  $ 33       9 %   $ 33       12 %   $ 23       11 %
- Information Technology
  $ 11       3 %   $ 35       13 %   $ 20       10 %
                                     
    $ 369       100 %   $ 270       100 %   $ 213       100 %
                                     
 
Beginning 2005, the descriptions of the Core Business Areas were modified as compared to descriptions used in our Form 10-Ks for 2004 and 2003. The results for 2004 and 2003, have been re-categorized using the modified Core Business Area descriptions. Revenues and percentages are based on management estimates.
      Defense Operations. Our defense operations units provide the following services to the U.S. Department of Defense, including individual service components:
  •  Military transformation: we identify and analyze issues and programs of major importance for the Office of the Secretary of Defense (OSD) and related U.S. military services transformation initiatives such as joint warfare experimentation. We also integrate command, control, communication and computer intelligence (C4I) initiatives and develop net-centric initiatives.
 
  •  Logistics management: we provide support to the U.S. Army on a broad range of requirements including infrastructure assessment, reserve force mobilization, defense industrial base assessment, financial management, cost analysis, and base realignment, from planning to implementation.
 
  •  Readiness assessments and operational support: we deliver strategic planning and decision-making process improvements by providing technical assistance and decision support tools, such as Full Spectrum Analysis and Distributed Information System Collaboration Architecture (DISCATM).
 
  •  Training and education services: we assist the U.S. Department of Defense in the development of its department-wide education and training policies. We develop the necessary technology, compile the information to be used in the courseware, and then translate this into an electronic or web-based advanced distant learning medium so that the student can interact with the courseware from a remote location.
 
  •  Critical infrastructure protection (CIP), risk and vulnerability analysis: we provide techniques, tools, and operational support to assess vulnerabilities and defend infrastructure, including ports, power plants and communications nodes.
 
  •  Ordnance management: we provide inventory management, inspection and distribution of ordnance for the U.S. Navy.
      Wireless Communications. We provide wireless communications research and spectrum engineering services primarily to the U.S. Department of Defense, but also to other agencies of the federal government. To

3



 

a lesser extent, we provide wireless communications research and spectrum engineering services to commercial customers and foreign governments. We have expertise in four primary areas:
  •  Wireless and communications-electronics engineering: we perform work for the government “communications-electronics” and commercial wireless communities. The term “communications-electronics” refers to all devices or systems that use the radio frequency spectrum. Our work for the government sector includes such tasks as conducting modeling and simulation of communications networks, testing and evaluating navigational systems, and analyzing radar and space systems performance. For our commercial customers, both foreign and domestic, we determine whether wireless communication networks have the geographic coverage the customers desire, and whether the systems operate free of interference, and we make recommendations designed to improve network performance. We also evaluate and make recommendations for the design of radio transmitters, receivers and antennas for our commercial customers. In the area of net-centric operations, we design next generation wireless networks and devices, including frequency and bandwidth-adaptive systems.
 
  •  Spectrum management: we perform studies and analyses related to the manner in which the radio frequency spectrum may be utilized without interruption or interference by both new and existing users and technologies. In addition, we assess existing and new technologies for their ability to utilize the radio frequency spectrum efficiently — in other words, to accomplish designated tasks without using too much of the available radio frequency spectrum. Our services, which include providing spectrum policy advice, are used to support decisions of senior government officials in the U.S. and abroad.
 
  •  C4ISR system engineering: we deliver Command, Control, Communication and Computer Intelligence, Surveillance, and Reconnaissance (C4ISR) engineering and analysis support for radio frequency communications, radar, Identification Friend or Foe (IFF), and navigation systems to the U.S. Department of Defense system developers and integrators. We also develop automated spectrum management software to assign frequencies to multiple users of the radio frequency spectrum in an effort to minimize interference. Our software tool, Spectrum XXI, is the automated spectrum management system used worldwide by the U.S. Department of Defense, and it is now also being used by other agencies of the federal government. We also design, integrate and deploy spectrum monitoring software to locate and track violators of the rules and regulations of spectrum usage.
 
  •  Electromagnetic environmental effects: we perform studies and analyses to measure and predict electromagnetic environmental effects for both government and commercial customers. Our work has involved building automated tools designed to predict the effects of potential hazards of electromagnetic radiation to ordnance, fuel and personnel. We also analyze electronic components in automotive parts such as brakes and airbags for electromagnetic interference issues on behalf of various commercial customers.
      Industrial Technology Solutions. We provide the following services to the U.S. Department of Defense and, to a lesser extent, to commercial customers:
  •  Reliability, material and manufacturing engineering: we apply technology to enhance production, improve performance, reduce cost and extend life of complex engineered products.
 
  •  Sensor technology development: we develop, evaluate, adapt and integrate sensor technologies and provide support to the U.S. Department of Defense’s Night Vision Electronic Sensors Laboratory.
 
  •  Facilities engineering/construction management: we provide expertise in engineering, architecture and related disciplines (e.g., construction management, logistics, design oversight and inspection).
 
  •  Research and analysis center management: we manage numerous U.S. Department of Defense information analysis centers such as the: Advanced Materials and Processes Technology Information Analysis Center (AMPTIAC), Manufacturing Technology Information Analysis Center (MTIAC), Electronic Packaging and Interconnection Technology Center and the DuPage Manufacturing Research Center.

4



 

  •  Acoustic engineering: we test and evaluate various components for sound transmission, absorption and intensity; field measurement testing; equipment vibration and isolation; noise abatement; and active silencing.
 
  •  Aerospace coating production and application: we develop and apply coatings to protect government and commercial satellites as well as the International Space Station.
 
  •  Innovative manufacturing technologies: we develop and integrate systems for low-volume productivity (e.g., laser cladding of parts), micro-machines and rapid manufacturing systems.
      Naval architecture/marine engineering. We provide technical services for ship and systems design from the initial phase of mission analysis and feasibility trade-off studies through contract and detail design, production supervision, testing and logistics support for the commercial and naval markets.
  •  Ship design: we provide total ship design services for military and commercial customers. The services encompass whole ship systems engineering including requirements definition, concept analysis, feasibility studies and contract design, detail design and production support.
 
  •  Naval architecture: we provide systems engineering/design integration, hull form development and performance analysis, structural design and analysis, weight engineering, and intact and damage stability analysis.
 
  •  Marine engineering: we design and engineer ship systems including propulsion, electrical, fluids/piping, auxiliary, HVAC, deck machinery, and machinery automation and control systems. We provide expertise for machinery integration, test and trials, failure analysis, modeling and simulation, and integrated logistics support.
 
  •  Combat systems engineering: we provide services including mission and threat analysis, evaluation of candidate warfare and combat systems, development of specifications and installation drawings for topside and below-deck interface requirements, and ship modernizations.
      Modeling and Simulation. Our modeling and simulation operations assist our customers in examining the outcome of events by providing services such as:
  •  Wargaming, experimentation, scenario design and execution: we design and conduct strategic and operations analytic wargames to evaluate future operational concepts and force transformation initiatives, create and implement training scenarios for 2 dimensional and 3 dimensional simulation systems, support Joint Forces Command’s (JFCOM) Millennium Challenge, and we support Joint Conflict and Tactical Simulation (JCATS) scenarios.
 
  •  C4I integration: for the U.S. Department of Defense, we design and develop policies to enable standard automated interfaces between simulation and Command, Control, Communication and Computer Intelligence systems which support improved planning, training and military operations.
 
  •  Analysis and visualization: we develop terrain modeling databases and realistic 3D visual systems for flight simulation and other training systems. We manage the Modeling and Simulation Information Analysis Center (MSIAC) for the U.S. Department of Defense (DoD).
 
  •  Phenomenological modeling: we develop phenomenological models for nuclear, chemical, biological and electromagnetic environments.
 
  •  Locomotive simulators: we design and build railroad car simulators and complementary training programs for railway carriers to train their employees. Participation in our simulation training is designed to improve safety and to minimize fuel consumption for carriers. Our training tools range from training simulators based on desktop computers to full motion simulators for both electric and diesel-electric locomotives. We have delivered our training tools and services to domestic government and commercial customers and to customers in the U.K., Brazil, Turkey, India, Australia and South Africa.

5



 

      Chemical, biological, nuclear and environmental sciences. Our chemical, biological, nuclear and environmental sciences operations provide a wide range of research primarily to the U.S. Department of Defense and the U.S. Environmental Protection Agency, but also to other departments of federal, state and local governments, including:
  •  Chemical/biological agent detection, destruction, and decontamination: we develop, test and evaluate safe methods for detection, destruction and chemical decontamination of chemical, biological and other toxic agents; and operate a chemical agent surety laboratory. We provide technical expertise to branches of the U.S. military, the FBI, police departments, hospitals, fire departments, and other federal government and commercial customers to reduce the threat of chemical-biological terrorism. We provide analytical methods to enhance safe handling of chemical substances and design methods to convert harmful chemical and biological materials into harmless materials.
 
  •  Laboratory support: using our laboratory facilities we analyze materials, wastes and effluents to determine constituents and/or properties; develop and validate analytical methods and instruments; and develop, test and implement methods for measuring air quality.
 
  •  Life sciences: we provide analysis, testing, operational and laboratory support in the areas of: biotechnology, biomedical sciences, drug development and toxicology.
 
  •  Detection, recovery and disposal of unexploded ordnance and explosives: we demilitarize conventional, toxic/radioactive and chemical warfare material; decontaminate and demolish buildings and equipment contaminated with explosives. We provide these services through our wholly-owned subsidiary, Human Factors Applications, Inc. (HFA).
 
  •  Environmental sciences: we provide analysis, operational and laboratory support in: air pollution research, toxicology, ecology and habitat, and quality assurance program support; underwater, airborne and radiated noise analysis; exhaust plume dispersion calculations and modeling; alternative fuels and fuel additives testing; emissions modeling; air and water pollution equipment evaluations; and technology evaluations of waste streams.
 
  •  Nuclear Safety and Analysis: we provide nuclear safety and analysis services to the U.S. Department of Energy (DOE) and its National Laboratories as well as to the commercial nuclear power industry. Our services include: modeling and simulation in the areas of computational fluid dynamics, structural response, materials behavior, and neutronics; safety and risk performance analysis in the areas of probabilistic safety assessments, accident consequence analysis, and source term dose assessment; design and performance assessment services to nuclear power facilities in the areas of control room habitability, power rate analysis, and license extension; management systems and technical program services in the areas of compliance (e.g., regulatory analysis, policy development, and audits), project management, and training; and regulatory compliance technical support services in the areas of nuclear plant operational readiness reviews and conduct of operations.
      Information Technology. Our information technology operations provide the following research primarily to agencies of the federal government, including the U.S. Department of Defense, the Internal Revenue Service and the National Institutes of Health, but also to commercial customers:
  •  Enterprise architecture development and integration: we design, develop and implement enterprise information systems.
 
  •  Applications development: we develop web-based and stand-alone solutions, as well as decision support tools.
 
  •  Knowledge management: we deliver solutions for data warehousing/mining, decision support, and information analysis.
 
  •  Network design and secure network operations: we provide information assurance, business continuity and disaster planning, network planning, call center modeling and re-engineering, and designs for virtual private networks (VPNs).

6



 

  •  Independent verification and validation: we implement modeling and simulation, test and evaluation, and database monitoring.
 
  •  Medical informatics: we develop and integrate technologies for acquisition, storage and use of information, including decision support, in-health and biomedicine.
      Software Tools and Technology Products. We have developed a series of software tools and technology products that complement our core business areas. Examples include:
  •  Frequency Assignment & Certification Engineering Tool (FACETtm): this software tool automates the assignment of radio frequencies, which we refer to as spectrum management, in a way that is designed to minimize interference between multiple users of the radio frequency spectrum.
 
  •  Advanced Cosite Analysis Tool (ACATtm): this software tool is designed to permit co-location of numerous antennas on towers, rooftops and other platforms by predicting interference between the various systems and informing the user how to minimize interference.
 
  •  Spectrum Monitoring Automatic Reporting and Tracking System (SMARTtm): this system characterizes the frequency usage in a given geographic area, allowing the customer to remotely monitor the spectrum to identify unauthorized users and to look for gaps in the spectrum usage.
 
  •  X-IGtm: this software provides 3-D images for managing and displaying visuals of terrain and environment used in flight simulation and other training systems.
 
  •  MobSimtm/ SimViewertm: this software provides for tracking components across multiple modes of transportation (e.g., air, sea, rail and truck).
 
  •  Virtual Ocean: this software provides visualization of ship motions based on analytically correct representation of the seaway.
 
  •  Countermeasurestm: we provide vulnerability/risk assessment software used to analyze and quantify physical or electronic security.
 
  •  Cave Dog: this product is a small, remote-controlled hemispherical, multi-spectral vision robot vehicle used for surveillance and reconnaissance.
 
  •  Real Time Location System (RTLS): this product is designed to enable customers to track thousands of users in a defined area, such as a seaport, a football stadium or an office building, using low cost antennas and badges.
 
  •  Isis- 3Dtm: we provide fire code software with specific models for weapon thermal hazard response, including aerosol and radiation models.
 
  •  PRISMtm: we provide software used for system level failure rate modeling with the ability to model both operating and non-operating failure rates. The system considers non-component failure causes through process assessment.
Corporate History
      Alion Science and Technology Corporation, formerly known as Beagle Holdings, Inc., was organized on October 10, 2001, as a for-profit Delaware corporation for the purposes of purchasing substantially all of the assets and assuming certain liabilities of IITRI, a not-for-profit Illinois corporation. Alion is an employee-owned company that is the successor in interest to IITRI, a government contractor in existence for more than sixty years. On December 20, 2002, some of the eligible employees of IITRI directed funds from their eligible retirement account balances into Alion’s Employee Stock Ownership Plan (ESOP). State Street Bank and Trust Company, the ESOP Trustee, used these proceeds, together with funds described elsewhere in this annual report, to purchase substantially all of IITRI’s assets and certain liabilities (hereafter referred to as the “Selected Operations of IITRI”). We refer to this purchase as “the Transaction.” Given the significance of the Transaction, and its effect on Alion’s capital structure, summary descriptions of the acquisition and the related deal terms, the purchase of Alion common stock by the ESOP, and Alion’s ESOP are provided below.

7



 

The Acquisition and Deal Terms for the Purchase of Assets from IITRI (The “Transaction”)
      Acquired Business. On December 20, 2002, Alion acquired substantially all of the assets, rights and liabilities of IITRI’s business except for, amongst others, those assets, rights and liabilities associated with the Life Sciences Operation (other than its accounts receivable, which Alion did acquire), and IITRI’s real property, some of which we leased upon completion of the acquisition.
      Purchase Price. The aggregate purchase price we paid to IITRI for its assets was approximately $127.3 million that included the following components:
               
• a $57.0 million cash component, which consisted of:
           
 
- approximately $25.8 million from the sale of our common stock to the ESOP;
  $25.8 million (approximately)        
 
- approximately $31.2 million in proceeds from a loan to Alion arranged by LaSalle Bank National Association;
  $31.2 million (approximately)        
• an approximate $60.2 million debt component, which consisted of:
           
 
- issuance of a promissory note, the mezzanine note, by Alion to IITRI with a face value of approximately $20.3 million;
  $20.3 million (approximately)        
 
- issuance of a promissory note, the subordinated note, by Alion to IITRI with a face value of $39.9 million;
  $39.9 million (approximately)        
• the payment by Alion at closing of approximately $6.2 million for IITRI’s outstanding bank debt, $2.3 million for IITRI’s cost related to the transaction, and $1.6 million for purchase price adjustments due IITRI;
  $10.1 million (approximately)        
• warrants issued to IITRI to purchase up to approximately 38% of our common stock, on a fully diluted basis (assuming the exercise of all outstanding warrants), at the closing date.
  Warrants        
           
    $127.3 million (approximately)   Plus warrants and the assumption of additional liabilities.
      Assumption of Liabilities. Alion assumed substantially all of the liabilities of IITRI’s business, with certain identified exceptions.
      Indemnification. IITRI agreed to indemnify us, within limits agreed to by the parties, against any losses resulting from its breach of any of its representations, warranties or covenants and against losses resulting from liabilities retained by IITRI. We, in turn, indemnified IITRI, within limits agreed to by the parties, against losses resulting from our breach of any of our representations, warranties or covenants and against losses resulting from liabilities we assumed.

8



 

The Purchase of Alion Common Stock by ESOP Trust
      On December 20, 2002, we entered into a stock purchase agreement with the ESOP trust pursuant to which at closing we issued 2,575,408 shares of our common stock at $10 per share, in exchange for the funds our employees directed to be invested in the ESOP component of the KSOP (a “KSOP” is an employee benefit plan that consists of an ESOP and a 401(k) element, which allows employees to have diversified retirement savings in other investments) in the initial one-time ESOP investment election.
      Representations and Warranties. Within the stock purchase agreement, we made representations and warranties to the ESOP trust that are customary to transactions of this type, related to, but not limited, to:
  •  Alion’s and HFA’s organization and corporate standing, their authority to enter into the stock purchase agreement and the binding effect of the agreement on us;
 
  •  the accuracy, compliance with U.S. generally accepted accounting principles and consistency with past practice of the financial statements with respect to the portion of IITRI’s business transferred to Alion; and
 
  •  our obligation to repurchase any shares of our common stock distributed to ESOP participants.
 
  •  the ESOP trustee, on behalf of the ESOP trust, made representations and warranties to us, including, but not limited to:
  •  the trustee’s authority to enter into the stock purchase agreement and the binding effect of the agreement on the ESOP trust; and
 
  •  the investment intent of the ESOP trust.
      Covenants. As part of the stock purchase agreement, we agreed with the ESOP trust that:
  •  we will not take any steps without the ESOP trust’s consent to change our status as an S corporation;
 
  •  we will not enter into any transactions with any of our officers or directors without approval from our board of directors or compensation committee;
 
  •  we will enforce our obligations under the asset purchase agreement with IITRI and other related agreements;
 
  •  we will obtain the ESOP trust’s consent before effecting our first public offering of stock to be listed on any securities exchange;
 
  •  we will not take actions that would prevent the ESOP trust from acquiring any additional shares of our stock under the control share acquisition provisions of the Delaware General Corporation Law;
 
  •  we will repurchase any shares of common stock distributed to participants in the ESOP component of the KSOP, to the extent required by the ESOP, any ESOP related documents and applicable laws;
 
  •  we will maintain the KSOP and the ESOP trust so that they will remain in compliance with the qualification and tax exemption requirements under the Internal Revenue Code; and
 
  •  we will use our best efforts to ensure that the ESOP trust fully enjoys its right to elect a majority of our board of directors and to otherwise control Alion.
      Certain of the covenants listed above will lapse if the ESOP trust fails to own or otherwise control at least 20% of the voting power of all our capital stock.
      Indemnification. We agreed to indemnify the ESOP trust, within limits agreed to by the parties, against any losses resulting from our breach of any of our representations, warranties or covenants. The ESOP trust will indemnify us, within limits agreed to by the parties, against losses resulting from its breach of any of its representations, warranties or covenants.

9



 

The Alion ESOP
      The Alion Science and Technology Corporation Employee Ownership, Savings and Investment Plan, which we refer to as the KSOP, is a qualified retirement plan and is comprised of what we refer to as an ESOP component and a non-ESOP component. The ESOP component of the KSOP owns 100% of the Company’s outstanding shares of common stock.
      Eligible employees of the Company can purchase beneficial interests in the Company’s common stock by:
  •  rolling over their eligible retirement account balances into the ESOP component of the KSOP by making an individual one-time ESOP investment election available to new hires; and/or
 
  •  directing a portion of their pre-tax payroll income to be invested in the ESOP component of the KSOP.
      The Company’s ESOP trustee, State Street Bank & Trust Company, uses the monies that eligible employees invest in the ESOP to purchase shares of the Company’s common stock, for allocation to those employees’ ESOP accounts.
      The Company makes retirement plan contributions to all of its employees who are eligible participants in the Alion KSOP. These retirement plan contributions are made to eligible employees’ accounts in both the ESOP and the non-ESOP components of the KSOP. The Company also makes matching contributions on behalf of eligible employees, in the ESOP component, based on their pre-tax deferrals of their Alion salary.
      The ESOP trustee holds record title to all of the shares of Company common stock allocated to the employees’ ESOP accounts, and except in certain limited circumstances, the ESOP trustee will vote those shares on behalf of the employees at the direction of the ESOP committee. The ESOP committee is comprised of four members of Alion’s management team and three other Alion employees and is responsible for the financial management and administration of the ESOP component.
      By law, Alion is required to value the common stock held in the ESOP component at least once a year. Alion has elected to have the common stock in the ESOP component valued by the ESOP trustee twice a year — as of March 31 and September 30. Because all ESOP transactions must occur at the current fair market value of the common stock held in the ESOP trust, having bi-annual valuations affords eligible employees the opportunity to invest in Company common stock and, when applicable, request distributions of their ESOP accounts at the end of each semi-annual period, rather than waiting until the end of each plan year.
Growth Strategy
      Our objective is to continue to grow by capitalizing on our highly educated work force, our established position in our core business areas and by synergistic acquisitions. Our strategies for meeting this objective are:
        To build on our experience in wireless communications. We anticipate that U.S. Department of Defense budgets for the next few years will reflect continued emphasis on communications and spectrum issues in which we have established expertise. For example, we expect to play a significant role for the U.S. Department of Defense in the development of Global Electromagnetic Spectrum Information (GEMSIS) as part of the Department of Defense’s move toward net-centric warfare. In addition, civilian agencies of the federal government are interested in the communications solutions we have developed for the U.S. Department of Defense. We also intend to try to expand our communications research base to include more foreign and commercial customers.
 
        To support the nation in homeland security. Alion has a long history of research and development in defense and destruction of chemical and biological agents. We have also developed a suite of software tools to support first responders in training to deal with potential release of chemical, biological, or nuclear material. We plan to expand our support to the Department of Homeland Security (DHS) and state and local governments in these areas.
 
        To expand our defense operations research. We will seek to provide new services to the U.S. Department of Defense. We intend to expand our military planning, operations, readiness

10



 

  assessment, and distance learning services to the Navy; historically, more of our services in the defense arena have been provided to the Army and Air Force. We also intend to use our technical capabilities to develop modeling and simulation systems for all branches of the U.S. armed forces.
 
        To expand our support to the United States Navy. Through a strategy of internal growth and acquisition, we are a significant support contractor to the United States Navy and its prime contractors. Our support to the U.S. Navy includes both ship design (from conceptual studies to detail design) and programmatic support. Utilizing the depth of our engineering and programmatic talent, we anticipate expanding our support to the U.S. Navy in new ship systems such as DD(x) and LCS.
 
        To expand our information technology research. We intend to promote our specialized information technology expertise to a broader range of customers, including the civilian agencies of the federal government, primarily by applying technology research and solutions originally developed for military use.
 
        To develop new software tool and technical products. We will seek to capture some of our intellectual property in the form of stand-alone tools and products to increase revenue. We intend to develop these tools and products to better serve existing customers, and to offer them separately as stand-alone tools and products for new customers.
 
        To recruit and retain highly skilled employees. We will seek to recruit and retain engineers, scientists, and technical experts with the experience, skills and innovation necessary to design and implement solutions to the complex problems our customers face. We will also seek to attract and retain other motivated professionals who have the qualities necessary to assist us in implementing our future business strategy and meeting our future business goals. As an employee-owned company, we believe we will be able to provide enhanced financial incentives to our employees, and that those incentives will be important recruitment and retention tools.
 
        To pursue strategic acquisitions and investments. We intend to broaden our customer base and our capabilities in our core research fields by pursuing strategic acquisitions from companies with talent and technologies complementary to our current fields and to our future business goals in order to add new clients and expand our core competencies. During fiscal year 2005, Alion completed the following four acquisitions and one strategic investment:
  •  Countermeasures, Inc. — On October 28, 2004, Alion purchased substantially all of the assets of Countermeasures, Inc. Alion acquired technology and software (e.g. “Buddy System”tm), used in vulnerability assessment) for identifying, quantifying and managing physical, infrastructure, program and electronic risks. Countermeasures, Inc. had two employees and was located in Hollywood, Maryland.
 
  •  Mantech Environmental Technology, Inc. (METI) — On February 11, 2005, Alion acquired 100 percent of the outstanding stock of ManTech Environmental Technology, Inc., (now known as Alion — METI Corporation), an environmental and life sciences research and development company. METI had approximately 110 employees and was headquartered in Research Triangle Park, North Carolina.
 
  •  Carmel Applied Technologies, Inc. (CATI) — On February 25, 2005, Alion acquired 100 percent of the outstanding stock of Carmel Applied Technologies, Inc. (now known as Alion — CATI Corporation), a flight training software and simulator development company. CATI had approximately 55 employees and was headquartered in Seaside, California.
 
  •  VectorCommand, Ltd — On March 22, 2005, Alion acquired approximately 12.5 percent of the A ordinary shares in VectorCommand Ltd. VectorCommand Ltd., headquartered in the United Kingdom, designs and develops technologies used in training and operations by emergency managers and incident commanders in Australia, Europe, North America and the United Kingdom.
 
  •  John J. McMullen Associates, Inc. (JJMA) — On April 1, 2005, Alion acquired all of the outstanding stock of John J. McMullen Associates, Inc. (now known as Alion — JJMA Corporation), a provider of ship and systems design from mission analysis and feasibility trade-off studies through contract and

11



 

  detail design, production supervision, testing and logistics support for the commercial and naval markets. JJMA had approximately 600 employees and was headquartered in Iselin, New Jersey.
Market and Industry Background
Trends in government spending likely to affect our business.
      Funding for our federal government contracts is linked to trends in U.S. defense spending. We believe that domestic defense spending will grow over the next several years as a result of the following trends and developments:
Department of Defense spending. Congress appropriated $390 billion in defense spending for fiscal year 2006
Sustained Spending for National Defense.
      The ongoing efforts in Iraq and Afghanistan, in conjunction with global war on terror, reflect the federal government’s continued commitment to strengthen our country’s military, intelligence, and homeland security capabilities. Department of Defense appropriations, excluding military construction and supplemental appropriations to pay for the ongoing efforts in Iraq and Afghanistan, remained constant at approximately $390 billion in federal fiscal year 2006. An additional $50 billion is budgeted for contingency operations related to the global war on terror. In addition, the federal fiscal year 2006 Homeland Security budget proposal totaled approximately $31 billion.
Sustained interest in procurement and development.
      We believe the sustained level of spending for defense and homeland security will result in a growth of our revenues because of the correlation between the areas of projected spending and our core business areas, and the fact that through internal growth and strategic acquisitions, we have increased our technical depth and breadth which we expect will increase our market penetration in the defense and homeland security areas. The following areas of sustained levels of spending for defense and homeland security, as identified in the U.S. Budget for fiscal year 2006, have a direct correlation with our core business areas:
  •  training and training transformation;
 
  •  modeling and simulation as basis for mission planning and preparation;
 
  •  the enhancement of defenses against biological, chemical and nuclear attacks;
 
  •  the use of information technology for national security; and
 
  •  an overall sustained level of spending for homeland defense.
We are primarily a government contractor.
      For fiscal years ended September 30, 2005, 2004, and 2003, revenue that we obtained from federal government contracts was approximately 96%, 98%, and 98% of our total revenue for each respective year. The U.S. Department of Defense is our largest customer. We expect that most of our revenues will continue to result from contracts with the federal government. We perform our government contracts as a prime contractor or as a subcontractor. As a prime contractor, we have direct contact with the applicable government agency. As a subcontractor, we perform work for a prime contractor, which serves as the point of contact with the government agency overseeing the program.
      Our federal government contracts are generally multi-year contracts but are funded on an annual basis at the discretion of Congress. Congress usually appropriates funds for a given program on an October 1 fiscal year commencement basis. That means that at the outset of a major program, the contract is usually only partially funded, and normally the procuring agency commits additional monies to the contract only as Congress makes appropriations for future fiscal years. The government can modify or discontinue any contract at its discretion or due to default by the contractor. Termination or modification of a contract at the government’s discretion

12



 

may be for any of a variety of reasons, including funding constraints, modified government priorities or changes in program requirements. If one of our contracts is terminated at the government’s discretion, we typically get reimbursed for all of our services performed and costs incurred up to the point of termination, a negotiated amount of the fee on the contract, and termination-related costs we incur.
      Contract Types. As of September 30, 2005, we had over 650 active contract engagements, each employing one of three types of price structures: cost-reimbursement, time-and-material, or fixed-price.
  •  Cost-reimbursement contracts allow us to recover our direct labor and allocable indirect costs, plus a fee which may be fixed or variable depending on the contract arrangement. Allocable indirect costs refer to those costs related to operating our business that can be recovered under a contract.
 
  •  Time-and-material contracts allow us to recover our labor costs, based on negotiated, fixed hourly rates, as well as certain other costs.
 
  •  Under fixed-price contracts, customers pay us a fixed dollar amount to cover all direct and indirect costs, plus a fee. Under fixed-price contracts, we assume the risk of any cost overruns and receive the benefit of any cost savings.
      Our historical contract mix, measured as a percentage of total revenue for the fiscal years ended September 30, 2005, 2004, and 2003, is summarized in the table below.
                                                 
    For the Year Ended September 30,
     
Contract Type   2005   2004   2003
             
Cost-plus
  $ 216       58 %   $ 160       59 %   $ 133       62 %
Fixed-price
  $ 77       21 %   $ 44       16 %   $ 34       16 %
Time-and-material
  $ 76       21 %   $ 66       25 %   $ 46       22 %
                                     
Total
  $ 369       100 %   $ 270       100 %   $ 213       100 %
                                     
      Any costs we incur prior to the award of a new contract or prior to modification of an existing contract are at our own risk. This is a practice that is customary in our industry, particularly when a contractor has received verbal advice of a contract award, but has not yet received the authorizing contract documentation. In most cases the contract is later executed or modified and we receive full reimbursement for our costs. We cannot be certain, however, when we commence work prior to authorization of a contract, that the contract will be executed or that we will be reimbursed for our costs. As of September 30, 2005, we had incurred $1.9 million in pre-contract costs at our own risk.
      Government Oversight. Our contract administration and cost accounting policies and practices are subject to oversight by federal government inspectors, technical specialists and auditors. All costs associated with a federal government contract are subject to audit by the federal government. An audit may reveal that some of the costs that we may have charged against a government contract are not in fact allowable, either in whole or in part. In these circumstances, we would have to return to the federal government any monies paid to us for non-allowable costs, plus interest and possibly penalties. The federal government has audited all indirect costs for our government contracts through fiscal year 2001, and any impact of these audits is reflected in our financial statements. Government audit of fiscal year 2002 on indirect costs has been completed pending final negotiation of the rates. Audits for fiscal year 2003 and 2004 are in process. We plan to submit our fiscal year 2005 indirect cost claim to the federal government on or about March 31, 2006. The findings of an audit could result in adjustments that may change the financial data reported for fiscal year 2002 and subsequent periods.
      Backlog. Contract backlog represents an estimate, as of a specific date, of the remaining future revenues anticipated from our existing contracts. It consists of two elements:
  •  funded backlog, which refers to contracts that have been awarded to us and whose funding has been authorized by the customer, less revenue previously recognized under the same contracts, and

13



 

  •  unfunded backlog, which refers to the total estimated value of contracts awarded to us, but whose funding has not yet been authorized by the customer.
      Options not yet exercised by a customer for additional years and other extension opportunities included in contracts are included in unfunded backlog. Contract backlog does include pre-negotiated options to continue existing contracts. Changes in our contract backlog calculation result from additions for future revenues as a result of the execution of new contracts or the extension or renewal of existing contracts, reductions as a result of completing contracts, reductions due to early termination of contracts, and adjustments due to changes in estimates of the revenues to be derived from previously included contracts. Estimates of future revenues from contract backlog are by their nature inexact and the receipt and timing of these revenues are subject to various contingencies, many of which are outside of our control. The table below shows the value of our funded and unfunded contract backlog as of September 30, 2005, 2004, and 2003, respectively.
                             
    September 30,
     
    2005   2004   2003
             
    (In millions)
Backlog:
                       
   
Funded
  $ 193     $ 161     $ 107  
   
Unfunded
  $ 2,581     $ 1,793     $ 1,435  
                   
 
Total
  $ 2,774     $ 1,954     $ 1,542  
                   
      Proposal backlog represents an estimate, as of a specific date, of the proposals we have in process or submitted and for which we are waiting to hear results of the award. It consists of two elements:
  •  in-process backlog, which refers to proposals that we are preparing to submit following a request from a customer, and
 
  •  submitted backlog, which refers to proposals that we have submitted to a customer and for which we are awaiting an award decision.
      The amount of our proposal backlog that ultimately may be realized as revenues depends upon our success in the competitive proposal process, and on the receipt of tasking and associated funding under the ensuing contracts. We will not be successful in winning contract awards for all of the proposals that we submit to potential customers. Our past success rates for winning contract awards from our proposal backlog should not be viewed as an indication of our future success rates. The table below shows the value of our proposal backlog as of September 30, 2005, 2004, and 2003, respectively.
                           
    September 30,
     
    2005   2004   2003
             
    (In millions)
In-process
  $ 276     $ 56     $ 31  
Submitted
  $ 1,121     $ 425     $ 392  
                   
 
Total
  $ 1,397     $ 481     $ 423  
                   
Seasonality and Cyclicality
      We believe that our business may be subject to seasonal fluctuations. The federal government’s fiscal year end (i.e., September 30) can trigger increased purchase requests from our customers for equipment and materials. Any increased purchase requests we receive as a result of the federal government’s fiscal year end would serve to increase our fourth quarter revenues but will generally decrease profit margins for that quarter, as these activities typically are not as profitable as our normal service offerings. In addition, expenditures by our customers tend to vary in cycles that reflect overall economic conditions as well as budgeting and buying patterns. Our revenue has in the past been, and may in the future be materially affected by a decline in the defense budget or in the economy in general. Such future declines could alter our current or prospective customers’ spending priorities or budget cycles which has the affect of extending our sales cycle.

14



 

Corporate Culture
      Employees and Recruiting. We strive to create organizational culture that promotes excellence in job performance, respect for the ideas and judgment of our colleagues and recognition of the value of the unique skills and capabilities of our professional staff. We seek to attract highly qualified and ambitious staff. We strive to establish an environment in which all employees can make their best personal contribution and have the satisfaction of being part of a unique team. We believe that we have in the past successfully attracted and retained highly skilled employees because of the quality of our work environment, the professional challenges of our assignments, and the financial and career advancement opportunities we make available to our staff.
      We view our employees as our most valuable asset. Our success depends in large part on attracting and retaining talented, innovative and experienced professionals at all levels. We rely on the availability of skilled technical and administrative employees to perform our research, development and technological services for our customers. The market for certain skills in areas such as information technology and wireless communications is at times extremely competitive. This makes recruiting and retention of employees in these and other specialized areas extremely important. We recognize that our benefits package, work environment, incentive compensation, and employee-owned culture will be important in recruiting and retaining these highly skilled employees.
      As of September 30, 2005, we had 2,508 employees, of whom 2,285 were full-time, 67 half-time, and 156 part-time employees. Over 80% of our employees have federal government security clearances. Approximately 6% of our employees have Ph.D.’s, approximately 40% have master’s degrees, and approximately 70% of our employees have undergraduate degrees. We also use consultants from time to time for technical work, promotional activities, and proposal preparation. We believe that our relationship with our employees is good. None of our employees are covered by a collective bargaining agreement.
      Our facilities include laboratory facilities at locations in Chicago and Geneva, Illinois; Annapolis and Lanham, Maryland; West Conshohocken, Pennsylvania; Huntsville, Alabama; Rome, New York; and Albuquerque, New Mexico where we provide our engineers and scientists with advanced tools to research and apply new technologies to issues of national significance.
Our Customers
      During the fiscal year ended September 30, 2005, we derived approximately 96% of our revenue from contracts with various agencies or departments of the federal government. Of our total revenue, we derived 88% from contracts with the U.S. Department of Defense. For the fiscal year ended September 30, 2004, approximately 98% of our revenue was from contracts with the federal government, and 91% was derived from contracts with the U.S. Department of Defense. The balance of our revenue was from a variety of commercial customers, U.S. state and local governments and foreign governments. We derived less than 1% of our revenues from international customers in the fiscal years ended September 30, 2005, 2004, and 2003. The table below shows revenues, by customer, for fiscal years ended September 30, 2005, 2004, and 2003, respectively:
                                                   
    2005   2004   2003
             
    (In millions)
U.S. Department of Defense (DoD)
  $ 324       88 %   $ 245       91 %   $ 202       95 %
Other Federal Civilian Agencies
  $ 30       8 %   $ 19       7 %   $ 7       3 %
Commercial and International
  $ 15       4 %   $ 6       2 %   $ 4       2 %
                                     
 
Total
  $ 369       100 %   $ 270       100 %   $ 213       100 %
                                     
Competition
      Our industry is very competitive. In most significant federal government procurements, we compete with much larger, well-established companies, as well as a number of smaller companies. They include Booz-Allen Hamilton, Science Applications International Corporation, Lockheed Martin Corporation, General Dynamics

15



 

Corporation, Northrop Grumman Corporation, Anteon International Corporation, CACI International, Inc., and SRA International, Inc. In the commercial arena, we compete most often with smaller, but highly specialized technical companies, as well as a number of larger companies. They include CRIL Technology, Tadiran Communications Ltd., Spectrocan, Orthstar Incorporated, and Elite Electronic Engineering.
      In most cases, government contracts for which we compete are awarded based on a competitive process. We believe that in general, the key factors considered in awarding contracts are:
  •  technical capabilities and approach;
 
  •  quality of the personnel, including management capabilities;
 
  •  successful past contract performance; and
 
  •  price.
      It is our experience that in awarding contracts to perform complex technological programs, the two most important considerations for a customer are technical capabilities and price.
S Corporation Status
      The Internal Revenue Code provides that a corporation that meets certain requirements may elect to be taxed as an S corporation for federal income tax purposes. These requirements provide that an S corporation may only have:
  •  one class of stock;
 
  •  up to 100 shareholders; and
 
  •  certain types of shareholders, such as individuals, trusts and some tax-exempt organizations, including ESOPs.
      Since the ESOP (which counts as one shareholder for S corporation purposes) is our only stockholder, and we only have one class of stock, we currently meet the requirements to be taxed as an S corporation.
      Alion filed an election with the IRS to be treated as an S corporation under the Internal Revenue Code. The election was accepted and became effective on October 11, 2001. An S corporation, unlike a C corporation, generally does not pay federal corporate income tax on its net income. Rather, such income is allocated to the S corporation’s shareholders. Shareholders must take into account their allocable share of income when filing their income tax returns. An ESOP is a tax-exempt entity and does not pay tax on its allocable share of S corporation income. Because neither we nor the ESOP should be required to pay federal corporate income tax, we expect to have substantially more cash available to repay our debt and invest in our operations than we would if Alion were to be taxed as a C corporation.
      Many states follow the federal tax treatment of S corporations. In some states, Alion is subject to different tax treatment for state income tax purposes than for federal income tax purposes. The Company and its subsidiaries operate in several states where we are subject to state income taxes. The Company is also subject to other taxes such as franchise and business taxes in certain jurisdictions.
      The Company’s wholly-owned operating subsidiaries are qualifying subchapter S subsidiaries. For federal income tax purposes, these subsidiaries are consolidated into Alion’s federal income tax returns.
      Under a provision of the Internal Revenue Code, significant penalties can be imposed on a subchapter S employer which maintains an ESOP (i) if the amount of ESOP stock allocated to certain “disqualified persons” exceeds certain statutory limits or (ii) if disqualified persons together own 50% or more of the company’s stock. For this purpose, a “disqualified person” is generally someone who owns 10% or more of the subchapter S employer’s stock (including deemed ownership through stock options, warrants, stock appreciation rights, or SARs, phantom stock, and similar rights). The KSOP, the SAR plan and the phantom stock plan include provisions designed to prohibit allocations in violation of these Internal Revenue Code limits. We expect never to exceed the 50% limit. Apart from the warrants representing approximately 24% of our

16



 

common stock that were issued to IITRI at the closing of the Transaction (and subsequently transferred to the Illinois Institute of Technology), no one person is expected to hold ownership interests representing more than 5% of Alion.
Business Development and Promotional Activities
      We primarily promote our contract research services by meeting face-to-face with customers or potential customers, by obtaining repeat work from satisfied customers, and by responding to requests for proposals, referred to as RFPs, and international tenders that our customers and prospective customers publish or direct to our attention from time to time. We use our knowledge of and experience with federal government procurement procedures, and relationships with government personnel, to help anticipate the issuance of RFPs or tenders and to maximize our ability to respond effectively and in a timely manner to these requests. We use our resources to respond to RFPs and tenders that we believe we have a good opportunity to win and that represent either our core research fields or logical extensions to those fields for new research. In responding to an RFP or tender, we draw on our expertise in our various business areas to reflect the technical skills we could bring to the performance of that contract.
      Our technical staff is an integral part of our promotional efforts. They develop relationships with our customers over the course of contracts that can lead to additional work. They also become aware of new research opportunities in the course of performing tasks on current contracts.
      We hold weekly company-wide business development meetings to review specific proposal opportunities and to agree on our strategy in pursuing these opportunities. At times we also use independent consultants for promoting business, developing proposal strategies and preparing proposals.
      For internal research and development, we spent approximately $0.5 million, $0.4 million and $0.2 million in fiscal years 2005, 2004 and 2003, respectively. This is in addition to the substantial research and development activities that we have undertaken on projects funded by our customers. We believe that actively fostering an environment of innovation is critical to our future success in that it allows us to be proactive in addressing issues of national concern in public health, safety, and national defense.
Resources
      For most of our work, we use computer and laboratory equipment and other supplies that are readily available from multiple vendors. As such, disruption in availability of these types of resources from any particular vendor should not have a material impact on our ability to perform our contracts. In some of the specialized work we perform in a laboratory, we depend on the supply of special materials and equipment whose unavailability could have adverse effects on the experimental tasks performed at the laboratory. However, we believe that the overall impact of these types of delays or disruptions on our total operations and financial condition is likely to be minimal.
Patents and Proprietary Information
      Our patent portfolio consists of fourteen issued and active U.S. patents, eleven pending U.S. patents, two active foreign patents and eight pending foreign patents. We routinely enter into intellectual property assignment agreements with our employees to protect our rights to any patents or technologies developed during their employment with us. However, our research and development and engineering services do not depend on patent protection.
      Our federal government contracts often provide the federal government with certain rights to our inventions and copyright works, including use of the inventions by government agencies, and a right to exploit these inventions or have them exploited by third-party contractors, including our competitors. Similarly, our federal government contracts often license to us patents and copyright works owned by others.

17



 

Foreign Operations
      In fiscal years 2005, 2004 and 2003, nearly 100% of the Company’s revenue was derived from services provided under contracts with U.S.-based customers. The Company treats revenues resulting from U.S. government customers as sales within the United States regardless of where the services are performed.
Company Information Available on the Internet
      The Company’s internet address is www.alionscience.com. The Company makes available free of charge through its internet site, via a hyperlink to the U.S. Securities and Exchange Commission EDGAR filings web site, its annual report on Form 10-K; quarterly reports on Form 10-Q; current reports on Form 8-K; and any amendments to those reports filed or furnished pursuant to the Securities Exchange Act of 1934, or the “Exchange Act,” as soon as reasonably practicable after such material is electronically filed with, or furnished to, the U.S. Securities and Exchange Commission.
Environmental Matters
      Our operations are subject to federal, state and local laws and regulations relating to, among other things:
  •  emissions into the air,
 
  •  discharges into the environment,
 
  •  handling and disposal of regulated substances, and
 
  •  contamination by regulated substances.
      Operating and maintenance costs associated with environmental compliance and prevention of contamination at our facilities are a normal, recurring part of our operations, are not material relative to our total operating costs or cash flows, and are generally allowable as contract costs under our contracts with the federal government. These costs have not been material in the past and, based on information presently available to us and on federal government environmental policies relating to allowable costs in effect at this time, all of which are subject to change, we do not expect these to have a materially adverse effect on us. Based on historical experience, we expect that a significant percentage of the total environmental compliance costs associated with our facilities will continue to be allowable costs.
      Under existing U.S. environmental laws, potentially responsible parties are jointly and severally liable and, therefore, we would be potentially liable to the government or third parties for the full cost of remediating contamination at our sites or at third-party sites in the event contamination is identified and remediation is required. In the unlikely event that we were required to fully fund the remediation of a site, the statutory framework would allow us to pursue rights of contribution from other potentially responsible parties.
Risk Factors
Risks Related to Our Business
An economic downturn could harm our business.
      Our business, financial condition and results of operations may be affected by various economic factors. Unfavorable economic conditions may make it more difficult for us to maintain and continue our revenue growth. In an economic recession, or under other adverse economic conditions, customers and vendors may be more likely to be unable to meet contractual terms or their payment obligations. A decline in economic conditions may have a material adverse effect on our business.
We face intense competition from many competitors that have greater resources than we do, which could result in price reductions, reduced profitability, and loss of market share.
      We operate in highly competitive markets and generally encounter intense competition to win contracts. If we are unable to successfully compete for new business, our revenue growth and operating margins may

18



 

decline. Many of our competitors are larger and have greater financial, technical, marketing, and public relations resources, larger client bases, and greater brand or name recognition than we do. Larger competitors include federal systems integrators such as Booz Allen Hamilton, Science Applications International Corporation, CACI International, Inc., SRA International, Inc., Anteon International Corporation and divisions of large defense contractors such as Lockheed Martin Corporation, General Dynamics Corporation, and Northrop Grumman Corporation. Our larger competitors may be able to compete more effectively for very large-scale government contracts. Our larger competitors also may be able to provide clients with different or greater capabilities or benefits than we can provide in areas such as technical qualifications, past performance on large-scale contracts, geographic presence, price, and the availability of key professional personnel. Our competitors also have established or may establish relationships among themselves or with third parties, including through mergers and acquisitions, to increase their ability to address client needs. Accordingly, it is possible that new competitors or alliances among competitors may emerge.
We incurred a significant amount of debt in order to complete the IITRI acquisition and through subsequent debt refinancing, which may limit our operational flexibility and negatively affect the value of your investment in the ESOP component.
      In order to complete the acquisition of IITRI’s assets and to partially fund our growth through the completion of subsequent acquisitions, we have incurred a substantial amount of indebtedness, including approximately $31.2 million in senior debt, approximately $20.3 million in debt in the form of a mezzanine note issued to IIT and approximately $39.9 million in debt in the form of a subordinate note issued to IIT. The mezzanine note has been redeemed, but the subordinate note remains outstanding. On August 2, 2004, we refinanced the Company’s senior debt and subsequently on April 1, 2005, entered into an incremental term loan and amended our credit facility, which made available approximately $323 million of debt financing to fund acquisitions, refinance existing debt, and provide working capital. As of September 30, 2005, our senior consolidated debt was approximately $143 million. Although we have managed significant amounts of debt since December 2002, we do not have extensive experience in functioning as a highly leveraged company for sustained periods of time.
      Our indebtedness could:
  •  limit our ability to obtain additional financing for working capital, capital expenditures, acquisitions and other general corporate activities;
 
  •  limit our flexibility in planning for, or reacting to, changes in our business and the industry in which we operate;
 
  •  make it more difficult for us to satisfy our obligations to our creditors, including our repurchase obligations to ESOP participants, and, if we fail to comply with the requirements of the indebtedness, may require refinancing on terms unfavorable to us, or if refinancing is not possible, our creditors could accelerate the maturity of our indebtedness, which could cause us to default under other indebtedness, dispose of assets or declare bankruptcy;
 
  •  limit our ability to successfully withstand a downturn in our business or the economy generally; and
 
  •  place us at a competitive disadvantage against other less leveraged competitors.
Our ability to service our debt and meet other future obligations is dependent on our future operating results and we cannot be sure that we will be able to meet these obligations as they come due.
      Our ability to meet our payment obligations and to comply with the financial covenants contained in the agreements relating to our indebtedness is subject to a variety of factors, including changes in:
  •  funding of our contract backlog;
 
  •  the time within which our customers pay our accounts receivable;
 
  •  new contract awards and our performance under these contracts;

19



 

  •  continued increase in revenues on an annual basis;
 
  •  interest rate levels;
 
  •  our status as an S corporation for federal income tax purposes; and
 
  •  general economic conditions.
      These factors will also affect our ability in the future to meet our obligations related to the put rights associated with the warrants and to our repurchase obligations under the KSOP. We also are required to pay the principal amounts outstanding under our revolving credit facility and term loan in 2009 and are required to pay fifty percent of the principal amount outstanding, including the amount due under the payment-in-kind notes, under the Seller Note in each of 2009 and 2010.
      We may not generate sufficient cash flows to comply with our financial covenants and to meet our payment obligations when they become due. If we are unable to comply with our financial covenants, or if we are unable to generate sufficient cash flow or otherwise obtain funds necessary to make the required payments on our indebtedness, then we may be required to refinance our indebtedness. We cannot be certain that our indebtedness could be refinanced on terms that are favorable to us, if at all. In the absence of a refinancing, our lenders would be able to accelerate the maturity of our indebtedness, which could cause us to default under our other indebtedness, dispose of assets or declare bankruptcy.
Risks Related to Our Industry
We are dependent on government contracts for substantially all of our revenues.
      Approximately 96% of our revenues for fiscal year 2005 were derived from contracts with the federal government. Contracts with the U.S. Department of Defense accounted for approximately 88%, and contracts with other government agencies accounted for approximately 8%, of our total revenues in fiscal year 2005. For fiscal year 2004, contracts with the U.S. Department of Defense accounted for approximately 91% of our revenues, and contracts with other government agencies accounted for approximately 7% of our revenues. We expect that government contracts are likely to continue to account for a significant portion of our revenues in the future. A significant decline in government expenditures, or a shift of expenditures away from government programs that we support, could cause a decline in our revenues.
The failure by Congress to approve budgets timely for the federal agencies we support could delay or reduce spending and cause us to lose revenue.
      On an annual basis, Congress must approve budgets that govern spending by each of the federal agencies we support. When Congress is unable to agree on budget priorities, and thus is unable to pass the annual budget on a timely basis, then Congress typically enacts a continuing resolution. A continuing resolution allows government agencies to operate at spending levels approved in the previous budget cycle. When government agencies must operate on the basis of a continuing resolution it may delay funding we expect to receive from clients on work we are already performing and will likely result in any new initiatives being delayed, and in some cases being cancelled, both of which may adversely affect our business.
Historically, a few contracts have provided us with most of our revenues, and if we do not retain or replace these contracts our operations will suffer.
      The following five large federal government contracts accounted for approximately 48% of our revenues for the fiscal year ended September 30, 2005:
  1.  Modeling and Simulation Information Analysis Center for the U.S. Department of Defense — Defense Information Systems Agency (19%);
 
  2.  Joint Spectrum Center Engineering Support Services for the U.S. Department of Defense Joint Spectrum Center (12%);

20



 

  3.  Information Technology Services for General Services Administration — U.S. Department of Defense (7%);
 
  4.  Night Vision HighTech Omnibus Contract for the U.S. Department of Army (5%); and
 
  5.  Engineering, Financial and Program Management Services to the U.S. Department of the Navy’s Virtual SYSCOM (VS) program (5%).
      These contracts, some of which are performed for multiple customers, are likely to continue to account for a significant percentage of our revenues in the future. Termination of these contracts or our inability to renew or replace them when they expire could cause our revenues to decrease. During the year ended September 30, 2005, the support services contract to the Joint Spectrum Center underwent a full and open competition for the follow-on support contract that was to commence beginning October 2005. The Company filed a formal bid protest before the Government Accountability Office (GAO) with respect to the JSC contract award. The Company’s principal argument was that the successful bidder had an organizational conflict of interest with respect to its proposed performance of the contract. In its decision dated January 9, 2006, the GAO sustained the protest and recommended that the contracting agency take certain corrective action in order to address the awardee’s organizational conflict of interest. The Company is awaiting further action from the contracting agency. In the meantime, the Company expects to continue to generate revenue from its existing JSC contract until the issues involved in its protest are fully resolved.
Government contracts contain termination provisions that are unfavorable to us.
      Generally, government agencies can terminate contracts with their suppliers at any time without cause. If a government agency does terminate one of its contracts with us without cause, we will likely be entitled to receive compensation for the services provided or costs incurred up to the date of termination as well as a negotiated amount of the fee on the contract and termination-related costs we incur. Further, if a government contract is terminated because we defaulted under the terms of the contract, we will likely be entitled to receive compensation for the services provided and accepted up to the date of termination plus a percentage of the fee relating to the provided and accepted services. However, if a default were to occur, we may be liable for excess costs the government incurs in procuring the undelivered portion of the contract from another source. Termination of any of our large government contracts may negatively impact our revenues.
Actual or perceived conflicts of interest may prevent us from being able to bid on or perform contracts.
      Government agencies have conflict of interest policies that may prevent us from bidding on or performing certain contracts. Typically, a conflict of interest policy prohibits a contractor that assisted the government agency in the design of a program and/or the associated procurement process from competing to perform the resulting contract. When dealing with government agencies that have conflict of interest policies, we must decide, at times with insufficient information, whether to participate in the design process and lose the chance of performing the contract or to turn down the opportunity to assist in the design process for the chance of performing on the contract. We have, on occasion, declined to bid on particular projects because of actual or perceived conflicts of interest, and we are likely to continue encountering such conflicts of interest in the future, particularly if we acquire other government contractors. Future conflicts of interest could cause us to be unable to secure key research and technology contracts with government customers.
We may not receive the full amount of our backlog, which could lower future revenues.
      The maximum contract value specified under a government contract is not necessarily indicative of revenues that we will realize under that contract. Congress normally appropriates funds for a given program on a fiscal year basis, even though actual contract performance may take many years. As a result, contracts ordinarily are only partially funded at the time of award, and normally the procuring agency commits additional monies to the contract only as Congress makes appropriations in subsequent fiscal years. The portion of a government contract which has not yet been performed is referred to as backlog. The original value of a government contract is used in estimating the amount of our backlog. We define backlog to include both funded and unfunded orders for services under existing signed contracts, assuming the exercise of all

21



 

options relating to those contracts that have been priced. We define funded backlog to be the portion of backlog for which funding currently is appropriated and obligated to us under a contract or other authorization for payment which an authorized purchasing authority signs, less the amount of revenue we have previously recognized under the contract. We define unfunded backlog as the total estimated value of signed contracts, less funding to date. Unfunded backlog includes all contract options that have been priced but not yet funded. Estimates of future revenues attributed to backlog are not necessarily precise and the receipt and timing of any of these revenues are subject to various contingencies such as changed federal government spending priorities and government decisions not to exercise options on existing contracts. Many of these contingencies are beyond our control. The backlog on a given contract may not ultimately be funded or may only be partially funded, which may cause our revenues to be lower than anticipated.
Because government contracts are subject to government audits, contract payments are subject to adjustment and repayment which may result in revenues attributed to a contract being lower than expected.
      Government contract payments received that are in excess of allowable costs are subject to adjustment and repayment after government audit of the contract payments. Government audits have been completed on indirect costs related to our federal government contracts through fiscal year 2001. Government audit of fiscal year 2002 on indirect costs has been completed pending final negotiation of the rates. Audits for fiscal year 2003 and 2004 are in process. We have included estimated reserves in our financial statements for excess billings and contract losses, which we believe are adequate based on our interpretation of contracting regulations and past experience. These reserves, however, may not be adequate. If our reserves are not adequate, revenues attributed to our contracts may be lower than expected.
Our subcontractors’ failure to perform contractual obligations could damage our reputation as a prime contractor and thereby our ability to obtain future business.
      As a prime contractor, we often rely significantly upon other companies as subcontractors to perform work we are obligated to deliver to our customers. A failure by one or more of our subcontractors to satisfactorily perform the agreed-upon services on a timely basis may cause us to be unable to perform our duties as a prime contractor. We have limited involvement in the work our subcontractors perform, and as a result, we may have exposure to problems our subcontractors cause. Performance deficiencies on the part of our subcontractors could result in a government customer terminating our contract for default. A default termination could expose us to liability for the customer’s costs of reprocurement, damage our reputation, and hurt our ability to compete for future contracts.
If we fail to recover pre-contract costs, it may result in reduced fees or in losses.
      Any costs we incur before the execution of a contract or contract renewal are incurred at our risk, and it is possible that the customer will not reimburse us for these pre-contract costs. At September 30, 2005, we had pre-contract costs of $1.9 million. While such costs were associated with specific anticipated contracts and we believe their recoverability from such contracts is probable, we cannot be certain that contracts or contract renewals will be executed or that we will recover the related pre-contract costs.
If we do not accurately estimate the expenses, time and resources necessary to satisfy our contractual obligations, our profit will be lower than expected.
      Cost-reimbursement contracts provided approximately 58%, 59% and 62% of our revenues for the fiscal years ended September 30, 2005, 2004, 2003, respectively. Fixed-price contracts provided approximately 21%, 16%, and 16% of our revenues for the fiscal years ended September 30, 2005, 2004, and 2003, respectively.
      In a cost-reimbursement contract, we are allowed to recover our approved costs plus a negotiated fee. The total price on a cost-reimbursement contract is based primarily on allowable costs incurred, but generally is subject to a maximum contract funding limit. Federal government regulations require us to notify our customers of any cost overruns or underruns on a cost-reimbursement contract. If we incur costs in excess of

22



 

the funding limitation specified in the contract, we may not be able to recover those cost overruns. As a result, on a cost-reimbursement contract we may not earn the full amount of the anticipated fee.
      In a fixed-price contract, we estimate the costs of the project and agree to deliver the project for a definite, predetermined price regardless of our actual costs to be incurred over the life of the project. We must fully absorb cost overruns. Our failure to anticipate technical problems, estimate costs accurately or control costs during performance of a fixed-price contract may reduce the fee margin of a fixed-price contract or cause a loss. Although we have not historically experienced significant contract losses on fixed-price contracts, the provisions in our financial statements for estimated losses on our fixed-price contracts may not be adequate to cover all actual future losses.
Our operating margins and operating results may suffer if cost-reimbursement contracts increase in proportion to our total contract mix.
      In general, cost-reimbursement contracts are the least profitable of our contract types. Our government customers typically determine what type of contract will be awarded to us. Cost-reimbursement contracts accounted for 58%, 59%, and 62% of our revenue for the fiscal years ended September 30, 2005, 2004, and 2003, respectively. To the extent that we enter into more or larger cost-reimbursement contracts in proportion to our total contract mix in the future, our operating margins and operating results may suffer.
If the volume of services we provide under fixed-price contracts decreases in total or as a proportion of our total business, or if profit rates on these contracts decline, our operating margins and operating results may suffer.
      We have historically earned higher relative profits on our fixed-price contracts. Fixed-price contracts accounted for 21%, 16%, and 16% of our revenue for the fiscal years ended September 30, 2005, 2004, and 2003, respectively. If the volume of services we deliver under fixed-price contracts decreases, or shifts to other types of contracts, our operating margins and operating results may suffer. Furthermore, we cannot assure you that we will be able to maintain our historic levels of profitability on fixed-price contracts in general.
As a federal government contractor, we must comply with complex procurement laws and regulations and our failure to do so could have a negative impact upon our business.
      We must comply with and are affected by laws and regulations relating to the formation, administration and performance of federal government contracts, which may impose added costs on our business. If a government review or investigation uncovers improper or illegal activities, we may be subject to civil and criminal penalties and administrative sanctions, including termination of contracts, forfeiture of fees, suspension of payments, fines and suspension or debarment from doing business with federal government agencies, which may impair our ability to conduct our business. To the knowledge of management, we are not at present the subject of any investigation that may adversely affect our ability to secure future government work.
Our failure to obtain and maintain necessary security clearances may limit our ability to carry out confidential work for government customers, which could cause our revenues to decline.
      As of September 30, 2005, we have approximately one hundred thirty five U.S. Department of Defense (DoD) classified contracts that require the Company to maintain facility security clearances at our fifteen sites. Approximately 2,000 of our employees hold security clearances to enable performance on these classified contracts. Each cleared facility has a Facility Security Officer and Key Management Personnel whom the DoD-Defense Security Service requires to be cleared to the level of the facility security clearance. In addition to these clearances, individual employees are selected to be cleared, based on the task requirement of the specific classified contract, for their technical, administrative or management expertise. Once the security clearance is granted, the employee is allowed access to the classified information on the contract based on the clearance and need to know for the information within the contract. Protection of classified information with regard to a classified contract is paramount. Loss of a facility clearance or an employee’s inability to obtain

23



 

and/or maintain a security clearance could result in a government customer terminating an existing contract or choosing not to renew a contract upon its expiration. If we cannot maintain or obtain the required security clearances for our facilities or our employees, or if these clearances are not obtained in a timely manner, we may be unable to perform on a contract. Lack of required clearances could also impede our ability to bid on or win new contracts, which may result in the termination of current research activities. Termination of current research activities may damage our reputation and our revenues would likely decline.
We derive significant revenues from contracts awarded through a competitive bidding process which is an inherently unpredictable process.
      We obtain most of our government contracts through a competitive bidding process that subjects us to risks associated with:
  •  the frequent need to bid on programs in advance of the completion of their design, which may result in unforeseen technological difficulties and/or cost overruns;
 
  •  the substantial time and effort, including design, development and promotional activities, required to prepare bids and proposals for contracts that may not be awarded to us; and
 
  •  the design complexity and rapid rate of technological advancement of most of our research offerings.
      Upon expiration, government contracts may be subject to a competitive rebidding process. We may not be successful in winning contract awards or renewals in the future. Our failure to win contract awards, or to renew or replace existing contracts when they expire, would negatively impact our future business and the value of your investment. During the year ended September 30, 2005, the support services contract to the Joint Spectrum Center underwent a full and open competition for the follow-on support contract that was to commence beginning October 2005. In August 2005, we were notified that we were not the successful bidder for these services. The loss of this contract had no material effect on performance for the year ended September 30, 2005. Further discussion of the potential future impact of this contract loss to Alion is provided in the Management Discussion and Analysis section (Item 7) of this annual report.
Intense competition in the technology and defense industries could limit our ability to win and retain government contracts.
      We expect to encounter significant competition for government contracts from other companies, especially in our information technology and defense operations units. Some of our competitors will have substantially greater financial, technical and marketing resources than we do.
      Our ability to compete for these contracts will depend on:
  •  the effectiveness of our research and development programs;
 
  •  our ability to offer better performance than our competitors at a lower or comparable cost;
 
  •  the readiness of our facilities, equipment and personnel to perform the programs for which we compete; and
 
  •  our ability to attract and retain key personnel.
      If we do not continue to compete effectively and win contracts, our future business will be materially compromised.
Risks Related To Our Operations
We depend on key management and personnel and may not be able to retain those employees due to competition for their services.
      We believe that our future success will be due, in part, to the continued services of our senior management team. The loss of any one of these individuals could cause our operations to suffer. On

24



 

December 20, 2002, we entered into new employment agreements with most of these individuals for five-year terms. We do not, however, maintain key man life insurance policies on any members of management.
      In addition, competition for certain employees, such as scientists and engineers, is intense. Our ability to implement our business plan is dependent on our ability to hire and retain these technically skilled professionals. Our failure to recruit and retain qualified scientists and engineers may cause us to be unable to obtain and perform future contracts.
Our business could suffer if we fail to attract, train and retain skilled employees.
      The availability of highly trained and skilled professional, administrative and technical personnel is critical to our future growth and profitability. Competition for scientists, engineers, technicians, management and professional personnel is intense and competitors aggressively recruit key employees. Due to our growth and this competition for experienced personnel, particularly in highly specialized areas, it has become more difficult to meet all of our needs for these employees in a timely manner. We intend to continue to devote significant resources to recruit, train and retain qualified employees; however, we cannot be certain that we will be able to attract and retain such employees on acceptable terms. Any failure to do so could have a material adverse effect on our operations. If we are unable to recruit and retain a sufficient number of these employees, our ability to maintain and grow our business could be negatively impacted. In addition, some of our contracts contain provisions requiring us to commit to staff a program with certain personnel the customer considers key to our successful performance under the contract. In the event we are unable to provide these key personnel or acceptable substitutions, the customer may terminate the contract, and we may not be able to recover our costs.
Our employees may engage in misconduct or other improper activities, which could harm our business.
      We are exposed to the risk that employee fraud or other misconduct could occur. Misconduct by employees could include intentional failures to comply with federal government procurement regulations, engaging in unauthorized activities, seeking reimbursement for improper expenses or falsifying time records. Employee misconduct could also involve the improper use of our customers’ sensitive or classified information, which could result in regulatory sanctions against us and serious harm to our reputation. It is not always possible to deter employee misconduct, and the precautions we take to prevent and detect this activity may not be effective in controlling unknown or unmanaged risks or losses, which could harm our business.
If we are unable to manage our growth, our business could be adversely affected.
      Sustaining our company’s growth has placed significant demands on management, as well as on our administrative, operational and financial resources. To continue to manage our growth, we must continue to improve our operational, financial and management information systems and expand, motivate and manage our workforce. If we are unable to successfully manage our growth without compromising our quality of service and our profit margins, or if new systems we implement to assist in managing our growth do not produce the expected benefits, our business, prospects, financial condition or operating results could be adversely affected.
We may undertake acquisitions that could increase our costs or liabilities or be disruptive.
      One of our key operating strategies is to selectively pursue acquisitions. We have made a number of acquisitions in the past, are currently pursuing a number of potential acquisition opportunities, and will consider other acquisitions in the future. We may not be able to consummate the acquisitions we are currently pursuing on favorable terms, or at all. We may not be able to locate other suitable acquisition candidates at prices we consider appropriate or to finance acquisitions on terms that are satisfactory to us. If we do identify an appropriate acquisition candidate, we may not be able to successfully negotiate the terms of an acquisition, finance the acquisition or, if the acquisition occurs, integrate the acquired business into our existing business. Negotiations of potential acquisitions and the integration of acquired business operations could disrupt our business by diverting management away from day-to-day operations. Acquisitions of businesses or other

25



 

material operations may require additional debt or equity financing, resulting in additional leverage or dilution of ownership. The difficulties of integration may be increased by the necessity of coordinating geographically dispersed organizations, integrating personnel with disparate business backgrounds and combining different corporate cultures. We also may not realize cost efficiencies or synergies that we anticipated when selecting our acquisition candidates. In addition, we may need to record write-downs from future impairments of intangible assets, which could reduce our future reported earnings. At times, acquisition candidates may have liabilities or adverse operating issues that we fail to discover through due diligence prior to the acquisition, but which we generally assume as part of an acquisition. Such liabilities could have a material adverse effect on our financial condition.
Covenants in our credit facility may restrict our financial and operating flexibility.
      Our credit facility contains covenants that limit or restrict, among other things, our ability to borrow money outside of the amounts committed under the credit facility, make other restricted payments, sell or otherwise dispose of assets other than in the ordinary course of business, or make acquisitions, in each case without the prior written consent of our lenders. Our credit facility also requires us to maintain specified financial covenants relating to the interest coverage and maximum debt coverage. Our ability to satisfy these financial ratios can be affected by events beyond our control, and we cannot assure ourselves that we will meet these ratios. Default under our credit facility could allow the lenders to declare all amounts outstanding to be immediately due and payable. We have pledged substantially all of our assets, to secure the debt under our credit facility. If the lenders declare amounts outstanding under the credit facility to be due, the lenders could proceed against those assets. Any event of default, therefore, could have a material adverse effect on our business if the creditors determine to exercise their rights. We also may incur future debt obligations that might subject us to restrictive covenants that could affect our financial and operational flexibility, or subject the company to other events of default. Any such restrictive covenants in any future debt obligations the company incurs could limit our ability to fund our business operations or expand our business.
      From time to time we may require consents or waivers from our lenders to permit actions that are prohibited by our credit facility. If, in the future, our lenders refuse to provide waivers of our credit facility’s restrictive covenants and/or financial ratios, then we may be in default under the terms of the credit facility, and we may be prohibited from undertaking actions that are necessary or desirable to maintain and expand its business.
Environmental laws and regulations and our use of hazardous materials may subject us to significant liabilities.
      Our operations are subject to federal, state and local environmental laws and regulations, as well as environmental laws and regulations in the various countries in which we operate. In addition, our operations are subject to environmental laws and regulations relating to the discharge, storage, treatment, handling, disposal and remediation of regulated substances and waste products, such as radioactive materials and explosives. The following may require us to incur substantial costs in the future:
  •  modifications to current laws and regulations;
 
  •  new laws and regulations;
 
  •  new guidance or new interpretation of existing laws and regulations; or
 
  •  the discovery of previously unknown contamination.
Item 2. Properties
      Our principal operating facilities are located in McLean, Virginia and Chicago, Illinois, and consist of approximately 21,573 square feet and 49,231 square feet of office space, respectively, held under leases. We also lease an additional 62 office facilities totaling approximately 728,639 square feet. Of these, our largest offices are located in Fairfax, Alexandria, Hampton, Newport News, and King George County, Virginia; Washington, DC; West Conshohocken, Pennsylvania; Huntsville, Alabama; Rockville, Annapolis and

26



 

Lanham, Maryland; Orlando, Florida; Rome, New York; Iselin, New Jersey; Pascagoula, Mississippi; Fairborn, Ohio; Mt. Clements and Ishpeming, Michigan; San Diego, California; Albuquerque and Los Alamos, New Mexico; Naperville and Warrenville, Illinois.
      We lease twelve laboratory facilities totaling 119,707 square feet, for research functions in connection with the performance of our contracts. Of these, our largest laboratories are located in Chicago and Geneva, Illinois; Annapolis and Lanham, Maryland;, West Conshohocken, Pennsylvania; Huntsville, Alabama; Rome, New York; and Albuquerque, New Mexico., The lease terms are annual, varying from one to eight years, and are generally at market rates.
      Aggregate average monthly base rental expense for fiscal years 2005 and 2004 was $1,091,594 and $953,120, respectively.
      We periodically enter into other lease agreements that are, in most cases, directly chargeable to current contracts. These obligations are usually either covered by currently available contract funds or cancelable upon termination of the related contracts.
      All leased space is considered to be adequate for the operation of our business, and no difficulties are foreseen in meeting any future space requirements.
Item 3. Legal Proceedings
AB Tech settlement
      On September 12, 2002, the former owners of AB Technologies, Inc. (“AB Tech”) filed a lawsuit (“AB Tech Lawsuit”) against IITRI in Circuit Court for Fairfax County, Virginia. The complaint alleged breach of the AB Tech asset purchase agreement (“Asset Purchase Agreement”), and claims damages of $8.2 million. The former owners of AB Tech (“Former Owners”) asked the court to order an accounting of their earn out.
      On September 16, 2002, IITRI filed a lawsuit against the Former Owners which asked the court to compel the Former Owners to submit disputed issues to an independent accounting firm in accordance with the requirements of the Asset Purchase Agreement, make a declaratory judgment concluding that IITRI is entitled to an approximately $1.1 million downward adjustment of the purchase price paid under the Asset Purchase Agreement, and conclude that IITRI properly computed the earnout in accordance with the earnout formula in the Asset Purchase Agreement.
      Upon the closing of the Transaction, Alion assumed responsibility for and acquired all claims under these lawsuits.
      On July 22, 2005, the Company settled the dispute with the Former Owners. Under the terms of the settlement, the Company paid $3.4 million to the Former Owners, and has a remaining obligation to pay $0.7 million to the Former Owners within fifteen days following the date that the Company’s fiscal 2005 year-end audited financial statement report by the Company’s auditor is issued and made publicly available by the Company.
     Joseph Hudert vs. Alion; Frank Stotmeister vs. Alion
      On December 23, 2004, the estate of Joseph Hudert filed an action against Grunley-Walsh Joint Venture, L.L.C. (Grunley-Walsh) and the Company in the District of Columbia Superior Court for damages in excess of $80 million. On January 6, 2005, the estate of Frank Stotmeister filed an action against the Company in the same court on six counts, some of which are duplicate causes of action, claiming $30 million for each count. Several other potential defendants may be added to these actions in the future.
      The suits arose in connection with a steam pipe explosion that occurred on or about April 23, 2004 on a construction site at 17th Street, N.W. in Washington, D.C. Frank Stotmeister and Joseph Hudert died, apparently as a result of the explosion. The deceased were employees of the prime contractor on the site, Grunley-Walsh, and the subcontractor, Cherry Hill Construction Company Inc., respectively. Grunley-Walsh

27



 

had a contract with the U.S. General Services Administration (GSA) for construction on 17th Street N.W. near the Old Executive Office Building in Washington, D.C. Sometime after the award of Grunley-Walsh’s construction contract, Alion was awarded a separate contract by GSA. Alion’s responsibilities on this contract were non-supervisory monitoring of Grunley-Walsh’s activities and reporting to GSA of any deviations from contract requirements.
      The Company intends to defend these lawsuits vigorously, based on the facts currently known to the Company. The Company’s management does not believe that these lawsuits will have a materially adverse effect upon the Company, its operations or its financial condition.
      Alion’s primary provider of general liability insurance, St. Paul Travelers, has assumed defense of these lawsuits subject to a reservation of rights to deny coverage. American International Group, the Company’s excess insurance carrier, has also been notified regarding these lawsuits.
      Other than the foregoing actions, the Company is not involved in any legal proceeding other than routine legal proceedings occurring in the ordinary course of business. The Company believes that these routine legal proceedings, in the aggregate, are not material to its financial condition and results of operations.
      As a government contractor, the Company may be subject from time to time to federal government inquiries relating to its operations and audits by the Defense Contract Audit Agency. Contractors found to have violated the False Claims Act, or which are indicted or convicted of violations of other federal laws, may be suspended or debarred from federal government contracting for some period. Such an event could also result in fines or penalties. Given the Company’s dependence on federal government contracts, suspension or debarment could have a material adverse effect on it. The Company is not aware of any such pending federal government claims or investigations.
Item 4. Submission of Matters to a Vote of Security Holders
      No matters were submitted to the vote of security holders for the fourth quarter of the fiscal year ended September 30, 2005.
PART II
Item 5. Market for Registrant’s Common Equity, Related Stockholders Matters and Issuer Purchases of Equity Security
      There is no established public trading market for Alion’s common stock. As of September 30, 2005, the ESOP was the only holder of our common stock.
      There have been no sales of securities other than sales of securities already reported by the Company in current reports on Form 8-K.
Dividend Policy
      Unlike regular C corporations, S corporations do not pay “dividends.” Rather, S corporations make “distributions.” Use of the term “distributions” in this context is unrelated to the term when used in the context of our repurchase obligations under the KSOP. To avoid confusion, when referring to a distribution that would constitute a dividend in a C corporation, we will use the term distribution/dividend. We do not expect to pay any distributions/dividends. We currently intend to retain future earnings, if any, for use in the operation of our business. Any determination to pay cash distributions/dividends in the future will be at the discretion of our board of directors and will be dependent on our results of operations, financial condition, contractual restrictions and other factors our board of directors determines to be relevant, as well as applicable law. The terms of the senior credit facility and the subordinated note prohibit us from paying distributions/dividends without the consent of the respective lenders.

28



 

Item 6. Selected Financial Data
      The following table presents selected historical and pro forma consolidated financial data for Alion or the Selected Operations of IITRI for each of the fiscal years in the five-year period ended September 30, 2005. The information set forth below should be read in conjunction with “Management’s Discussion and Analysis of Financial Condition and Results of Operations” and our historical consolidated financial statements and notes to those statements included elsewhere in this annual report. The consolidated operating data for the fiscal years ended September 30, 2005, 2004 and 2003 and the consolidated balance sheet data as of September 30, 2005 and 2004 are derived from, and are qualified by reference to, the consolidated financial statements of Alion included elsewhere in this annual report. The balance sheet data as of September 30, 2003, are derived from, and are qualified by reference to, the consolidated financial statements of Alion not included in this annual report.
      The consolidated operating data for the fiscal years ended September 30, 2002 and 2001, and the consolidated balance sheet data as of September 30, 2002 and 2001 are derived from and are qualified by reference to, the consolidated financial statements of Selected Operations of IITRI, included elsewhere in this annual report. The historical consolidated financial information of Selected Operations of IITRI has been carved out from the consolidated financial statements of IITRI using the historical results of operations and bases of assets and liabilities of the portion of IITRI’s business that was sold and gives effect to allocations of expenses from IITRI.
      Alion completed the acquisition of substantially all of the assets and certain of the liabilities of IITRI on December 20, 2002 (the Transaction). The pro forma consolidated data for the fiscal year ended September 30, 2003, assume that the acquisition had been consummated as of October 1, 2001.
      Our historical consolidated financial information may not be indicative of our future performance and does not necessarily reflect what our financial position and results of operations would have been had we operated as a separate, stand-alone entity during the periods presented.
Selected Financial Data of Alion Science and Technology Corporation
For Years Ended September 30,
                                                 
                        Pro Forma
    2005(1)   2004(2)   2003(3)   2002(4)   2001(4)   2003(12)
                         
    (In thousands, except share and per share data)
Consolidated Operating Data:
                                               
Contract revenue
  $ 369,231     $ 269,940     $ 165,917     $ 201,738     $ 193,152     $ 213,182  
Direct contract expenses
    267,241       196,388       120,559       147,377       140,555       155,214  
Operating expenses(5)
    104,081       73,703       46,273       48,488       41,726       64,842  
                                     
Operating income (loss)
    (2,091 )     (151 )     (915 )     5,873       10,871       (6,874 )
Other income (expense)(6)
    (38,081 )     (14,943 )     (11,701 )     (586 )     (1,072 )     (13,847 )
Income tax (expense) benefit(7)
    (66 )     (17 )           (589 )     (302 )     (27 )
                                     
Net income (loss)(8)
  $ (40,238 )   $ (15,111 )   $ (12,616 )   $ 4,698     $ 9,497     $ (20,748 )
                                     
Basic and diluted loss per share
  $ (9.50 )   $ (4.91 )   $ (6.05 )                        
Basic and diluted weighted-average common shares outstanding
    4,235,947       3,074,709       2,085,274                          
                                     
Unaudited pro forma as adjusted basic and diluted earnings (loss) per common share(9)
                                          $ (7.83 )
                                     

29



 

                                                   
                        Pro Forma
    2005(1)   2004(2)   2003(3)   2002(4)   2001(4)   2003(12)
                         
    (In thousands, except share and per share data)
Consolidated Balance Sheet Data at End of Period:
                                               
Net accounts receivable
  $ 80,898     $ 68,949     $ 42,775     $ 49,051     $ 56,095          
Total assets
    334,249       188,461       144,754       71,096       76,309          
Current portion of long-term debt
    1,404       468       5,000       3,330       141          
Long-term debt, excluding current portion
    180,833       99,631       74,719       1,654       11,886          
Redeemable common stock warrants
    44,590       20,777       14,762                      
Long-term deferred gain on sale of building to Illinois Institute of Technology, excluding current portion
                      3,523       4,054          
Other Data:
                                               
Depreciation and amortization
  $ 17,771     $ 13,447     $ 9,553     $ 3,447     $ 3,488          
Capital expenditures
    2,223       3,678       1,329       3,643       1,940          
Cash flows provided by (used in):
                                               
 
Operating activities
  $ 35,140     $ 5,675     $ 14,264     $ 14,713     $ 7,907          
 
Investing activities
    (78,017 )     (23,625 )     (61,428 )     (4,466 )     9,863          
 
Financing activities
    75,938       22,173       47,652       (9,851 )     (17,770 )        
Funded contract backlog(10)
    193,000       161,000       107,000       72,000       67,000          
Unfunded contract backlog(11)
    2,581,000       1,793,000       1,435,000       1,431,000       737,000          
Number of employees
    2,508       1,880       1,604       1,622       1,458          
 
  (1)  During fiscal year 2005, the Company completed four acquisitions and made one strategic investment as described below. The results of operations for the companies acquired are included in Alion’s operations from the dates of the acquisitions. On October 28, 2004, Alion purchased substantially all of the assets of Countermeasures for approximately $2.4 million. Countermeasures had two employees and was located in Hollywood, Maryland. As of September 30, 2005, the Company has recorded approximately $1.4 million in goodwill relating to this acquisition.
On February 11, 2005, Alion acquired 100 percent of the outstanding stock of METI, an environmental and life sciences research and development company for approximately $7.0 million in cash. METI had approximately 110 employees and was headquartered in Research Triangle Park, North Carolina. As of September 30, 2005, the Company has recorded $5.5 million in goodwill related to this acquisition.
 
On February 25, 2005, Alion acquired 100 percent of the outstanding stock of CATI, a flight training software and simulator development company, for approximately $7.3 million in cash. CATI had approximately 55 employees and was headquartered in Seaside, California. The transaction is subject to an earn-out provision not-to-exceed a cumulative amount of $9.0 million based on attaining certain cumulative revenue goals for fiscal years 2005, 2006, and 2007, and a second earn-out provision not-to-exceed $1.5 million for attaining certain revenue goals in the commercial aviation industry. As of September 30, 2005, the Company has recorded approximately $12.9 million in goodwill related to this acquisition.
 
On April 1, 2005, the Company acquired 100% of the issued and outstanding stock of JJMA. The Company paid the equity holders of JJMA approximately $51.9 million, issued 1,347,197 shares of Alion common stock to the JJMA Trust valued at approximately $37.3 million, and agreed to make $8.3 million in future payments. Including acquisition costs of $1.1 million, the aggregate purchase price was $99.5 million. As of September 30, 2005, the Company has recorded approximately $61.9 million in goodwill related to the JJMA acquisition.

30



 

On March 22, 2005, Alion acquired approximately 12.5 percent of the A ordinary shares in VectorCommand Ltd. for $1.5 million, which investment is accounted for at cost.
  (2)  During fiscal year 2004, the Company completed two acquisitions as described below. Operating results for these businesses are included in our consolidated totals from the respective dates of acquisitions. On October 31, 2003, Alion acquired 100% of the outstanding stock of Innovative Technology Solutions Corporation (“ITSC”), for $4.0 million. The transaction is subject to an earn out provision not-to-exceed $1.5 million. ITSC is a New Mexico corporation with approximately 53 employees, the majority of whom are located in New Mexico. As of September 30, 2005, the Company has recorded approximately $5.0 million of goodwill relating to this acquisition.
On February 13, 2004, Alion acquired 100% of the outstanding stock of Identix Public Sector, Inc. (IPS, now known as Alion-IPS Corporation) for $8.0 million in cash. IPS, formerly ANADAC, was a wholly-owned subsidiary of Identix Incorporated. Following the closing, the Company paid Identix approximately $4.3 million for intercompany payables. As of September 30, 2005, the Company has recorded approximately $6.1 million of goodwill relating to this acquisition.
  (3)  For fiscal year 2003 (October 1, 2002 to September 30, 2003), the operations data presented reflects approximately nine months of Alion operations since the Transaction occurred on December 20, 2002, which was at the end of IITRI’s first quarter of operations for fiscal 2003. During the period October 1, 2002 to December 20, 2002, Alion was organizationally a business shell, operationally inactive until the Transaction occurred.
 
  (4)  Represents consolidated operating and balance sheet data of the Selected Operations of IITRI which was acquired by Alion on December 20, 2002.
 
  (5)  Operating expenses include (i) non-recurring transaction expenses of approximately $6.7 million and $6.4 million for fiscal years ended September 30, 2003 and 2002, respectively, and (ii) non-recurring, conversion and roll-out expenses of approximately $1.5 million for the fiscal year ended September 30, 2003.
 
  (6)  For the years ended September 30, 2005, 2004 and 2003, other income (expense) includes approximately $38.7 million, $16.8 million and $13.9 million, respectively, in interest-related expense associated with the debt financing (which includes the related change in warrant valuation associated with the change in the share price of Alion stock) resulting from the Transaction and the acquisitions which were completed in fiscal years 2005 and 2004, as described above. Other income (expense) for the year ended September 30, 2004 includes a gain of approximately $2.1 million on the sale of the Company’s minority interest in Matrics Incorporated.
 
  (7)  Income tax (expense) benefit primarily relates to income (loss) of our for-profit, wholly-owned subsidiary, HFA prior to HFA becoming a Q-sub beginning on December 21, 2002.
 
  (8)  The decrease in net income for the year ended September 30, 2002, as compared to the year ended September 30, 2001 is primarily attributable to approximately $6.4 million in non-recurring costs (e.g., outside legal, finance, accounting and audit fees) related to the acquisition of the Selected Operations of IITRI.
 
  (9)  IITRI operated as a non-stock, not-for-profit corporation since its inception. Therefore, prior to 2003, our historical capital structure is not indicative of our current capital structure and, accordingly, historical earnings per share information has not been presented. Pro forma basic and diluted earnings per common share are computed based upon approximately 2.575 million shares of our stock outstanding after closing of the Transaction and completion of the one-time ESOP investment election being reflected as outstanding for the period prior to the closing of the Transaction. As of September 30, 2003, the pro forma basic and diluted earnings per common share are computed based upon approximately 2.65 million weighted average shares outstanding.
(10)  Funded backlog represents the total amount of contracts that have been awarded and whose funding has been authorized minus the amount of revenue booked under the contracts from their inception to date.
 
(11)  Unfunded backlog refers to the estimated total value of contracts which have been awarded but whose funding has not yet been authorized for expenditure.

31



 

(12)  The unaudited pro forma consolidated statements of operations set forth below should be read in connection with, and are qualified by reference to, our consolidated financial statements and related notes, as well as “Management’s Discussion and Analysis of Financial Condition and Results of Operations,” included elsewhere in this annual report. We believe that the assumptions used in the preparation of this unaudited pro forma information provide a reasonable basis for presenting the significant effects directly attributable to the transactions discussed below. The unaudited pro forma consolidated operating data are not necessarily indicative of the results that would have been reported had such events actually occurred on the dates described below, nor are they indicative of our future results. The unaudited pro forma consolidated operating data have been prepared to reflect the following adjustments to our historical results of operations and to give effect to the following transactions as if those transactions had been consummated on October 1, 2001:
  •  our incurrence of approximately $96.1 million of debt with detachable warrants to purchase common stock, in connection with the purchase of IITRI’s assets;
 
  •  the acquisition of IITRI’s assets, which was accounted for under the purchase method of accounting; and
 
  •  the purchase of our common stock for approximately $25.8 million by the ESOP Trust.

32



 

ALION SCIENCE AND TECHNOLOGY CORPORATION
Unaudited Pro Forma Consolidated Statement of Operations
For the Year Ended September 30, 2003
                                     
    Year Ended September 30, 2003
     
    Selected    
    Operations of IITRI   Alion   Pro Forma    
    Historical   Historical   Adjustments   Pro Forma
                 
    (In thousands, except per share information)
Contract revenue
  $ 47,265     $ 165,917             $ 213,182  
Direct contract expense
    34,655       120,559               155,214  
                         
   
Gross profit
    12,610       45,358               57,968  
                         
Operating expenses:
                               
 
Indirect contract expense
    2,568       8,685               11,253  
 
Research and development
    36       177               213  
 
General and administrative
    4,732       19,909       29 (1)     24,670  
 
Stock-based and deferred compensation
          856               856  
 
Non-recurring transaction expense
    6,000       726               6,726  
 
Rental and occupancy expense
    2,089       6,892       112 (2)     9,093  
 
Depreciation and amortization
    886       9,553       (474 )(3)     12,436  
                      2,471 (4)        
 
Bad debt expense (recovery)
    120       (525 )             (405 )
                         
Total operating expenses
    16,431       46,273               64,842  
                         
   
Operating income (loss)
    (3,821 )     (915 )             (6,874 )
Other income (expense):
                               
 
Interest income
    22       21               43  
 
Interest expense
    (51 )     (11,724 )     (1,685 )(5)     (13,869 )
                      (106 )(6)        
                      (303 )(7)        
 
Other
    (23 )     2               (21 )
                         
   
Income (loss) before income taxes
    (3,873 )     (12,616 )             (20,721 )
   
Income tax expense
    (27 )                   (27 )
                         
   
Net income (loss)
  $ (3,900 )   $ (12,616 )           $ (20,748 )
                         
Basic and diluted (loss) per share
                          $ (7.83 )(8)
Basic and diluted weighted average common shares outstanding
                    2,649 (8)        
See accompanying notes to unaudited pro forma consolidated statement of operations.
 
(1)  Represents Alion board of director expenses and interest expense on the $0.9 million note due to officer under terms of a compensation agreement, net of estimated fair value of detachable warrants.
 
(2)  Represents the elimination of the amortization of the deferred gain related to the sale of real estate during the year ended September 30, 2001.
 
(3)  Reversal of IITRI’s historical amortization expense related to pre-acquisition goodwill.
 
(4)  Under the provisions of SFAS No. 141,“Business Combinations”, the Transaction purchase price was allocated between net tangible assets, the value attributed to identifiable intangible assets (purchased contracts) and goodwill. For purposes of the pro forma consolidated statements of operations, the excess purchase price over the identifiable net assets acquired is considered to be goodwill with an indefinite life

33



 

and therefore is not amortizable. The estimated value of $30.6 million attributed to intangible assets has an estimated useful life of three years and has been amortized accordingly using the straight-line method in the pro forma statements of operations. Additionally, an estimated value of approximately $1.5 million was assigned to a single lot of non-capitalized assets (e.g., office furnishings, laptop computers, etc.). This asset has an estimated useful life of three years and has been amortized accordingly using the straight-line method in the pro forma statement of operations.
 
(5)  Represents interest expense on approximately $96.1 million of debt, utilizing a weighted average interest factor of approximately 8.1% per year, issued to finance the Transaction. The senior term note is a variable rate note that is indexed to the prime rate. The prime rate used for the weighted average interest rate calculation was 4.25%.
 
(6)  Represents amortization of debt issuance costs under the effective interest method over the life of the senior term note of five years.
 
(7)  Represents accretion of long-term debt to face value over the term of the debt using the effective interest method. Discount to debt reflects estimated fair value of detachable warrants of $10.3 million.
 
(8)  Our historical capital structure is not indicative of our current structure, and accordingly, historical earnings per share information has not been presented. For the fiscal year ended September 30, 2003, unaudited pro forma basic and diluted loss per share of common stock has been calculated in accordance with the rules for initial public offerings. These rules require that the weighted average share calculation give retroactive effect to any changes in our capital structure. Accordingly, pro forma weighted average shares assume the approximately 2.575 million shares issued by Alion after completion of the initial one-time ESOP investment on December 20, 2002, were outstanding for the entire period presented.
Item 7. Management’s Discussion and Analysis of Financial Condition and Results of Operations
      The following discussion of Alion’s financial condition and results of operations should be read together with the consolidated financial statements and the notes to those statements included elsewhere in this annual report. This discussion contains forward-looking statements about our business and operations that involve risks and uncertainties. Our actual results may differ materially from those we currently anticipate as a result of the “Risk Factors” described beginning on page 26, and elsewhere in this annual report.
About This Management’s Discussion and Analysis
      The discussion and analysis that follows is organized to:
  •  provide an overview of our business;
 
  •  explain the year-over-year trends in our results of operations;
 
  •  describe our liquidity and capital resources; and,
 
  •  explain our critical accounting policies.
Overview
Pro Forma Comparisons of Results of Operations
      The following discussion and analysis of results of operations relates to the results of operations for the fiscal years ended September 30, 2005 and 2004 and for the pro forma results of operations for the fiscal year ended September 30, 2003. On December 20, 2002, the last day of the Company’s first interim period for the fiscal year ended September 30, 2003, Alion completed the acquisition of substantially all of the assets and certain of the liabilities of IIT Research Institute (the “Transaction”). The pro forma statements reflect adjustments as if the Transaction had been consummated on October 1, 2001.

34



 

      We apply our scientific and engineering expertise to research and develop technological solutions for problems relating to national defense, public health and safety, and nuclear safety and analysis. We provide our research and development and engineering services primarily to agencies of the federal government, but also to state, local and foreign governments as well as commercial customers both in the U.S. and abroad. Our revenues increased 36.5%, 26.6%, and 5.7% for the fiscal years ended September 30, 2005, 2004, and 2003, respectively, through a combination of internal growth and acquisitions. The following table reflects, for each fiscal year indicated, summary results of operations and contract backlog data:
                             
    For the Years Ended September 30,
     
    2005   2004   2003
             
    (In millions)
Revenue
  $ 369.2     $ 269.9     $ 213.2  
                   
Net loss
  $ (40.2 )   $ (15.1 )   $ (20.7 )
                   
Contract Backlog:
                       
   
Funded
    193.0       161.0       107.0  
   
Unfunded
    2,581.0       1,793.0       1,435.0  
                   
 
Total
  $ 2,774.0     $ 1,954.0     $ 1,542.0  
                   
      We contract primarily with the federal government. We expect most of our revenues to continue to come from government contracts and we expect that most of these contracts will be with the U.S. Department of Defense. The balance of our revenue comes from a variety of commercial customers, state and local governments, and foreign governments. The following table reflects, for each fiscal year indicated, the percentage of the Company’s revenue derived from each of its major types of customers:
                                                   
    2005   2004   2003
             
    (In millions)
U.S. Department of Defense (DoD)
  $ 324       88 %   $ 245       91 %   $ 202       95 %
Other Federal Civilian Agencies
  $ 30       8 %   $ 19       7 %   $ 7       3 %
Commercial and International
  $ 15       4 %   $ 6       2 %   $ 4       2 %
                                     
 
Total
  $ 369       100 %   $ 270       100 %   $ 213       100 %
                                     
      We intend to continue to expand our research offerings in commercial and international markets; however, the expansion, if any, will be incremental. Revenues from commercial/ state and local government/ international research together amounted to approximately 4% of total revenues in fiscal year 2005 and approximately 2% in each of fiscal years 2004 and 2003. We derive our international revenue primarily from spectrum management research and software tools.
      Most of our revenue is generated based on services provided either by our employees or subcontractors. To a lesser degree, the revenue we earn includes reimbursable travel and other items to support the contractual effort. Thus, once we win new business, the key to delivering the revenue is through hiring new employees to meet customer requirements, retaining our employees, and ensuring that we deploy them on direct-billable jobs. Therefore, we closely monitor hiring success, attrition trends, and direct labor utilization. A key challenge in growing our business is to hire enough employees with appropriate security clearances. Since we earn higher profits from the labor services that our employees provide compared with subcontracted efforts and other reimbursable items such as hardware and software purchases for customers, we seek to optimize our labor content on the contracts we win.

35



 

      The table below provides a summary of annual revenues by significant contracts performed by the Company.
Summary of Annual Revenue by Customer/ Government Agency
                                 
        Primary Core   FY05 Annual   FY05 Annual
Sponsor/Government Agency   Title   Business Area*   Revenue   Revenue
                 
            (In millions)
Department of Defense - Defense Modeling and Simulation Information Systems Agency
  Information Analysis Center   Modeling and Simulation   $ 69       19 %
Department of Defense - Joint Spectrum Center
  Joint Spectrum Center Engineering Support Services   Wireless Communications   $ 46       12 %
General Services Administration
  Information Technology Services - U.S. Department   Information Technology   $ 25       7 %
Department of Defense - Army
  U.S. Army Night Vision Lab Hightech Omnibus contract     Defense Operations     $ 19       5 %
Department of Defense - Navy
  Engineering, Financial and Program Management Services to the Virtual SYSCOM program   Naval Architecture and Marine Engineering   $ 19       5 %
                         
Subtotal
                  $ 178       48 %
Other Sponsors/ Agencies
                  $ 191       52 %
                         
Total Revenues
                  $ 369       100 %
                         
 
The total annual revenue identified with a sponsor/government agency may include revenue within multiple business areas. The primary core business area is the single largest business area with the sponsor/government agency.
      During the year ended September 30, 2005, the support services contract to the Joint Spectrum Center underwent a full and open competition for the follow-on support contract that was to commence beginning October 2005. In August 2005, we were notified that we were not the successful bidder for these services. The JSC contract represented approximately 12%, 18%, and 21% of our revenue for the years ended September 30, 2005, 2004, and 2003, respectively. The Company filed a formal bid protest before the Government Accountability Office (GAO) with respect to the JSC contract award. The Company’s principal argument was that the successful bidder had an organizational conflict of interest with respect to its proposed performance of the contract. In its decision dated January 9, 2006, the GAO sustained the protest and recommended that the contracting agency take certain corrective action in order to address the awardee’s organizational conflict of interest. The Company is awaiting further action from the contracting agency. In the meantime, the Company expects to continue to generate revenue from its existing JSC contract until the issues involved in its protest are fully resolved.
      Our revenues and our operating margins are affected by, among other things, our mix of contract types (e.g., cost-reimbursement, fixed-price, and time-and-material). Significant portions of our revenues are generated by services performed on cost-reimbursement contracts under which we are reimbursed for approved costs, plus a fee, which reflects our profit on the work performed. We recognize revenue on cost-reimbursement contracts based on actual costs incurred plus a proportionate share of the fees earned. We also have a number of fixed-price government contracts. We use the percentage-of-completion method to recognize revenue on fixed-price contracts. These contracts involve higher financial risks, and in some cases higher margins, because we must deliver the contracted services for a predetermined price regardless of our

36



 

actual costs incurred in the project. Our failure to anticipate technical problems, estimate costs accurately or control costs during performance of a fixed-price contract may reduce the overall fee on the contract or cause a loss. Under time-and-material contracts, labor and related costs are reimbursed at negotiated, fixed hourly rates. Revenue on time-and-material contracts is recognized at contractually billable rates as labor hours and direct expenses are incurred. The following table summarizes the percentage of revenues attributable to each contract type for the periods indicated.
                                                 
    For the Year Ended September 30,
     
Contract Type   2005   2004   2003
             
Cost-plus
  $ 216       58 %   $ 160       59 %   $ 133       62 %
Fixed-price
  $ 77       21 %   $ 44       16 %   $ 34       16 %
Time-and-material
  $ 76       21 %   $ 66       25 %   $ 46       22 %
                                     
Total
  $ 369       100 %   $ 270       100 %   $ 213       100 %
                                     
      For the three years ended September 30, 2005, 2004, and 2003, the percentage distribution among these three types of contracts has remained relatively constant. Nonetheless, the percentage distribution reflects, to some extent, the increased use by governmental procuring agencies of General Services Administration Schedules which usually involve an increased number of both time-and-material and fixed-price orders.
      Our objective is to continue to grow by capitalizing on our highly educated work force and our established position in our core research fields, and by synergistic acquisitions. From 1998 through September 30, 2005, the Company and its predecessor, IITRI, have completed ten acquisitions. For the year ended September 30, 2005, the following four acquisitions and one strategic investment were completed:
        Countermeasures, Inc. — On October 28, 2004, Alion purchased substantially all of the assets of Countermeasures. Alion acquired technology and software (e.g., “Buddy Systemtm” used in vulnerability assessment) for identifying, quantifying and managing physical, infrastructure, program and electronic risks. Countermeasures had two employees and was located in Hollywood, Md.
 
        Mantech Environmental Technology, Inc. — On February 11, 2005, Alion acquired 100 percent of the outstanding stock of METI, an environmental and life sciences research and development company. METI had approximately 110 employees and was headquartered in Research Triangle Park, NC.
 
        Carmel Applied Technologies, Inc. — On February 25, 2005, Alion acquired 100 percent of the outstanding stock of CATI, a flight training software and simulator development company. CATI had approximately 55 employees and was headquartered in Seaside, Ca.
 
        VectorCommand, Ltd — On March 22, 2005, Alion acquired approximately 12.5 percent of the A ordinary shares in VectorCommand Ltd. VectorCommand Ltd., headquartered in the United Kingdom, designs and develops technologies used in training and operations by emergency managers and incident commanders in Australia, Europe, North America and the United Kingdom.
 
        John J. McMullen Associates, Inc. — On April 1, 2005, Alion acquired all of the outstanding stock of JJMA, a provider of ship and systems design from mission analysis and feasibility trade-off studies through contract and detail design, production supervision, testing and logistics support for the commercial and naval markets. JJMA had approximately 600 employees and was headquartered in Iselin, New Jersey.
      We have integrated the acquired entities listed above into our research base and capabilities, enabling us to expand our research offerings for our government and commercial customers. Management believes that synergistic acquisitions like these provide several potential benefits to our organization and the public in that they:
  •  help us expand our research base to include increasingly large and complex programs;
 
  •  increase our opportunities to exploit the synergies between different research fields in which we work to broaden our offerings to our existing customers;

37



 

  •  bring new strengths to our technical capabilities through cross-utilization of research technology and engineering skills; and
 
  •  increase the overall depth and experience of our management.
Results of Operations
      For fiscal years ended September 30, 2005, 2004 and 2003, the Transaction had two significant impacts on net income: first, the value assigned to the purchased contracts are amortized on a straight-line basis over three years resulting in approximately a $10.2 million, non-cash expense per year, and second, there are two additional expense categories that appear on the operating statements: non-recurring third party transaction expenses (e.g. outside legal, finance, accounting and audit fees of approximately $6.7 million for fiscal year 2003) and the interest-related expense associated with the debt financing which includes the related change in warrant valuation associated with change in share price of Alion common stock of approximately $38.7 million, $16.8 million, and $13.9 million for the fiscal years ended September 30, 2005, 2004, and 2003, respectively.
Year Ended September 30, 2005 Compared to Year Ended September 30, 2004
      For purposes of comparability, the table below reflects the relative financial impact of the METI, CATI and JJMA acquisitions, which we refer to as the “acquired operations” of Alion, as they relate to the financial performance of Alion for the fiscal year ended September 30, 2005 compared to the financial performance for fiscal year ended September 30, 2004. Significant differences in the results of Alion’s operations for the years September 30, 2005 and 2004, arise from the effects of these acquisitions. The discussion of the results of operations will include references to the financial information shown in the table below in conjunction with the consolidated financial statements of Alion provided elsewhere in this document. The financial information provided in the table is based on estimates from Alion management.
Acquisitions Completed in the Year Ended September 30, 2005
  •  We completed the acquisition of substantially all of the assets Countermeasures on October 28, 2004. Countermeasures had two employees and was located in Hollywood, Maryland. Alion acquired technology and software (e.g. “Buddy Systemtm” used in vulnerability assessment) for identifying, quantifying and managing physical, infrastructure, program and electronic risks.
 
  •  On February 11, 2005, we completed the acquisition of METI, an environmental and life sciences research and development company. METI had approximately 110 employees and was headquartered in Research Triangle Park, North Carolina.
 
  •  On February 25, 2005, we completed the acquisition of CATI, a provider of flight training software and simulator development systems. CATI had approximately 55 employees and was headquartered in Seaside, California.
 
  •  On April 1, 2005, we completed the acquisition of JJMA, a provider of ship and systems design from mission analysis and feasibility trade-off studies through contract and detail design, production supervision, testing and logistics support for the commercial and naval markets. JJMA had approximately 600 employees and was headquartered in Iselin, New Jersey.

38



 

                                                     
    Year Ended September 30, 2005   Year Ended September 30, 2004
         
        Acquired   Consolidated       Consolidated
        Operations   Operations of       Operations of
    Consolidated   (METI,   Alion Less   Consolidated   Acquired   Alion Less
    Operations of   CATI, and   the Acquired   Operations of   Operations   the Acquired
Financial Information   Alion   JJMA)*   Operations   Alion   (ITSC and IPS)*   Operations
                         
    (In millions)
Total revenue
  $ 369.2     $ 65.3     $ 303.9     $ 269.9     $ 28.4     $ 241.6  
 
Material and subcontract revenue
    102.7       16.9       85.8       70.3       11.5       58.9  
Total direct contract expenses
    267.2       46.1       221.1       196.4       19.5       176.9  
 
Major components of direct contract expense:
                                               
   
Direct labor cost
    152.5       26.6       125.9       120.0       8.1       111.9  
   
Other direct cost (ODC)
    13.7       2.9       10.8       8.1       0.3       7.9  
   
Material and subcontract (M&S) cost
    101.0       16.6       84.4       68.3       11.1       57.1  
Gross profit
    102.0       19.2       82.8       73.6       5.3       68.3  
Total operating expense
    104.1       13.1       91.0       73.7       4.4       69.3  
 
Major components of operating expense:
                                               
   
Indirect personnel and facilities
    41.6       6.9       34.7       28.6       2.2       26.4  
   
General and administrative
    33.0       2.9       30.1       28.1       1.8       26.3  
   
Depreciation and amortization
    17.8       3.2       14.6       13.4       0.3       13.1  
   
Stock-based compensation
    10.6       0.0       10.6       2.5       0.0       2.5  
Loss from operations
  $ (2.1 )   $ 6.1     $ (8.2 )   $ (0.2 )   $ 0.9     $ (1.1 )
 
For the years ended September 30, 2005 and 2004, the operations of the acquired entities, Countermeasures, METI, CATI and JJMA, and ITSC and IPS, respectively, have been fully integrated within Alion on a consolidated basis. The financial information attributed to these entities are the estimates of management.
      Contract Revenues. Revenues increased $99.3 million, or 36.8%, to $369.2 million for the year ended September 30, 2005, from $269.9 million for the year ended September 30, 2004. This increase is attributable to the following:
             
  Revenue generated by the activities of acquired operations   $ 65.3 million  
  Revenue generated by the activities of the non-acquired operations   $ 34.0 million  
      Total:   $ 99.3 million  
      For the year ended September 30, 2005, additional revenue generated by the acquired operations included approximately $49.2 million, $8.0 million and $8.1 million from the activities of JJMA, METI and CATI, respectively. Additional revenue of approximately $33.9 million generated by the non-acquired operations included an increase of approximately $16.5 million in support to the U.S. Army Night Vision Hightech Omnibus contract, an increase of approximately $6.0 million to the Modeling and Simulation Information Analysis Center (MSIAC) contract to the Department of Defense, and an increase of approximately $3.7 million in support of the Weapons Systems Technology Analysis Center contract. On the balance of our contracts performed by the non-acquired operations, revenue increased by approximately $7.7 million.

39



 

      As a component of revenue, material and subcontract (M&S) revenue increased approximately $32.4 million, or 46.1%, to $102.7 million for the year ended September 30, 2005 from $70.3 million for the year ended September 30, 2004. M&S revenue of the acquired operations was approximately $16.9 million, of which approximately $13.6 million, $1.7 million and $1.6 million was generated by JJMA, CATI and METI, respectively. Approximately $15.5 million of M&S revenue increase was generated by non-acquired operations of which approximately $16.1 million of additional M&S revenue was generated in support to the U.S. Army Night Vision Hightech Omnibus contract and approximately $5.8 million was generated in support of the MSIAC contract. On the balance of our contracts performed by the non-acquired operations, M&S revenue decreased by approximately $6.4 million. As a percentage of revenue, M&S revenue was 27.8% for the fiscal year ended September 30, 2005 as compared to 26.1% for the year ended September 30, 2004. For the year ended September 30, 2005, the M&S revenue content of total revenue performed under contracts of the acquired operations was approximately 25.8% while the M&S content of total revenue performed by the non-acquired operations was approximately 28.2%. The revenue activity of the acquired operations has a higher percentage level of M&S revenue that results from the amount of subcontractor support required.
      Direct Contract Expenses. Direct contract expenses increased $70.8 million, or 36.1%, to $267.2 million for the year ended September 30, 2005 from $196.4 million for the year ended September 30, 2004. As a percentage of revenue, direct contract expenses were 72.4% and 72.8% for the years ended September 30, 2005 and 2004, respectively. The changes in specific components of direct contract expenses are:
  •  Direct labor costs for the year ended September 30, 2005 increased by $32.5 million, or 27.1%, to $152.5 million from $120.0 million for the year ended September 30, 2004. As a percentage of revenue, direct labor cost was 41.3% for the year ended September 30, 2005 as compared to 44.5% for the year ended September 30, 2004. The percentage decrease in direct labor cost is directly associated with the relative percentage increase in M&S cost associated with the increase in the percentage of M&S revenue, as described above.
 
  •  M&S cost increased approximately $32.7 million, or 47.9%, to $101.0 million for the year ended September 30, 2005, compared to $68.3 million for the year ended September 30, 2004. As a percentage of revenue, M&S cost was 27.5% for the year ended September 30, 2005 as compared to 25.3% for the year ended September 30, 2004. The percentage increase in M&S cost is directly associated with the relative percentage increase in M&S cost associated with the contracts, as described above. As a percentage of M&S revenue, M&S cost was approximately 98.3% and 97.2% for the years ended September 30, 2005 and 2004, respectively.
      Gross Profit. Gross profit increased $28.4 million, or 38.6%, to $102.0 million for the year ended September 30, 2005, from $73.6 million for the year ended September 30, 2004. The $28.4 million increase is attributable to the following:
             
  Gross profit generated by the activities of the acquired operations   $ 19.2 million  
  Gross profit generated by the activities of the non-acquired operations   $ 9.2 million  
      Total:   $ 28.4 million  
      As a percentage of revenue, gross profit was 27.6% for each of the year ended September 30, 2005 and 27.3% for the year ended September 30, 2004. For the year ended September 30, 2005, we experienced an increased proportion of M&S contract revenue, which typically generates lower profit margins; however, we were able to increase our overall gross profit margin due to an increase in profit margins on time-and-materials and fixed price contract work coupled with our ability to sustain our proportionate amount of time-and-material and fixed price contract work.

40



 

      Operating Expenses. Operating expenses increased $30.4 million, or 41.3%, to $104.1 million for the year ended September 30, 2005, from $73.7 million for the year ended September 30, 2004. The $30.4 million increase is attributable to the following:
             
  Operating expense incurred by the activities of the acquired operations   $ 13.1  million  
  Operating expense incurred by activities of the non-acquired operations   $ 17.3  million  
      Total:   $ 30.4  million  
      As a percentage of revenue, operating expenses were 28.3% for the year ended September 30, 2005 as compared to 27.3% for the year ended September 30, 2004. The changes in specific components of operating expenses are:
  •  Stock-based compensation was approximately 2.9 and 0.9 percentage points of revenue for the years ended September 30, 2005 and 2004, respectively. Stock-based compensation and deferred compensation relate primarily to the expense associated with the stock appreciation rights and phantom stock plans. Stock-based compensation increased approximately $8.1 million, or 324% to $10.6 million for the year ended September 30, 2005, from approximately $2.5 million for the year ended September 30, 2004. The increase in stock-based compensation and deferred compensation is a result of the increase in the value of Alion’s common stock and the increase in awards granted.
 
  •  Operating expenses for indirect personnel and facilities costs related to rental and occupancy expenses increased approximately $13.0 million, or 45.4%, to $41.6 million for the year ended September 30, 2005, from $28.6 million for the year ended September 30, 2004. As a percentage of revenue, operating expenses relating to indirect personnel and facilities expense was 11.3% for the year ended September 30, 2005 as compared to 10.6% for the year ended September 30, 2004. The increase, as a percentage of revenue, is partially attributable to the increase in indirect labor costs associated with the integration activities of the CATI, METI and JJMA acquisitions. Management intends to reduce facility lease costs through efforts to sublet excess space which resulted from additional space acquired through the acquisition process.
 
  •  General and administrative (G&A) expense increased approximately $4.9 million, or 17.4%, to $33.0 million for the year ended September 30, 2005, compared to $28.1 million for the year ended September 30, 2004. As a percentage of revenues, general and administrative expenses were 9.0% for the year ended September 30, 2005, compared to 10.4% for the year ended September 30, 2004. As a result of integrating the activities of CATI, METI and JJMA, the costs associated with providing G&A activities for the acquired operations have been partially absorbed by the existing G&A infrastructure, resulting in a decrease in expense expressed as a percentage of revenue.
 
  •  Depreciation and amortization expense increased approximately $4.4 million, or 32.8%, to $17.8 million for the year ended September 30, 2005, as compared to $13.4 million for the year ended September 30, 2004. Depreciation is associated primarily with the value assigned to fixed assets while

41



 

  amortization expense is associated primarily with the intangible asset value assigned to the purchased contracts of the acquired entities. The $4.4 million increase is primarily attributable to the following:
                     
    Year Ended
    September 30,
     
    2005   2004
         
    (In millions)
Depreciation expense
  $ 4.4     $ 2.8  
Amortization expense for purchased contracts of:
               
 
- IITRI
  $ 10.2     $ 10.2  
 
- ITSC
  $ 0.1        
 
- IPS
  $ 0.5     $ 0.4  
 
- METI
  $ 0.3        
 
- JJMA
  $ 2.2        
Amortization expense for non-compete agreements
  $ 0.1        
             
   
Total
  $ 17.8     $ 13.4  
             
      As a percentage of revenue, operating expense relating to depreciation and amortization expense was 4.8% for the year ended September 30, 2005 as compared to 5.0% for the year ended September 30, 2004.
      Loss from Operations. For the year ended September 30, 2005, the loss from operations was $2.1 million compared with $0.2 million operating loss for the year ended September 30, 2004. The $1.9 million loss increase is associated with factors discussed above and is attributable to the following:
             
  Operating income generated from the acquired operations   $ 6.1    million
  Operating loss generated from the non-acquired operations*   $ (8.0 )  million
      Total:   $ (1.9 )  million
 
For the year ended September 30, 2005, stock-based compensation expense of approximately $10.6 million was not attributed to the activities of acquired operations.
      Other Income and Expense. As a category, other income and expense increased approximately $23.2 million, or 155.7%, to $38.1 million for the year ended September 30, 2005 as compared to $14.9 million for the year ended September 30, 2004. As a component of other income and expense, interest expense increased approximately $21.9 million, or 125.6%, to $38.7 million for the year ended September 30, 2005 from approximately $16.8 million for the year ended September 30, 2004. The $21.9 million increase in interest expense is attributable to the following:
                   
    Year Ended
    September 30,
     
    2005   2004
         
    (In millions)
Revolving facility
  $ 0.2     $ 0.8  
Senior term loan
    6.9       3.1  
Mezzanine Note - cash-pay interest
    1.8       2.4  
                  - accretion of debt discount
    2.2       0.7  
Subordinated note - PIK interest
    2.3       2.4  
                    - accretion of long-term deferred interest
    0.6       0.4  
                    - accretion of debt discount
    0.9       0.8  
Agreements with officers
    0.0       0.2  
Accretion of warrants(a)
    23.5       5.9  
Other
    0.3       0.1  
             
 
Total
  $ 38.7     $ 16.8  
             

42



 

 
(a)  Reflects change in value assigned to the detachable warrants associated with Mezzanine and Subordinated notes based on the change in the value of Alion common stock.
      The remaining increase of approximately $1.3 million is attributable to interest expense and the recognition of a gain of approximately $2.1 million on the sale of our minority interest in Matrics, Inc. For the year ended September 30, 2005, we did not have any significant recognized gains.
      Income Tax (Expense) Benefit. The Company has filed qualified subchapter S elections for all of its wholly-owned subsidiaries to treat them as disregarded entities for federal income tax purposes. Some states do not recognize the effect of these elections or Alion’s S corporation status. As a result, the Company recorded approximately $0.07 million and $0.02 million of state income tax expense for the years ended September 30, 2005 and 2004, respectively
      Net Loss. The net loss increased approximately $25.1 million, or 166.2%, to $40.2 million for the year ended September 30, 2005 as compared to $15.1 million for the year ended September 30, 2004. The $25.1 million increase is associated with factors discussed above.
Year Ended September 30, 2004 Compared to Pro Forma Year Ended September 30, 2003
      For purposes of comparability, the table below reflects the relative financial impact of the ITSC and IPS acquisitions as they relate to the financial performance of Alion for the fiscal year ended September 30, 2004 compared to the pro forma financial performance for fiscal year ended September 30, 2003. The discussion of the results of operations will include references to the financial information shown in the table below in conjunction with the consolidated financial statements of Alion provided elsewhere in this document. The financial information provided in the table is based on estimates from Alion management.
  •  On February 13, 2004, we completed the acquisition of ITSC, a provider of nuclear safety and analysis services to the U.S. Department of Energy (DOE) as well as to the commercial nuclear power industry.

43



 

  •  On October 31, 2003, we completed the acquisition of IPS a provider of program and acquisition management, integrated logistics support, and foreign military support primarily to U.S. Navy customers.
                                     
        Pro Forma
    Year Ended September 30, 2004   Year Ended
        September 30,
        Consolidated   2003
        Operations of    
    Consolidated   Acquired   Alion Less the   Consolidated
    Operations of   Operations   Acquired   Operations of
Financial Information   Alion   (ITSC and IPS)   Operations   Alion
                 
        (In thousands)
    (In thousands)    
Total revenue
  $ 269,940     $ 28,359     $ 241,581     $ 213,182  
Material and subcontract revenue
    70,328       11,465       58,863       43,391  
Total direct contract expenses
    196,388       19,488       176,900       155,214  
 
Major components of direct contract expense:
                               
   
Direct labor cost
    119,999       8,106       111,894       105,469  
   
Other direct cost (ODC)
    8,109       252       7,857       7,617  
   
Material and subcontract (M&S) cost
    68,280       11,131       57,149       42,128  
Gross profit
    73,552       5,296       68,256       57,968  
Total operating expense
    73,703       4,372       69,331       64,842  
 
Major components of operating expense:
                               
   
Indirect personnel and facilities
    28,637       2,206       26,431       20,346  
   
Non-recurring Transaction expense
                      6,726  
   
General and administrative
    28,116       1,850       26,266       24,670  
   
Stock-based and deferred compensation
    2,513             2,513       856  
   
Depreciation and amortization
    13,448       317       13,131       12,436  
Income (loss) from operations
  $ (151 )   $ 924     $ (1,075 )   $ (6,874 )
 
The operations of the acquired entities, ITSC and IPS, have been fully integrated within Alion on a consolidated basis. The financial information attributed to these entities are the estimates of management.
      Contract Revenues. Revenues increased $56.7 million, or 26.6%, to $269.9 million for the year ended September 30, 2004, from $213.2 million for the year ended September 30, 2003. The $56.7 million increase is attributable to the following:
             
  Revenue generated by the activities of acquired operations   $ 28.3 million  
  Revenue generated primarily by work performed under Company contracts that were in existence during the prior year   $ 28.4 million  
      Total:   $ 56.7 million  
      For the year ended September 30, 2004, our performance of additional work under Company contracts that were in existence during the prior year includes an increase in our decommissioning and demilitarization support services to the U.S. Army’s Newport Chemical Agent Disposal Facility (NECDF) under a subcontract to Parsons Infrastructure and Technology Group, Inc. that accounted for approximately $4.2 million of increased revenue, while our continued support to the Department of Defense Joint Spectrum Center (JSC) accounted for approximately $4.1 million of increased revenue. The Modeling and Simulation Information Analysis Center (MSIAC) contract to the Department of Defense accounted for approximately $3.5 million of the revenue increase.
      As a component of revenue, material and subcontract (M&S) revenue increased approximately $26.9 million, or 62.1%, to $70.3 million for the year ended September 30, 2004 from $43.4 million for the year ended September 30, 2003. As a percentage of revenue, M&S revenue was 26.0% for the fiscal year

44



 

ended September 30, 2004 as compared to 20.4% for the year ended September 30, 2003. The increase in M&S revenue content can be attributed to two factors: 1) the M&S revenue of the acquired operations was approximately $11.5 million, or 40.5% of total acquired revenue, and 2) the M&S revenue content performed under existing contracts increased to approximately 24.4% of revenue. The revenue activity of the acquired operations has an increased percentage level of M&S revenue that results from the amount of subcontractor support which is provided to the commercial utility customers of the ITSC operation and the increased level of subcontract activity required under our support contracts to the U.S. Navy performed by the IPS operation.
      Direct Contract Expenses. Direct contract expenses increased $41.2 million, or 26.5%, to $196.4 million for the year ended September 30, 2004 from $155.2 million for the year ended September 30, 2003. As a percentage of revenue, direct contract expenses were 72.8% for the years ended September 30, 2004 and 2003. The changes in specific components of direct contract expenses are:
  •  Direct labor costs for the year ended September 30, 2004 increased by $14.5 million, or 13.8%, to $120.0 million from $105.5 million for the year ended September 30, 2003. As a percentage of revenue, direct labor cost was 44.5% for the year ended September 30, 2004 as compared to 49.5% for the year ended September 30, 2003. The percentage decrease in direct labor cost is directly associated with the relative percentage increase in M&S cost associated with the M&S revenue of the acquired operations, as described above.
 
  •  M&S cost increased approximately $26.2 million, or 62.1%, to $68.3 million for the year ended September 30, 2004, compared to $42.1 million for the year ended September 30, 2003. As a percentage of revenue, M&S cost was 25.3% for the year ended September 30, 2004 as compared to 19.8% for the year ended September 30, 2003. The percentage increase in M&S cost is directly associated with the relative percentage increase in M&S cost of the contracts performed by acquired operations, as described above. As a percentage of M&S revenue, M&S cost was approximately 97.1% during the years ended September 30, 2004 and 2003.
      Gross Profit. Gross profit increased $15.6 million, or 26.9%, to $73.6 million for the year ended September 30, 2004, from $58.0 million for the year ended September 30, 2003. The $15.6 million increase is attributable to the following:
             
  Gross profit generated by the activities of the acquired operations   $ 5.3 million  
  Gross profit generated primarily by work performed under Company contracts that were in existence during the prior year   $ 10.3 million  
      Total:   $ 15.6 million  
      As a percentage of revenue, gross profit was 27.2% for years ended September 30, 2004 and 2003. For the year ended September 30, 2004, we experienced an increased proportion of M&S contract revenue, which typically generates lower profit margins; however, we were able to sustain our overall gross profit margin due to the increase in the proportionate amount of time-and-material and fixed price contract work, which typically generate higher profit margins.
      Operating Expenses. Operating expenses increased $8.9 million, or 13.7%, to $73.7 million for the year ended September 30, 2004, from $64.8 million for the year ended September 30, 2003. However, for the year ended September 30, 2003, there was approximately $6.7 million in non-recurring, transaction-related expense associated with Alion’s purchase of the Selected Operations of IITRI. There were no such costs incurred for the year ended September 30, 2004. As such, the adjusted increase in operating expense was approximately $15.6 million ($8.9 million plus $6.7 million). The $15.6 million adjusted increase is attributable to the following:
             
  Operating expense incurred by the activities of the acquired operations   $ 4.4 million  
  Operating expense incurred for the infrastructure needs in support of revenue growth of existing operations   $ 11.2  million  
      Total:   $ 15.6  million  

45



 

      As a percentage of revenue, operating expense was 27.3% for the year ended September 30, 2004 as compared to 30.4% for the year ended September 30, 2003. For the year ended September 30, 2004, the percentage decrease in operating expense is directly attributable to the absence of Transaction-related expenses. The changes in other specific components of operating expenses are:
  •  Overhead expenses for indirect personnel and facilities costs related to rental and occupancy expenses increased approximately $8.3 million, or 40.8%, to $28.6 million for the year ended September 30, 2004, from $20.3 million for the year ended September 30, 2003. As a percentage of revenue, operating expense relating to indirect personnel and facilities expense was 10.6% for the year ended September 30, 2004 as compared to 9.5% for the year ended September 30, 2003. The increase, as a percentage of revenue, is partially attributable to the increase in indirect labor costs associated with the integration activities of the ITSC and IPS acquisitions.
 
  •  General and administrative (G&A) expense increased approximately $3.6 million, or 14.1%, to $28.1 million for the year ended September 30, 2004, compared to $24.7 million for the year ended September 30, 2003. As a percentage of revenues, general and administrative expenses were 10.4% for the year ended September 30, 2004, compared to 11.6% for the year ended September 30, 2003. As a result of integrating the activities of ITSC and IPS, the costs associated with providing G&A activities for the acquired operations have been partially absorbed by the existing G&A infrastructure, resulting in a decrease in expense expressed as a percentage of revenue.
 
  •  Stock-based compensation and deferred compensation relate primarily to the expense associated with the SAR and phantom stock plans. Stock-based compensation increased approximately $1.6 million, or 178% to $2.5 million for year ended September 30, 2004, from approximately $0.9 million for the year ended September 30, 2003. As a percentage of revenue, operating expense relating to stock-based compensation and deferred compensation expense was 0.9% for the year ended September 30, 2004 as compared to 0.4% for the year ended September 30, 2003. The increase in stock-based compensation and deferred compensation is a result of the increase in the value of Alion’s common stock and the increase in awards granted.
 
  •  Non-recurring Transaction-related expenses (e.g., third party legal, accounting, and finance) was not incurred during the year ended September 30, 2004. For the year ended September 30, 2003, Transaction-related expenses were approximately $6.7 million.
 
  •  Depreciation and amortization expense increased approximately $1.0 million, or 8.1%, to $13.4 million for the year ended September 30, 2004, as compared to $12.4 million for the year ended September 30, 2003.
      For each year ended September 30, 2004 and 2003, approximately $10.2 million of amortization expense was incurred associated with the intangible asset value assigned to purchased customer contracts of IITRI. For the year ended September 30, 2004, approximately $0.3 million of amortization expense was incurred associated with intangible asset value assigned to the purchased contracts of ITSC and IPS. Also, for each respective year ended September 30, 2004 and 2003, approximately $0.5 million of depreciation expense was incurred associated with the fair value assigned to the purchased fixed assets of IITRI. As a percentage of revenue, operating expense relating to depreciation and amortization expense was 5.0% for the year ended September 30, 2004 as compared to 5.8% for the year ended September 30, 2003.
  •  Bad debt expense increased $1.0 million to $0.6 million for the year ended September 30, 2004 as compared to a recovery of $0.4 million for the year ended September 30, 2003. During the year ended September 30, 2003, approximately $0.5 million of cash was received due to the favorable resolution of a contractual dispute. As a percentage of revenue, bad debt expense was 0.2% for the year ended September 30, 2004 as compared to a recovery of 0.2% for the year ended September 30, 2003.

46



 

      Loss from Operations. For the year ended September 30, 2004, the loss from operations was $0.1 million compared with $6.8 million operating loss for the year ended September 30, 2003. The $6.7 million decrease is associated with factors discussed above and is attributable to the following:
             
  Operating income generated from the activities of the acquired operations   $ 0.9  million  
  Decrease in operating loss generated from the existing operations   $ 5.8  million  
      Total:   $ 6.7  million  
      Other Income and Expense. As a category, other income and expense increased approximately $1.2 million, or 8.6%, to $15.1 million for the year ended September 30, 2004 as compared to $13.9 million for the year ended September 30, 2003. As a component of other income and expense, interest expense increased approximately $3.0 million, or 21.6%, to $16.8 million for the year ended September 30, 2004 from approximately $13.9 million for the year ended September 30, 2003. The $3.0 million increase in interest expense is attributable to the following:
                   
    For Year Ended
    September 30,
     
    2004   2003
         
    (In millions)
Revolving debt
  $ 0.8     $ 0.3  
Senior term note
    3.1       2.4  
Mezzanine note - stated 12% interest
    2.4       2.4  
                 - accretion of debt discount
    0.7       1.7  
Subordinated note - stated PIK interest
    2.4       2.5  
                    - accretion of long term deferred interest
    0.4       0.2  
                    - accretion of debt discount
    0.8       3.3  
Promissory notes with officers
    0.2       0.0  
Warrants
    5.9       0.7  
Other
    0.1       0.4  
             
 
Total
  $ 16.8     $ 13.9  
             
 
(a)  Reflects change in value assigned to the detachable warrants associated with the change in the value of Alion common stock. The warrants are associated with the Mezzanine and Subordinated notes.
      In September 2004, we recognized a gain of approximately $2.1 million on the sale of our minority interest in Matrics, Inc.
      Income Tax (Expense) Benefit. Although HFA became a qualified subchapter S subsidiary as of December 20, 2002 and is no longer treated as a separate entity for federal income tax purposes, some states do not recognize this tax election. In addition, some states do not recognize Alion’s S corporation status. As a result, the Company recorded approximately $0.02 million of state income tax expense for the year ended September 30, 2004.
      Net Loss. The net loss decreased approximately $5.7 million, or 27.4%, to $15.1 million for the year ended September 30, 2004 as compared to $20.8 million for the year ended September 30, 2003. The $5.7 million decrease is associated with factors discussed above.
Liquidity and Capital Resources
      The Company’s primary liquidity requirements are for debt service, working capital, capital expenditures, and acquisitions. The principal working capital need is to fund accounts receivable, which increases with the growth of the business. We are funding our present operations, and we intend to fund future operations, primarily through cash provided by operating activities and through use of our revolving credit facility.

47



 

      The following discussion relates to the cash flow of Alion for the fiscal years ended September 30, 2005 and 2004.
      Operating activities generated approximately $35.1 million and $5.7 million net cash for the years ended September 30, 2005 and 2004, respectively. The $29.4 million increase in cash from operating activities, despite a higher net loss in fiscal year 2005, is primarily attributable to increased non-cash interest expense related to the fair value of common stock warrants, stock-based compensation expense and depreciation and amortization expenses. These amounts were approximately $25.8 million and approximately $4.4 million for the years ended September 30, 2005 and 2004, respectively. The Company also collected approximately $26.3 million more cash on accounts receivable for the year ended September 30, 2005, as compared to the prior year.
      Net cash used in investing activities (principally for strategic acquisitions) was approximately $78.0 million for the year ended September 30, 2005. During the year ended September 30, 2005, the Company paid, net of cash acquired, approximately $74.6 million in the aggregate for the acquisitions of CATI, METI, and JJMA and for the assets of Countermeasures and approximately $1.2 million for the investment in VectorCommand. In addition, the Company spent approximately $2.2 million for capital expenditures. During the year ended September 30, 2004, the Company used approximately $21.7 million to make acquisitions and pay earn out obligations. Alion paid approximately $4.0 million for the ITSC acquisition, approximately $10.6 million ($8.0 million in cash at closing plus approximately $2.6 million in subsequent payments for intercompany payables) for the IPS acquisition and $7.1 million in earn out obligations due for the AB Tech acquisition. We spent approximately $3.7 million for capital expenditures and approximately $1.0 million to make a minority investment in Matrics Incorporated. We sold our Matrics investment for $3.1 million in September 2004.
      Net cash provided by financing activities was approximately $75.9 million for the year ended September 30, 2005, compared to net cash provided by financing activities of approximately $22.2 million for the year ended September 30, 2004. The most significant components of the Company’s financing activities are: 1) net proceeds from (or repayment of) short term borrowings and 2) net proceeds from (or repayment of) long term debt securities. During the year ended September 30, 2005, Alion borrowed $94.0 million under the Term B Senior Credit Facility. The Company used approximately $58.7 million for the JJMA acquisition, approximately $22.0 million to redeem the Mezzanine Note and approximately $13.3 million to finance the other acquisitions discussed above. In the year ended September 30, 2005, the Company raised approximately $14.5 million from sales of common stock to the ESOP Trust. During the year ended September 30, 2004, Alion borrowed $50.0 million under the Term B Senior Credit Facility to repay the senior term note payable and revolving line credit facility with LaSalle Bank of approximately $29.3 million and $24.0 million, respectively. During the year ended September 30, 2003, the financing was required to complete the purchase of substantially all of the assets of IITRI. Alion generated $25.8 million in cash from the initial sale of the Company’s common stock to the ESOP Trust and another approximately $0.8 million from a subsequent sale of common stock to the ESOP Trust. Alion also obtained $33.3 million from borrowings under the LaSalle Bank senior term note. During the year ended September 30, 2003, Alion repaid approximately $5.7 million of principal on the senior term loan and approximately $6.2 million of principal on LaSalle Bank’s revolving credit facility.
Discussion of Debt Structure
      To fund the Transaction, the Company entered into various debt agreements (e.g., Senior Credit Agreement, Mezzanine Note, and Subordinated Note) on December 20, 2002. On August 2, 2004, the Company entered into a new Term B senior secured credit facility (the Term B Senior Credit Facility), with a syndicate of financial institutions for which Credit Suisse serves as arranger, administrative agent and collateral agent. LaSalle Bank National Association serves as syndication agent under the Term B Senior Credit Facility. Proceeds from the Term B Senior Credit Facility were used to extinguish the LaSalle Bank senior term note, the LaSalle Bank revolving credit facility and the Mezzanine Note. On April 1, 2005, the Company entered into an incremental term loan facility and an amendment to the Term B Senior Credit Facility (Amendment One), which added $72 million in term loans to our total indebtedness under the Term

48



 

B Senior Credit Facility. Set forth below is a summary of the terms of the Term B Senior Credit Facility, as modified by Amendment One, followed by a description of the remaining debt agreements which were used to fund the Transaction.
      Term B Senior Credit Facility. The Term B Senior Credit Facility has a term of five years and consists of:
  •  a senior term loan in the approximate amount of $143.3 million, (which includes the incremental term loan), of which $142.9 million was drawn down as of September 30, 2005;
 
  •  a senior revolving credit facility, in the amount of $30.0 million, of which approximately $3.0 million was deemed borrowed as of September 30, 2005, through the issuance of letters of credit issued under the Company’s prior senior credit facility which remain outstanding under the Term B Senior Credit Facility and the issuance of additional letters of credit under the Term B Senior Credit Facility; and
 
  •  an uncommitted incremental term loan “accordion” facility in the amount of $150.0 million.
      On the senior term loan, until the quarter ending December 31, 2008, the Company is obligated to pay quarterly installments of principal in the amount of $360,000. On each of December 31, 2008, March 31, 2009, June 30, 2009 and August 2, 2009, the Company is obligated to pay installments of principal in the amount of $34,650,000.
      Under the senior revolving credit facility, the Company may request the issuance of up to $5.0 million in letters of credit and may borrow up to $5.0 million in swing line loans, a type of loan customarily used for short-term borrowing needs. All principal obligations under the senior revolving credit facility are to be repaid in full no later than August 2, 2009.
      The Company may prepay any of its borrowings under the Term B Senior Credit Facility, in whole or in part, in minimum increments of $1.0 million, in most cases without penalty or premium. The Company is responsible to pay any customary breakage costs related to the repayment of Eurodollar-based loans prior to the end of a designated Eurodollar rate interest period. The Company is required to pay a 1% prepayment premium on the amount of term loans prepaid from future debt proceeds if the interest rate margins of the future debt are lower than applicable interest rate margins then in effect under the Term B Senior Credit Facility and the Company makes the prepayment before April 1, 2006. If, during the term of the Term B Senior Credit Facility, the Company engages in the issuance or incurrence of certain permitted debt or the Company sells, transfers or otherwise disposes of certain of its assets, the Company must use all of the proceeds (net of certain costs, reserves, security interests and taxes) to repay term loan borrowings under the Term B Senior Credit Facility. If the Company engages in certain kinds of issuances of equity or has any excess cash flow for any fiscal year during the term of the Term B Senior Credit Facility, the Company must use 50 percent of the proceeds of the equity issuance (net of certain costs, reserves, security interests and taxes) or 50 percent of excess cash flow for that fiscal year to repay term loan borrowings under the Term B Senior Credit Facility. If the Company’s leverage ratio is less than 2.00 to 1.00 at the applicable time after taking into account the use of the net proceeds (in the case of an equity issuance), then the Company must use 25 percent of those net proceeds or excess cash flow for that fiscal year to repay term loan borrowings under the Term B Senior Credit Facility.
      If the Company borrows under the incremental term loan facility and certain economic terms of the incremental term loan, including applicable yields, maturity dates and average life to maturity, are more favorable to the incremental term loan lenders than the comparable economic terms under the senior term loan or the senior revolving credit facility, then the Term B Senior Credit Facility provides that the applicable interest rate spread will be adjusted upward. The upward adjustment will take place if the yield payable under the incremental term loan exceeds the yield under the senior term loan or senior revolving credit facility by more than 50 basis points. The effect of this provision is that an incremental term loan may make our borrowings under the senior term loan and the senior revolving credit facility more expensive.
      The Term B Senior Credit Facility requires that the Company’s existing subsidiaries and subsidiaries that the Company acquires during the term of the Term B Senior Credit Facility, other than certain insignificant

49



 

subsidiaries, guarantee the Company’s obligations under the Term B Senior Credit Facility. Accordingly, the Term B Senior Credit Facility is guaranteed by the Company subsidiaries, HFA, CATI, METI, and JJMA.
      Use of Proceeds. On August 2, 2004, the Company borrowed $50.0 million through the senior term loan under the Term B Senior Credit Facility. The Company used the proceeds to retire its then outstanding senior term loan and revolving credit facility administered by LaSalle Bank in the approximate amount of $47.2 million including principal and accrued and unpaid interest and to pay certain transaction fees associated with the refinancing in the approximate amount of $3.3 million. In October 2004, the Company borrowed approximately $22.0 million of the senior term loan to retire our existing mezzanine note in the approximate principal amount of $19.6 million and to pay accrued and unpaid interest and prepayment premium in the aggregate amount of approximately $2.4 million. On April 1, 2005, the Company borrowed $72 million in an incremental term loan under the Term B Senior Credit Facility. We used approximately $58.7 million of the incremental term loan proceeds to pay a portion of the JJMA acquisition price, and approximately $1.25 million to pay certain transaction fees associated with the incremental term loan. The remaining $12 million has been and will be used for general corporate purposes, which may include financing permitted acquisitions, and funding the Company’s working capital needs, as necessary.
      The Term B Senior Credit Facility permits the Company to use the remainder of its senior revolving credit facility for the Company’s working capital needs and other general corporate purposes, including to finance permitted acquisitions. The Term B Senior Credit Facility permits the Company to use any proceeds from the uncommitted incremental term loan facility to finance permitted acquisitions and to make certain put right payments required under the Company’s existing mezzanine warrant, if those put rights are exercised, and for any other purpose permitted by any future incremental term loan.
      Security. The Term B Senior Credit Facility is secured by a security interest in all of the Company’s current and future tangible and intangible property, as well as all of the current and future tangible and intangible property of the Company’s subsidiaries, HFA, CATI, METI, and JJMA.
      Interest and Fees. Under the Term B Senior Credit Facility, the senior term loan and the senior revolving credit facility can each bear interest at either of two floating rates. The Company was entitled to elect that interest be payable on the Company’s $143.3 million senior term loan at an annual rate equal to the prime rate charged by CSFB plus 125 basis points or at an annual rate equal to the Eurodollar rate plus 225 basis points. The Company was also entitled to elect that interest be payable on the Company’s senior revolving credit facility at an annual rate that varies depending on the Company’s leverage ratio and whether the borrowing is a Eurodollar borrowing or an alternate base rate (“ABR”) borrowing. Under the Term B Senior Credit Facility, if the Company were to elect a Eurodollar borrowing under its senior revolving credit facility, interest would be payable at an annual rate equal to the Eurodollar rate plus additional basis points as reflected in the table below under the column “Eurodollar Spread” corresponding to the Company’s leverage ratio at the time. Under the Term B Senior Credit Facility, if the Company elects an ABR borrowing under its senior revolving credit facility, the Company may elect an alternate base interest rate based on a federal funds effective rate or based on CSFB’s prime rate, plus additional basis points reflected in the table below under the column “Federal Funds ABR Spread” or “Prime Rate ABR Spread” corresponding to the Company’s leverage ratio at the time.

50



 

Eurodollar Prime Rate
                           
    Spread   ABR Spread   ABR Spread
Leverage Ratio   (In basis points)   (In basis points)   (In basis points)
             
Category 1
    275       225       175  
 
Greater than or equal to 3.00 to 1.00
                       
Category 2
    250       200       150  
 
Greater than or equal to 2.50 to 1.00 but less than 3.00 to 1.00
                       
Category 3
    225       175       125  
 
Greater than or equal to 2.00 to 1.00 but less than 2.50 to 1.00
                       
Category 4
    200       150       100  
 
Less than 2.00 to 1.00
                       
      On April 1, 2005, the Company elected to have the senior term loan bear interest at the Eurodollar rate and the senior revolving credit facility bear interest at the ABR rate (based on CSFB’s prime rate). As of September 30, 2005, the Eurodollar rate on the senior term loan was 6.45 percent (i.e., 4.20 percent plus 2.25 percent Eurodollar spread) and the ABR rate (based on CSFB’s prime rate) on the senior revolving credit facility was 7.50 percent (i.e., 5.75 percent plus 1.75 percent spread).
      Under the Term B Senior Credit Facility, the Company was required to enter into an interest rate hedge agreement acceptable to CSFB to fix or cap the actual interest the Company will pay on no less than 40 percent of the Company’s long-term indebtedness.
      On August 16, 2004, the Company entered into an interest rate cap agreement effective as of September 30, 2004 with one of the Company’s senior lenders. Under this agreement, in exchange for the Company’s payment to the senior lender of approximately $319,000, the Company’s maximum effective rate of interest payable with regard to an approximately $37.3 million portion of the outstanding principal balance of the Term B Senior Credit Facility was not to exceed 6.64 percent (i.e., LIBOR 3.89 percent cap plus maximum 2.75 percent Eurodollar spread) for the period September 30, 2004 through September 29, 2005 and was not to exceed 7.41 percent (i.e., LIBOR 4.66 percent cap plus 2.75 percent maximum Eurodollar spread) for the period September 30, 2005 through September 30, 2007.
      On April 15, 2005, the Company entered into a second interest rate cap agreement which covers an additional $28.0 million of the Company’s long-term indebtedness. The interest on such portion of the Company’s long-term indebtedness is capped at 7.25 percent (i.e., LIBOR 5.00 percent cap plus 2.25 percent Eurodollar spread). For this second cap agreement, the Company paid a senior lender $117,000. The second interest rate cap agreement terminates on September 30, 2007. Further, the Company’s maximum effective rate of interest payable under the first interest rate cap agreement was reset and capped at a maximum interest rate of 6.91 percent (i.e., LIBOR 4.66 percent cap plus maximum 2.25 percent Eurodollar spread). As of September 30, 2005, approximately $65.3 million, or 45.7 percent, of the $142.9 million drawn under the Term B Senior Credit Facility is at a capped interest rate. The maximum effective interest rate on the $65.3 million that is currently under cap agreements is approximately 7.06 percent. The remaining outstanding aggregate balance under the Term B Senior Credit Facility over $65.3 million, which was approximately $77.6 million as of September 30, 2005, is not subject to any interest rate cap agreements or arrangements.
      Subject to certain conditions, the Company may convert a Eurodollar-based loan to a prime rate based loan and the Company may convert a prime rate based loan to a Eurodollar-based loan.
      The Company is obligated to pay on a quarterly basis a commitment fee of 0.50 percent per annum on the daily unused amount in the preceding quarter of the commitments made to the Company under the Term B Senior Credit Facility including the unused portion of the senior term loan and the unused portion of the $30.0 million senior revolving credit facility.

51



 

      For fiscal year 2005, as of September 30, 2005, the Company has paid a 0.5 percent commitment fee of $0.2 million dollars and approximately $0.06 million on the unused amounts of the senior term loan and senior revolving credit facility, respectively. As of September 30, 2005, the unused amounts of the senior term loan and senior revolving credit facility were zero and approximately $30.0 million, respectively.
      Each time a letter of credit is issued on the Company’s behalf under the senior revolving credit facility, the Company will pay a fronting fee not in excess of 0.25 percent of the face amount of the letter of credit issued. In addition, the Company will pay quarterly in arrears a letter of credit fee based on the interest rate spread applicable to the revolving credit facility borrowing made to issue the letter of credit. The Company will also pay standard issuance and administrative fees specified from time to time by the bank issuing the letter of credit.
      In addition to letter of credit fees, commitment fees and other fees payable under the Term B Senior Credit Facility, the Company will also pay an annual agent’s fee.
      Covenants. The Term B Senior Credit Facility requires the Company to meet the following financial tests over the life of the facility:
  •  Leverage Ratio. The Company’s leverage ratio is calculated by dividing the total outstanding amount of all of the Company’s consolidated indebtedness, but excluding the amount owed under the Company’s subordinated note and the aggregate amount of letters of credit issued on the Company’s behalf other than drawings which have not been reimbursed, by the Company’s consolidated EBITDA for the previous four fiscal quarters on a rolling basis. The maximum total leverage ratio is measured as of the end of each of our fiscal quarters. For purposes of determining the Company’s leverage ratio as of or for the quarters ended on September 30, 2004, December 31, 2004 and March 31, 2005, the Term B Senior Credit Facility deems the Company’s consolidated EBITDA to be $7.5 million for the fiscal quarter ended December 31, 2003, $7.0 million for the fiscal quarter ended March 31, 2004, and $7.7 million for the fiscal quarter ended June 30, respectively. For each of the following time periods, the Company is required to maintain a maximum leverage ratio not greater than the following:
         
Period   Ratio
     
    3.75 to 1.00  
    3.50 to 1.00  
    3.25 to 1.00  
    2.75 to 1.00  
Thereafter
    2.25 to 1.00  
  •  Interest Coverage Ratio. The Company’s interest coverage ratio is calculated by dividing the Company’s consolidated EBITDA, less amounts the Company spends attributable to property, plant, equipment and other fixed assets, by the Company’s consolidated interest expense. For purposes of determining the Company’s interest coverage ratio as of or for the quarters ended on September 30, 2004, December 31, 2004 and March 31, 2005, the Term B Senior Credit Facility deems the Company’s consolidated EBITDA to be $7.5 million for the fiscal quarter ended December 31, 2003, $7.0 million for the fiscal quarter ended March 31, 2004, and $7.7 million for the fiscal quarter ended June 30, 2004. The Company is required to maintain a minimum fixed charge coverage ratio of at least the following:
         
Date or Period   Ratio
     
    3.75 to 1.00  
Thereafter
    4.00 to 1.00  

52



 

      The Term B Senior Credit Facility includes covenants which, among other things, restrict the Company’s ability to do the following without the prior consent of syndicate bank members that have extended 50 percent or more of the then outstanding aggregate senior credit facility:
  •  incur additional indebtedness other than permitted additional indebtedness;
 
  •  consolidate, merge or sell all or substantially all of the Company’s assets;
 
  •  make certain loans and investments including acquisitions of businesses, other than permitted acquisitions;
 
  •  pay dividends or distributions other than distributions needed for the ESOP to satisfy its repurchase obligations, for the Company to satisfy any put right if exercised by mezzanine warrant holders and for certain payments required under the Company’s equity based incentive plans;
 
  •  enter into transactions with the Company’s shareholders and affiliates;
 
  •  enter into certain transactions not permitted under ERISA;
 
  •  grant certain liens and security interests;
 
  •  enter into sale and leaseback transactions;
 
  •  change lines of business;
 
  •  repay subordinated indebtedness and redeem or repurchase certain equity; or
 
  •  use the proceeds of the Company’s borrowings other than as permitted by the Term B Senior Credit Facility.
      Events of Default. The Term B Senior Credit Facility contains customary events of default including, without limitation:
  •  payment default;
 
  •  breach of representations and warranties;
 
  •  uncured covenant breaches;
 
  •  default under certain other debt exceeding an agreed amount;
 
  •  bankruptcy and insolvency events;
 
  •  notice of debarment, suspension or termination under a material government contract;
 
  •  certain ERISA violations;
 
  •  unstayed judgments in excess of an agreed amount;
 
  •  failure of the subordinated note to be subordinated to the Term B Senior Credit Facility;
 
  •  failure of the guarantee of the Term B Senior Credit Facility to be in effect;
 
  •  failure of the security interests to be valid, perfected first priority security interests in the collateral;
 
  •  failure of the Company to remain an S-corporation;
 
  •  the Trust is subject to certain taxes in excess of an agreed amount;
 
  •  final negative determination that the ESOP is not a qualified plan; or
 
  •  change of control (as defined below).
      For purposes of the Term B Senior Credit Facility, a change of control generally occurs when, before the Company lists its common stock to trade on a national securities exchange or the NASDAQ National Market quotation system and obtains net proceeds from an underwritten public offering of at least $30,000,000, the Trust fails to own at least 51 percent of the Company’s outstanding equity interests, or, after the Company has

53



 

such a qualified public offering, any person or group other than IIT or the Trust owns more than 37.5 percent of the Company’s outstanding equity interests. A change of control may also occur if a majority of the seats (other than vacant seats) on the Company’s board of directors shall at any time be occupied by persons who were neither nominated by our board nor were appointed by directors so nominated. A change of control may also occur if a change of control occurs under any of the Company’s material indebtedness including the Company’s subordinated note, the warrants issued with the Company’s subordinated note and the warrants issued with the Company’s retired mezzanine note (which warrants remain outstanding).
      Senior Credit Agreement. On December 20, 2002, the Company executed a Senior Credit Agreement among LaSalle Bank National Association and other lenders to refinance and replace IITRI’s prior credit arrangements and to finance, in part, the Transaction. The Senior Credit Agreement consisted of a $35.0 million Senior Term Note and a $25.0 million revolving credit facility. All principal obligations under the Senior Credit Agreement were to be repaid in full no later than December 20, 2007. The Senior Credit Agreement was secured by a first priority, perfected security interest in all of the Company’s current and future tangible and intangible property.
      Prior to the CSFB refinancing in August 2004, the Company had approximately $47.2 million in borrowings under the Senior Credit Agreement (approximately $24.0 million under the revolving credit facility and approximately $23.2 million under the Senior Term Note), each of which bore interest at either of two floating rates: a per year rate equal to the Eurodollar rate plus 350 basis points, or LaSalle’s prime rate (base rate) plus 200 basis points. Under the Senior Credit Agreement, balances drawn on the revolving credit facility bore interest at the LaSalle Bank prime rate plus 200 basis points.
      Effective February 14, 2003, the Company elected that the Senior Term Note bear interest at a Eurodollar rate. This election did not affect the interest rate applicable to amounts borrowed under the revolving line of credit. Interest under the Senior Term Note was payable at LaSalle’s prime rate (base rate) plus 200 basis points until February 14, 2003. Thereafter, the Senior Term Note bore interest at the Eurodollar rate plus 350 basis points.
      On August 2, 2004, the revolving credit facility and Senior Term Note were extinguished with proceeds from the Term B Senior Credit Facility. As of August 2, 2004, the Company had approximately $24.0 million borrowed under the revolving credit facility at an interest rate equal to approximately 6.25% (LaSalle Bank prime rate plus 200 basis points).
      The Company had entered into an interest rate cap agreement effective as of February 3, 2003 with one of its senior lenders. Under this agreement, the Company’s maximum effective rate of interest payable on the first $25 million of principal under its term note was not to exceed 6 percent. Any interest the Company paid on the first $25 million of principal in excess of 6 percent was to be reimbursed to the Company semiannually by the senior lender pursuant to the cap agreement. On August 2, 2004, the cap agreement was extinguished and its remaining value was recognized as interest expense.
      Mezzanine Note. On December 20, 2002, the Company issued to IITRI a Mezzanine Note securities purchase agreement (Mezzanine Note) with a face value of approximately $20.3 million. The Mezzanine Note served as part of the consideration for the Transaction. On July 1, 2004, the Illinois Institute of Technology (IIT) acquired all of IITRI’s rights and interests in the Mezzanine Note and the related Warrant Agreement.
      On March 28, 2003, an officer of the Company purchased a portion of the Company’s Mezzanine Note owned by IITRI for $750,000, its face value (as described below in “Other Notes and Agreements”).
      On October 1, 2004, the Company borrowed $22.0 million under the Senior Secured Term B Loan. The Company used the proceeds of the October 1, 2004, borrowing to redeem the Mezzanine Note for approximately $19.6 million, to pay a prepayment penalty of approximately $1.8 million and to pay approximately $0.6 million in accrued interest. The Company recognized an expense of approximately $3.9 million on extinguishment of the Mezzanine Note, including approximately $2.1 million for amortization of original issue discount in addition to the $1.8 million prepayment penalty.

54



 

      Subordinated Note. On December 20, 2002, the Company issued a seller note to IITRI under a seller note securities purchase agreement (Subordinated Note) with a face value of $39.9 million. The Subordinated Note served as part of the consideration for the Transaction. On July 1, 2004, the Illinois Institute of Technology (IIT) acquired all of IITRI’s rights and interests in the Subordinated Note and the related Warrant Agreement. The Subordinated Note bears interest at a rate of 6% per year through December 2008 payable quarterly by the issuance of non-interest bearing notes (paid-in-kind notes or PIK notes) maturing at the same time as the Subordinated Note. The issuance of the PIK notes will have the effect of deferring the underlying cash interest expense on the Subordinated Note, but because the PIK notes will not themselves bear interest, they will not have the effect of compounding any interest on these interest payment obligations. Commencing December 2008, the Subordinated Note will bear interest at 16% per year payable quarterly in cash through the time of repayment in full of the Subordinated Note. Principal on the Subordinated Note will be payable in equal installments of $19.95 million in December 2009 and December 2010; the PIK notes are also due in equal installments of $7.2 million on these same dates.
      Warrants. The Company issued detachable warrants with the Mezzanine Note and the Subordinated Note. The outstanding warrants associated with the Mezzanine Note represent the right to buy approximately 504,902 shares of Alion common stock at an exercise price of $10.00 per share. These warrants are exercisable until December 20, 2008 and contain a put right giving the holder the right to require the Company to purchase the warrants back at the then-current fair value of the Company’s common stock, minus the warrants’ exercise price. The put right can be exercised within thirty days after a change in control, or within thirty days prior to December 20, 2008, or within thirty days after delivery to the current holders of an appraisal of the per share value of the Company’s common stock as of September 30, 2008, if the ESOP still exists and no public market price exists for the Company’s common stock. Although the Mezzanine Note was redeemed on October 1, 2004, the detachable warrants remained outstanding.
      As of September 30, 2005, the warrants associated with the Subordinated Note represent the right to buy approximately 1,080,437 shares of Alion common stock at an exercise price of $10.00 per share. These warrants are exercisable until December 20, 2010 and also contain a put right giving the holder the right to require the Company to purchase the warrants back at the then-current fair value of the Company’s common stock, minus the warrants’ exercise price. This put right applies to up to 50% of these warrants within thirty days prior to December 20, 2009 (or within thirty days after delivery to the warrant holders of an appraisal of the per share value of the Company’s common stock as of September 30, 2009, if the ESOP still exists and no public market price exists for its common stock), and up to 100% of these warrants within thirty days prior to December 20, 2010 (or within thirty days after delivery to the warrant holders of an appraisal of the per share value of its common stock as of September 30, 2010, if the ESOP still exists and no public market value exists for its common stock).
      All put rights terminate upon one or more underwritten public offerings of Alion common stock resulting in aggregate gross proceeds of at least $30.0 million to the sellers (excluding proceeds received from certain affiliates of Alion).
      In July 2004, IITRI transferred all of its rights, title and interest in the warrants to the Illinois Institute of Technology.
      Other Notes and Agreements. On December 20, 2002, the Company entered into a $0.9 million Deferred Compensation Agreement with Dr. Atefi, with payment terms substantially equivalent to those of the Mezzanine Note. The Company also issued Dr. Atefi detachable warrants representing the right to buy approximately 22,062 shares of Alion common stock at an exercise price of $10.00 per share, with put rights similar to those contained in the warrants accompanying the Mezzanine Note. On October 29, 2004, Dr. Atefi elected to redeem the amount due under his Deferred Compensation Agreement. The Company paid Dr. Atefi approximately $0.9 million, plus approximately $0.2 million in accrued interest.
      On February 11, 2004, the Company borrowed $750,000 from an officer of the Company. On June 7, 2004, the Company issued the officer a Promissory Note with interest at a rate of 15% per annum effective February 11, 2004 to March 31, 2009.

55



 

      The Company extinguished the Promissory Note on December 9, 2004, and paid $750,000 plus accrued interest of $21,635 to the officer.
      During fiscal year 2006 and the next four fiscal years, at a minimum, we expect that we will have to make the estimated interest and principal payments set forth below.
                                           
    5-Fiscal Year Period
     
    2006   2007   2008   2009   2010
                     
    ($ In thousands)
Bank revolving credit facility
                                       
 
- Interest(1)
  $ 150     $ 150     $ 150     $ 150     $  
Senior Secured Term B Loan
                                       
 
- Interest(2)
    9,775       9,902       9,938       5,068        
 
- Principal(3)
    1,440       1,440       1,440       138,600        
Subordinated note
                                       
 
- Interest(4)
                      6,384       3,192  
 
- Principal(4)
                      27,132       27,132  
                               
Total cash — Pay interest
    9,925       10,052       10,088       11,602        
Total cash — Pay principal
    1,440       1,440       1,440       165,732       27,132  
                               
 
Total
  $ 11,365     $ 11,492     $ 11,528     $ 177,334     $ 30,324  
                               
 
(1)  We anticipate accessing, from time to time, our $30.0 million bank revolving credit facility to finance our ongoing working capital needs. The term of the revolving credit facility is five years. For the fiscal years 2006 through 2009, we anticipate the balance drawn on the revolving credit facility to be minimal. The interest expense value includes an estimate for the unused balance fee on the $30.0 million revolving credit facility.
 
(2)  The projected average annual balance which we estimate will be drawn under the Senior Secured Term B Loan is as follows: $141.8 million, $140.4 million, $139.0 million, $69.9 million, and $0.0 million for fiscal years ending September 30, 2006, 2007, 2008, 2009, and 2010, respectively. Given the structure of the Term B senior credit facility, the Company expects that it will need to refinance the Term B Senior Credit Facility before the end of fiscal year 2008 and, therefore, interest expense would continue at levels similar to those set forth for prior years. Based on an estimated LIBOR rate plus the CSFB Eurodollar spread, the effective annual interest rate for fiscal years 2006, 2007, 2008, 2009 and 2010 is estimated to be approximately 7.2%, 7.1%, 7.2%, 7.4% and 7.8% respectively. The effective interest rate takes into account the interest rate cap agreements which limit the interest rate we will pay on a portion, but not all, of the outstanding principal balance of the Term B Senior Credit Facility. The current cap agreements expire in September 2007. Outstanding principal balances not under the cap agreements have interest expense based on the Eurodollar rate. The term of the Senior Secured Term B Loan is five years. The approximate impact of a 1% increase in the interest rate, as applied to principal balances drawn under the Senior Secured Term B Loan not covered by the current interest rate cap agreements would be $0.8 million, $0.8 million, $1.4 million, $0.7 million, and $0.0 million for the fiscal years ending September 30, 2006, 2007, 2008, 2009 and 2010, respectively. The estimated interest expense value includes an estimate for the commitment fee on the Senior Secured Term B Loan.
 
(3)  The Term B senior credit facility requires us to repay 1 percent of the principal balance outstanding under the senior term loan during the first four years (i.e. fiscal years 2005 through 2008) of its term and 96 percent of the principal balance outstanding during the fifth and final year (i.e. 2009) of the term. The table reflects the balance drawn of $142.9 as of September 30, 2005, resulting in expected annual principal payments of approximately $1.4 million in each of fiscal years 2006, 2007, and 2008. During the fifth year, or 2009, we are scheduled to pay principal in the amount of $138.6 million. The Term B Senior Credit Facility also requires us to make mandatory prepayments of principal depending upon whether we

56



 

generate certain excess cash flow in a given fiscal year, we issue certain equity, we issue or incur certain debt or we sell certain assets. As of September 30, 2005, no mandatory prepayments are due.
 
(4)  Interest expense on the subordinated note during the four fiscal years from 2005 to 2008 is 6% simple interest, paid-in-kind by the issuance of the PIK notes. These interest amounts accrue to principal increasing the principal value of the subordinated note. PIK notes do not bear interest. Interest obligations paid by issuance of the PIK notes will not be compounded. In the years 2005 through 2008, the PIK interest on the Subordinated Note will be approximately $2.4 million in each year. During the eight-year term of the Subordinated Note, approximately $14.2 million of principal accretes to the note through the PIK notes. These amounts are included in the principal payments in fiscal years 2009 and 2010. In years 2009 and 2010, interest will be 16% paid quarterly in cash on the original principal of $39.9 million. The principal, together with the outstanding balance of the PIK notes, will be paid in equal amounts at the end of fiscal years 2009 and 2010.
Other Obligations.
Earn-outs
      The Company has earn-out commitments related to the following acquisitions:
        AB Technologies (AB Tech) — Earn-out is based on an agreed-upon formula applied to net income of the business units that formerly comprised AB Tech. The earn-out obligation period expired on February 7, 2005, the fifth anniversary of the original acquisition date. As of September 30, 2005, approximately $1.4 million of earn-out has been recorded for fiscal year 2005. As of September 30, 2005, the maximum earn-out obligation of $11.5 million has been recorded from inception to date. On July 22, 2005, the Company settled the ongoing dispute between the Company and AB Tech. Under the terms of the settlement, the Company paid $3.4 million to the former shareholders of AB Tech in July 2005, and has a remaining obligation to pay $0.7 million to the former shareholders of AB Tech within fifteen days following the date that the Company’s fiscal 2005 year-end audited financial statement report by the Company’s auditor is issued and made publicly available by the Company.
 
        ITSC — Earn-out is based on a portion of the gross revenue of the business units that formerly comprised ITSC. The Company has a maximum earn-out provision not-to-exceed $2.5 million. As of September 30, 2005, approximately $1.8 million of earn-out has been recorded from the date of the acquisition, of which approximately $1.5 million was recorded in fiscal year 2005. The obligation continues through December 31, 2005.
 
        CATI — Earn-out is based on the performance of the business units that formerly comprised CATI. The Company has a maximum earn-out provision not-to-exceed a cumulative amount of $9.0 million based on attaining certain revenue goals for fiscal years 2005, 2006, and 2007, and the Company has a second earn-out provision not-to-exceed a maximum of $1.5 million for attaining certain revenue goals in the commercial aviation industry. As of September 30, 2005, no earn-out obligation has been recorded for fiscal year 2005. The obligation continues through February 25, 2007.
Lease payments
      The Company’s remaining minimum lease payment obligations under non-cancelable operating leases for the fiscal years ending 2006, 2007, 2008, 2009 and 2010 are $19.0 million, $16.7 million, $15.4 million, $12.3 million and $7.9 million, respectively. The remaining aggregate obligations on these leases thereafter are approximately $4.5 million. Commercial facility lease expenses are included in these amounts. These commercial facility lease obligations are currently reimbursable costs under the Company’s government contracts.

57



 

Repurchase obligations under KSOP
      As of September 30, 2005, the Company has spent a cumulative total, from inception to date, of approximately $9.9 million to repurchase shares of its common stock from the ESOP Trust to satisfy obligations under the KSOP to terminated employees.
Repurchase obligations under the KSOP
                         
    Number of Shares       Total Value
Date   Repurchased   Share Price   Purchased
             
June 2003
    5,248     $ 11.13     $ 58,412  
July 2003
    2,696     $ 11.13     $ 30,000  
December 2003
    50,031     $ 14.71     $ 735,956  
May 2004
    117     $ 16.56     $ 1,945  
June 2004
    727     $ 16.56     $ 12,039  
June 2004
    743     $ 16.56     $ 12,297  
July 2004
    48,309     $ 16.56     $ 799,997  
December 2004
    46,816     $ 19.94     $ 933,505  
March 2005
    5,691     $ 19.94     $ 113,486  
June 2005
    45,846     $ 29.81     $ 1,366,674  
August 2005
    1,090     $ 33.78     $ 36,803  
September 2005
    170,657     $ 33.78     $ 5,764,784  
Other contingent obligations which will impact the Company’s cash
  •  Obligations related to the holders’ put rights associated with the Mezzanine Note warrants;
 
  •  Obligations related to the holder’s put rights associated with the Subordinated Note warrants;
 
  •  Obligations relating to our stock appreciation rights and phantom stock programs; and
 
  •  Obligations relating to deferred compensation programs for senior managers.
      The Company believes that cash flow from operations and cash available under its revolving credit facility will provide it with sufficient capital to fulfill its current business plan and to fund its working capital needs for at least the next 36 months. Although the Company expects to have positive cash flow from operations, it will need to generate significant additional revenues beyond its current revenue base and to earn net income in order to repay principal and interest on the indebtedness it assumed under the new Term B Senior Credit Facility and the remaining outstanding indebtedness it incurred to fund the Transaction.
      The Company’s business plan calls for it to continue to acquire companies with complementary technologies. The Term B senior credit facility permits the Company to make certain permitted acquisitions, and the Company intends to use a portion of the financing available to it under the Term B Senior Credit Facility to make permitted acquisitions.
      Given the structure of the Term B senior credit facility, the Company expects that it will need to refinance the Term B Senior Credit Facility before the end of fiscal year 2008. The Company’s cash from operations will be insufficient to satisfy all of its obligations and it cannot be certain that it will be able to refinance on terms that will be favorable to the Company, if at all. Moreover, if the Company’s plans or assumptions change, if its assumptions prove inaccurate, if it consummates additional or larger investments in or acquisitions of other companies than are currently planned, if it experiences unexpected costs or competitive pressures, or if its existing cash and projected cash flow from operations prove insufficient, it may need to obtain greater amounts of additional financing and sooner than expected. While it is the Company’s intention only to enter into new financing or refinancing that it considers advantageous, it cannot be certain

58



 

that such sources of financing will be available to the Company in the future, or, if available, that financing could be obtained on terms favorable to the Company.
Contract performance — Joint Spectrum Center Contract
      The Company did not win the re-compete for its existing contract with the JSC. The Company filed a protest against the award of the contract to one of its competitors. The Company’s principal argument was that the successful bidder had an organizational conflict of interest with respect to its proposed performance of the contract. In its decision dated January 9, 2006, the GAO sustained the protest and recommended that the contracting agency take certain corrective action in order to address the awardee’s organizational conflict of interest. The Company is awaiting further action from the contracting agency. The Company continues to support the JSC customer under its existing contract until the issues involved in its protest are fully resolved.
Summary of Critical Accounting Policies
Revenue Recognition
      The Company’s revenue results from contract research and other services under a variety of contracts, some of which provide for reimbursement of cost plus fees and others of which are fixed-price or time-and-material type contracts. The Company generally recognizes revenue when a contract has been executed, the contract price is fixed or determinable, delivery of the services or products has occurred and collectibility of the contract price is considered probable.
      Revenue on cost-reimbursement contracts is recognized as costs are incurred and include estimates of applicable fees earned. Revenue on time-and-material contracts is recognized at contractually billable rates as labor hours and direct expenses are incurred. Under time-and-material contracts, labor and related costs are reimbursed at negotiated, fixed hourly rates.
      Revenue on fixed price contracts is recognized on the percentage-of-completion method based on various performance measures. From time to time, facts develop that require the Company to revise its estimated total costs or revenues expected. The cumulative effect of revised estimates is recorded in the period in which the facts requiring revisions become known. The full amount of anticipated losses on any type of contract are recognized in the period in which they become known.
      Contracts with agencies of the federal government are subject to periodic funding by the contracting agency concerned. Funding for a contract may be provided in full at inception of the contract or ratably throughout the term of the contract as the services are provided. If funding is not assessed as probable, revenue recognition is deferred until realization is probable.
      The amount of government contract expense reflected in the consolidated financial statements attributable to cost reimbursement contracts is subject to audit and possible adjustment by the Defense Contract Audit Agency (DCAA). The government considers the Company to be a major contractor and DCAA maintains an office on site to perform its various audits throughout the year. DCAA has concluded its audits of the Company’s indirect costs and cost accounting practices through fiscal year 2001. There were no significant disallowances for fiscal years ended September 31, 2000 and 2001. The fiscal year 2005 indirect expense rate submittal is scheduled to be provided to the government for review on or about March 30, 2006. Contract revenues on federal government contracts have been recorded in amounts that are expected to be realized upon final settlement.
      The Company recognizes revenue on unpriced change orders as expenses are incurred only to the extent that the Company expects it is probable that such costs will be recovered. The Company recognizes revenue in excess of costs on unpriced change orders only when management can also reliably estimate the amount of excess and experience provides a sufficient basis for recognition. The Company recognizes revenue on claims as expenses are incurred only to the extent that the Company expects it is probable that such costs will be recovered and the amount of recovery can be reliably estimated.

59



 

      Software revenue is generated from licensing software and providing services. Where professional services are considered essential to the functionality of the solution sold, revenue is recognized on the percentage of completion method, as prescribed by AICPA SOP 81-1, Accounting for Performance on Construction-Type and Certain Production-Type Contracts.
Goodwill and Intangible Assets
      The purchase price that we pay to acquire the stock or assets of an entity must be assigned to the net assets acquired based on the estimated fair value of those net assets. The purchase price in excess of the estimated fair value of the tangible net assets and separately identified intangible assets acquired represents goodwill. The purchase price allocation related to acquisitions involves significant estimates and management judgments that may be adjusted during the purchase price allocation period.
      The Company accounts for goodwill and other intangible assets in accordance with the provisions of SFAS No. 142, which requires, among other things, the discontinuance of goodwill amortization. In addition, goodwill is to be reviewed at least annually for impairment or more frequently if events and circumstances indicate that the asset might be impaired. The Company has elected to perform this review annually at the end of each fiscal year. An impairment loss would be recognized to the extent that the carrying amount exceeds the asset’s fair value. This determination consists of two steps. First, the Company estimates its fair value using an estimate of the fair value of its common stock based upon a valuation performed by an independent, third-party firm and compares it to its carrying amount. Second, if the carrying amount exceeds its fair value, an impairment loss is recognized for any excess of the carrying amount of goodwill over the implied fair value of that goodwill. The implied fair value of goodwill is determined by allocating the fair value in a manner similar to a purchase price allocation, in accordance with FASB Statement No. 141, Business Combinations. The residual fair value after this allocation is the implied fair value of the goodwill.
      As of September 30, 2005, the Company has goodwill of approximately $167.5 million, subject to annual impairment review. As of September 30, 2005, the Company has a recorded net intangible asset balance of approximately $26.2 million, comprised primarily of purchased contracts which were acquired in connection with the Transaction and the ITSC, IPS, Countermeasures, METI, CATI and JJMA acquisitions. The intangible assets have an estimated useful life of one to three years and are amortized using the straight-line method.
Recently Issued Accounting Pronouncements
      In December 2004, the Financial Accounting Standards board (FASB) issued SFAS No. 123 (revised 2004), Share-Based Payment, a revision of SFAS No. 123, Accounting for Stock-Based Compensation (SFAS 123(R)). SFAS 123(R) supersedes Accounting Principles Board Opinion No. 25, Accounting for Stock Issued to Employees. SFAS 123(R) requires all share-based payments to employees, including grants of employee stock options, to be recognized in the financial statements based on their fair value. SFAS 123(R) is effective in the first quarter of fiscal 2007. The Company is analyzing the expected impact of adoption of this Statement.
      In March 2005, the FASB issued Interpretation No. (FIN) 47, Accounting for Conditional Asset Retirement Obligations — an Interpretation of FASB Statement No. 143. FIN 47 clarifies the definition of a conditional asset retirement obligation, as used in SFAS No. 143, as a legal obligation to perform an asset retirement activity in which the timing and (or) method of settlement are conditional on a future event that may or may not be within the control of the entity. FIN 47 requires a liability to be recorded if the fair value of the obligation can be reasonable estimated. The Interpretation is effective no later than December 31, 2005. The Company is currently analyzing the expected impact of adoption of this Interpretation on its financial statements, but currently does not believe its adoption will have a significant impact on the financial position or results of operations of the Company.

60



 

Contractual Obligations
      The following table summarizes our contractual and other forecasted long-term debt obligations. For contractual obligations, we included payments that we have a legal obligation to make.
                                             
    Payments Due by Fiscal Year
     
    Total   2006   2007-2009   2010-2011   2012 and After
                     
    (In thousands)
Contractual Obligations:
                                       
 
Long-term debt(1)
  $ 242,043     $ 11,365     $ 200,354     $ 30,324     $  
 
Lease Obligations
    75,821       19,035       44,405       12,381     $  
                               
   
Total contractual obligations
  $ 317,864     $ 30,400     $ 244,759     $ 42,705     $  
                               
 
(1)  Includes interest payments and forecasted debt obligations. Given the structure of the Term B senior credit facility, the Company expects that it will need to refinance the Term B Senior Credit Facility before the end of fiscal year 2008.
Off-Balance Sheet Financing Arrangements
      The Company accounts for operating leases entered into in the routine course of business in accordance with Statement of Financial Accounting Standards 13, Leases. The Company has no off-balance sheet financing arrangements other than its operating leases. The Company has no relationship with any unconsolidated or special purpose entity, nor has it issued any guarantees.
Item 7a. Quantitative and Qualitative Disclosures About Market Risk
Interest rate risk
      The Company’s exposure to interest rate risk is primarily due to the debt it incurred to finance the Transaction and the subsequent refinancing of a portion of that debt in August 2004 and additional financing undertaken by the Company in October 2004 and April 2005. The Subordinated Note has a stated fixed interest rate, and therefore presents no risk of change to interest charges as a result of an increase in market interest rates. The balance drawn under the $30.0 million senior revolving credit facility bears interest at variable rates based on CSFB’s prime rate plus a maximum spread of 175 basis points. The balance on the Senior Secured Term B Loan bears interest at variable rates tied to the Eurodollar rate. Such variable rates increase the risk that interest charges will increase materially if market interest rates increase. The Company has reduced, in part, the maximum total amount of variable interest rate risk on the Senior Secured Term B Loan by entering into two interest rate cap agreements that cover the first $65.3 million of principal borrowed (which balance declines over time). Under the first cap agreement, in exchange for our payment to a senior lender of approximately $0.3 million, our maximum effective rate of interest payable with regard to an approximately $37.3 million portion of the outstanding principal balance of the Senior Secured Term B Loan will not exceed 6.64 percent. (i.e., LIBOR 3.89 percent cap plus maximum 2.75 percent Eurodollar spread) for the period September 30, 2004 through September 29, 2005 and is not to exceed 6.91 percent (i.e., LIBOR 4.66 percent cap plus 2.25 percent maximum Eurodollar spread) for the period September 30, 2005 through September 29, 2007. Under the second cap agreement, in exchange for our payment to a senior lender of approximately $0.1 million, our maximum effective interest rate payable with regard to an approximately $28.0 million additional portion of the outstanding principal balance under the Senior Secured Term B Loan will not exceed 7.25% (i.e., LIBOR 5.0 percent cap plus maximum 2.25 percent Eurodollar spread) through the date of termination of the second interest rate cap agreement on September 30, 2007. The remaining outstanding aggregate balance under the Term B Senior Credit Facility over $65.3 million, which was approximately $77.6 million as of September 30, 2005, is not subject to any interest cap rate cap agreements or arrangements. For a description of the existing interest rate cap arrangements, refer to “Discussion of Debt Structure” in “Management’s Discussion and Analysis of Financial Condition and Results of Operations.”

61



 

      The approximate impact of a 1% increase in the interest rate, as applied to principal balances drawn under the Senior Secured Term B Credit Facility that are not covered by the current interest rate cap agreement, would be $0.8 million, $0.8 million, $1.4 million, $0.7 million, and $0.0 million for fiscal years ending September 30, 2006, 2007, 2008, 2009 and 2010, respectively.
      The Company does not use derivatives for trading purposes. It invests its excess cash in short-term, investment grade, and interest-bearing securities.
Foreign currency risk
      Because the Company’s expenses and revenues from its international research contracts are generally denominated in U.S. dollars, the Company does not believe that its operations are subject to material risks associated with currency fluctuations.
Risk associated with value of Alion common stock
      The Company has exposure to change in the fair market value of Alion’s common stock as the economic basis for the estimate of contingent obligations relating to, among other things:
  •  Obligations related to the holders’ put rights associated with the Mezzanine Note warrants; and
 
  •  Obligations related to the holder’s put rights associated with the Subordinated Note warrants.
      The value of those obligations would increase by approximately $5.7 million if the price of the Company’s stock were to increase by 10% and would decrease by approximately $5.7 million if the price of the Company’s stock were to decrease by 10%. Such changes would be reflected as a component of interest expense in the Company’s consolidated statements of operations.
      The Company also has exposure to change in the fair market value of Alion’s stock as the economic basis for the estimate of contingent obligations relating to its repurchase obligations under the KSOP and obligations relating to stock appreciation rights and phantom stock programs.
      The amount of such exposure will depend upon a number of factors. These factors include, but are not limited to, the number of Alion employees who might seek to redeem shares of Alion stock for cash following termination of employment, and the number of employees who might exercise their rights under the stock appreciation and phantom stock programs during any particular time period.

62



 

Item 8. Financial Statements and Supplementary Data
INDEX TO FINANCIAL STATEMENTS
       
Consolidated Financial Statements of Alion Science and Technology Corporation
   
  64
Consolidated Financial Statements:
   
    65
    66
    67
    68
    70
Consolidated Financial Statement Schedule
   
    95
Consolidated Financial Statements of Selected Operations of IIT Research Corporation
   
  97
Consolidated Financial Statements:
   
    98
    99
    100
    101
  102

63



 

REPORT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
The Board of Directors
Alion Science and Technology Corporation:
      We have audited the consolidated financial statements of Alion Science and Technology Corporation and subsidiaries (the Company) as listed in the accompanying index. In connection with our audits of the consolidated financial statements, we also have audited the consolidated financial statement schedule as listed in the accompanying index. These consolidated financial statements and consolidated financial statement schedule are the responsibility of the Company’s management. Our responsibility is to express an opinion on these consolidated financial statements and consolidated financial statement schedule based on our audits.
      We conducted our audits in accordance with the standards of the Public Company Accounting Oversight Board (United States). Those standards require that we plan and perform the audit to obtain reasonable assurance about whether the financial statements are free of material misstatement. An audit includes examining, on a test basis, evidence supporting the amounts and disclosures in the financial statements. An audit also includes assessing the accounting principles used and significant estimates made by management, as well as evaluating the overall financial statement presentation. We believe that our audits provide a reasonable basis for our opinion.
      In our opinion, the consolidated financial statements referred to above present fairly, in all material respects, the financial position of Alion Science and Technology Corporation and subsidiaries as of September 30, 2005 and 2004, and the results of their operations and their cash flows for each of the years in the three-year period ended September 30, 2005, in conformity with U.S. generally accepted accounting principles. Also in our opinion, the related consolidated financial statement schedule, when considered in relation to the basic consolidated financial statements taken as a whole, presents fairly, in all material respects, the information set forth therein.
  /s/ KPMG LLP
Chicago, Illinois
January 31, 2006

64



 

ALION SCIENCE AND TECHNOLOGY CORPORATION
CONSOLIDATED BALANCE SHEETS
                       
    September 30,
     
    2005   2004
         
    (In thousands, except
    share and per share
    information)
Current assets:
               
 
Cash and cash equivalents
  $ 37,778     $ 4,717  
 
Accounts receivable, less allowance of $3,539 and $2,896 at September 30, 2005 and September 30, 2004, respectively
    80,898       68,949  
 
Stock subscriptions receivable
    1,733       1,556  
 
Prepaid expenses
    1,944       1,333  
 
Other current assets
    2,802       1,008  
             
     
Total current assets
    125,155       77,563  
Property, plant and equipment, net
    11,174       10,778  
Intangible assets, net
    30,198       13,618  
Goodwill
    163,419       83,075  
Other assets
    1,860       1,688  
Deferred compensation assets
    2,443       1,739  
             
     
Total assets
    334,249       188,461  
             
Current liabilities:
               
 
Current portion, Term B Senior Credit Facility note payable
    1,404       468  
 
Current portion, acquisition obligations
    3,616       3,059  
 
Trade accounts payable and accrued liabilities
    27,312       23,420  
 
Accrued payroll and related liabilities
    29,161       18,561  
 
ESOP liabilities
    274       136  
 
Current portion of accrued loss on operating leases
    1,054       832  
 
Billings in excess of costs and estimated earnings on uncompleted contracts
    2,559       676  
             
     
Total current liabilities
    65,380       47,152  
Acquisition obligations, excluding current portion
    7,100        
Term B Senior Credit Facility note payable, excluding current portion
    137,945       46,367  
Mezzanine note payable
          17,503  
Subordinated note payable
    42,888       34,247  
Agreements with officers
          1,514  
Deferred compensation liability
    2,465       1,735  
Accrued compensation, excluding current portion
    6,356       2,128  
Accrued postretirement benefit obligations
    3,357       3,398  
Non-current portion of lease obligations
    3,694       3,892  
Redeemable common stock warrants
    44,590       20,777  
             
     
Total liabilities
    313,775       178,713  
Shareholder’s equity, subject to redemption:
               
 
Common stock (subject to redemption), $0.01 par value, 8,000,000 shares authorized, 5,149,840 shares and 3,376,197 shares issued, and 5,149,840 shares and 3,376,197 shares outstanding at September 30, 2005 and September 30, 2004, respectively
    51       34  
 
Additional paid-in capital
    88,479       37,532  
 
Accumulated deficit
    (68,056 )     (27,818 )
             
     
Total shareholder’s equity, subject to redemption
    20,474       9,748  
             
   
Total liabilities and shareholder’s equity, subject to redemption
  $ 334,249     $ 188,461  
             
See accompanying notes to consolidated financial statements.

65



 

ALION SCIENCE AND TECHNOLOGY CORPORATION
CONSOLIDATED STATEMENTS OF OPERATIONS
                             
    Year Ended September 30,
     
    2005   2004   2003
             
    (In thousands, except share and
    per share information)
Contract revenue
  $ 369,231     $ 269,940     $ 165,917  
Direct contract expense
    267,241       196,388       120,559  
                   
 
Gross profit
    101,990       73,552       45,358  
                   
Operating expenses:
                       
 
Indirect contract expense
    29,017       17,647       8,685  
 
Research and development
    498       399       177  
 
General and administrative
    32,974       28,117       19,909  
 
Non-recurring transaction expense
                726  
 
Rental and occupancy expense
    12,542       10,990       6,892  
 
Depreciation and amortization
    17,771       13,447       9,553  
 
Stock-based compensation(1)
    10,628       2,513       856  
 
Bad debt expense (recovery)
    651       590       (525 )
                   
Total operating expenses
    104,081       73,703       46,273  
                   
   
Operating loss
    (2,091 )     (151 )     (915 )
Other income (expense):
                       
 
Interest income
    475       27       21  
 
Interest expense
    (38,696 )     (16,835 )     (11,724 )
 
Other
    140       1,865       2  
                   
   
Loss before income taxes
    (40,172 )     (15,094 )     (12,616 )
   
Income tax expense
    (66 )     (17 )      
                   
   
Net loss
    (40,238 )     (15,111 )     (12,616 )
                   
Basic and diluted loss per share
  $ (9.50 )   $ (4.91 )   $ (6.05 )
                   
Basic and diluted weighted average common shares outstanding
    4,235,947       3,074,709       2,085,274  
                   
 
(1)  Stock-based compensation is a separately reported component of general and administrative expense.
See accompanying notes to consolidated financial statements.

66



 

ALION SCIENCE AND TECHNOLOGY CORPORATION
CONSOLIDATED STATEMENTS OF SHAREHOLDER’S EQUITY (DEFICIT),
SUBJECT TO REDEMPTION
                                                         
            Additional                
    Common   Common   Paid-In-   Treasury   Treasury   Accumulated    
    Shares   Stock   Capital   Shares   Stock   Deficit   Total
                             
    (In thousands, except share information)
Balances at September 30, 2002
    100     $     $ 1           $     $ (91 )   $ (90 )
Issuance of common stock to KSOP Trust
    2,973,713       29       30,549                         30,578  
Purchase of common stock from KSOP Trust
    (7,944 )                 7,944       (88 )           (88 )
Release of treasury shares to KSOP Trust
    7,944               28       (7,944 )     88             116  
Net loss for the year ended September 30, 2003
                                  (12,616 )     (12,616 )
                                           
Balances at September 30, 2003
    2,973,813     $ 29     $ 30,578           $     $ (12,707 )   $ 17,900  
Purchase of common stock from KSOP Trust
    (99,927 )                 99,927       (1,562 )           (1,562 )
Release of treasury shares to KSOP Trust
    99,927                   (99,927 )     1,562             1,562  
Issuance of common stock to KSOP Trust
    402,384       5     $ 6,954                         6,959  
Net loss for the year ended September 30, 2004
                                $ (15,111 )     (15,111 )
                                           
Balances at September 30, 2004
    3,376,197     $ 34     $ 37,532     $     $     $ (27,818 )   $ 9,748  
Purchase of common stock from KSOP Trust
    (52,507 )                 52,507       (1,047 )           (1,047 )
Release of treasury shares to KSOP Trust
    52,507                   (52,507 )     1,047             1,047  
Issuance of common stock to KSOP Trust
    1,944,300       19       56,710                         56,729  
Retirement of common stock from KSOP Trust
    (170,657 )     (2 )     (5,763 )                       (5,765 )
Net loss for year ended September 30, 2005
                                  (40,238 )     (40,238 )
                                           
Balances at September 30, 2005
    5,149,840     $ 51     $ 88,479     $     $     $ (68,056 )   $ 20,474  
                                           
See accompanying notes to consolidated financial statements.

67



 

ALION SCIENCE AND TECHNOLOGY CORPORATION
CONSOLIDATED STATEMENTS OF CASH FLOWS
Years Ended September 30, 2005, 2004 and 2003
                           
    Year Ended September 30,
     
    2005   2004   2003
             
    (In thousands, except share and
    per share information)
Cash flows from operating activities:
                       
 
Net loss
  $ (40,238 )   $ (15,111 )   $ (12,616 )
Adjustments to reconcile net loss to net cash provided by operating activities:
                       
 
Depreciation and amortization
    17,771       13,447       9,553  
 
Accretion of debt to face value
    3,056       1,449       1,024  
 
Amortization of debt issuance costs
    840       1,462       353  
 
(Increase) decrease in value of interest rate cap agreement
    (118 )     204       148  
 
Change in fair value of redeemable common stock warrants
    23,729       6,015       4,453  
 
Stock-based compensation
    10,629       2,513       856  
 
Loss on disposal of assets
    27             7  
 
Gain on investments, net
    (72 )     (2,223 )     (113 )
Changes in assets and liabilities, net of effect of acquisitions:
                       
 
Accounts receivable, net
    12,078       (14,160 )     4,571  
 
Other assets
    1,036       (4,215 )     793  
 
Sale of marketable securities
          405        
 
Trade accounts payable and accruals
    6,200       13,808       5,664  
 
Other liabilities
    202       2,081       (429 )
                   
Net cash provided by operating activities
    35,140       5,675       14,264  
Cash flows from investing activities:
                       
 
Cash paid for acquisitions, net of cash acquired
    (74,591 )     (21,678 )     (60,099 )
 
Capital expenditures
    (2,233 )     (3,678 )     (1,329 )
 
Proceeds from sale of investment securities
          3,064        
 
Purchase of investment securities
    (1,193 )     (1,333 )      
                   
Net cash used in investing activities
    (78,017 )     (23,625 )     (61,428 )
Cash flows from financing activities:
                       
 
Proceeds from Term B Senior Credit Facility note payable
    94,000       50,000        
 
Proceeds from senior note payable
                35,000  
 
Payment of debt issuance costs
    (1,307 )     (3,280 )     (1,700 )
 
Repayment of Term B Credit Facility note payable
    (1,080 )            
 
Repayment of senior note payable
          (29,250 )     (5,750 )
 
Repayment of mezzanine note payable
    (20,201 )     (750 )      
 
Proceeds from agreement with officer
          750        
 
Repayment of agreements with officers
    (1,823 )            
 
Borrowings under revolving credit facility
          24,000       (6,185 )
 
Repayment of LaSalle revolving credit facility
          (24,000 )      
 
Repayment of ITSC revolving credit facility
          (375 )      
 
Purchase of interest rate cap agreement
          (319 )     (245 )
 
Purchase of shares of common stock from ESOP Trust
    (8,160 )     (1,562 )     (88 )
 
Cash received from issuance of common stock to Trust
    14,509       6,959       26,620  
                   
Net cash provided by financing activities
    75,938       22,173       47,652  
Net increase in cash
    33,061       4,223       488  
Cash and cash equivalents at beginning of period
    4,717       494       6  
                   
Cash and cash equivalents at end of period
  $ 37,778     $ 4,717     $ 494  
                   

68



 

ALION SCIENCE AND TECHNOLOGY CORPORATION
CONSOLIDATED STATEMENTS OF CASH FLOWS — (Continued)
                           
    Year Ended September 30,
     
    2005   2004   2003
             
    (In thousands, except share and
    per share information)
Supplemental disclosure of cash flow information:
                       
 
Cash paid for interest
    9,328       7,563       3,774  
 
Cash paid (received) for taxes
    367       (29 )     (105 )
Non-cash financing activities:
                       
 
Mezzanine note and warrants issued in connection with acquisition of selected operations of IITRI
                20,343  
 
Subordinated note and warrants issued in connection with acquisition of selected operations of IITRI
                39,900  
 
Bank debt assumed in connection with acquisition of selected operations of IITRI
                6,188  
 
IITRI transaction costs assumed in connection with acquisition of selected operations of IITRI
                2,300  
 
Additional non-cash consideration paid in connection with acquisition of selected operations of IITRI
                1,520  
 
Deferred compensation arrangement with officer
                857  
 
Common stock issued to ESOP Trust in satisfaction of employer contribution liability
    5,707       4,330       2,828  
 
Common stock issued for acquisitions
    37,250              
                   
See accompanying notes to consolidated financial statements.

69



 

ALION SCIENCE AND TECHNOLOGY CORPORATION
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
(1) Description and Formation of the Business
      Alion provides scientific and engineering expertise to research and develop technological solutions for problems relating to national defense, homeland security, and energy and environmental analysis. The Company provides these research services primarily to agencies of the federal government and, to a lesser extent, to commercial and international customers.
      Alion, a for-profit S Corporation, was formed in October 2001 for the purpose of purchasing substantially all of the assets and certain of the liabilities of IITRI, a not-for-profit membership corporation affiliated with and controlled by the Illinois Institute of Technology. Prior to the acquisition of substantially all of the assets and liabilities of IITRI (the Transaction), the Company’s activities had been organizational in nature. On December 20, 2002, Alion acquired substantially all of the assets and liabilities of IITRI (Business), excluding the assets and liabilities of IITRI’s Life Sciences Operation, for aggregate total proceeds of $127.3 million.
      The acquisition was accounted for using the purchase method. The purchase price has been allocated to the acquired assets and assumed liabilities based on their estimated fair values at the date of acquisition. As a result of the Transaction, the Company recorded goodwill of approximately $63.6 million, which is subject to an annual impairment review, as discussed below. In addition, the Company recorded intangible assets of approximately $30.6 million, comprised of purchased contracts. The intangible assets have an estimated useful life of three years and is amortized using the straight-line method.
      The total purchase consideration of approximately $127.3 million was allocated to the fair value of the net assets acquired as follows (In thousands):
         
Cash and restricted cash
  $ 1,187  
Accounts receivable
    47,485  
Other current assets
    3,784  
Acquired contracts
    30,645  
Goodwill
    63,610  
Fixed assets
    9,094  
Liabilities assumed
    (28,500 )
       
    $ 127,305  
       
(2) Summary of Significant Accounting Policies
Basis of Presentation and Principles of Consolidation
      The accompanying audited consolidated financial statements include the accounts of Alion Science and Technology Corporation and its subsidiaries (collectively, the “Company” or “Alion”) and have been prepared pursuant to the rules and regulations of the Securities and Exchange Commission (SEC) regarding annual financial reporting.
      The consolidated financial statements are prepared on the accrual basis of accounting and include the accounts of Alion and its wholly-owned subsidiaries: Human Factors Application, Inc. (HFA), acquired at the time of the Transaction, Innovative Technology Solution Corporation (ITSC), and Alion — IPS Corporation (IPS), which were acquired during the fiscal year ended September 30, 2004, Alion — METI Corporation (METI), Alion — CATI Corporation (CATI), Alion Canada (U.S.), Inc., Alion Science and Technology (Canada) Corporation, and Alion — JJMA Corporation (JJMA) which were acquired or established during the fiscal year ended September 30, 2005. All significant intercompany accounts have been eliminated in consolidation.

70



 

ALION SCIENCE AND TECHNOLOGY CORPORATION
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS — (Continued)
Fiscal, Quarter and Interim Periods
      The Company’s fiscal year ends on September 30. Beginning with the fiscal year ended September 30, 2004, the Company began operating based on a three-month quarter, four-quarter fiscal year. For the fiscal year ended September 30, 2003, the Company operated on a thirteen-period fiscal year that consisted of three, four-week periods in its first interim period; three, four-week periods in its second interim period; four, four-week periods in its third interim period; and the balance of the fiscal year of approximately three, four-week periods in its fourth interim period. Accordingly, any comparisons or references made between or with respect to interim or quarterly periods, will need to consider the differing lengths of time.
Use of Estimates
      The preparation of financial statements in conformity with U.S. generally accepted accounting principles requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosures of contingent assets and liabilities at the date of financial statements and the reported amounts of operating results during the reported period. Actual results are likely to differ from those estimates, but the Company’s management does not believe such differences will materially affect the Company’s financial position, results of operations, or cash flows.
Cash and Cash Equivalents
      The Company considers cash in banks, and deposits with financial institutions with maturities of three months or less and that can be liquidated without prior notice or penalty, to be cash and cash equivalents.
Revenue Recognition
      The Company’s revenue results from contract research and other services under a variety of contracts, some of which provide for reimbursement of cost plus fees and others of which are fixed-price or time-and-material type contracts. The Company generally recognizes revenue when a contract has been executed, the contract price is fixed or determinable, delivery of the services or products has occurred and collectibility of the contract price is considered probable.
      Revenue on cost-reimbursement contracts is recognized as costs are incurred and include estimates of applicable fees earned. Revenue on time-and-material contracts is recognized at contractually billable rates as labor hours and direct expenses are incurred. Under time-and-material contracts, labor and related costs are reimbursed at negotiated, fixed hourly rates.
      Revenue on fixed price contracts is recognized on the percentage-of-completion method based on various performance measures. From time to time, facts develop that require the Company to revise its estimated total costs or revenues expected. The cumulative effect of revised estimates is recorded in the period in which the facts requiring revisions become known. The full amount of anticipated losses on any type of contract are recognized in the period in which they become known.
      Contracts with agencies of the federal government are subject to periodic funding by the contracting agency concerned. Funding for a contract may be provided in full at inception of the contract or ratably throughout the term of the contract as the services are provided. If funding is not assessed as probable, revenue recognition is deferred until realization is probable.
      The amount of government contract expense reflected in the consolidated financial statements attributable to cost reimbursement contracts is subject to audit and possible adjustment by the Defense Contract Audit Agency (DCAA). The government considers the Company to be a major contractor and DCAA maintains an office on site to perform its various audits throughout the year. DCAA has concluded its audits of the Company’s indirect costs and cost accounting practices through fiscal year 2001. There were no significant

71



 

ALION SCIENCE AND TECHNOLOGY CORPORATION
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS — (Continued)
disallowances for fiscal years ended September 31, 2000 and 2001. The fiscal year 2005 indirect expense rate submittal is scheduled to be provided to the government for review on or about March 30, 2006. Contract revenues on federal government contracts have been recorded in amounts that are expected to be realized upon final settlement.
      The Company recognizes revenue on unpriced change orders as expenses are incurred only to the extent that the Company expects it is probable that such costs will be recovered. The Company recognizes revenue in excess of costs on unpriced change orders only when management can also reliably estimate the amount of excess and experience provides a sufficient basis for recognition. The Company recognizes revenue on claims as expenses are incurred only to the extent that the Company expects it is probable that such costs will be recovered and the amount of recovery can be reliably estimated.
      Software revenue is generated from licensing software and providing services. Where professional services are considered essential to the functionality of the solution sold, revenue is recognized on the percentage of completion method, as prescribed by AICPA SOP 81-1, Accounting for Performance on Construction-Type and Certain Production-Type Contracts.
Income Taxes
      The Company is an S corporation under the provisions of the Internal Revenue Code of 1986, as amended. For federal and certain state income tax purposes, the Company is not subject to tax on its income. The Company’s income is allocated to its shareholder, Alion Science and Technology Corporation Employee Stock Ownership, Savings and Investment Trust (the Trust). The Company may be subject to state income taxes in those states that do not recognize S corporations and to additional types of taxes including franchise and business taxes. All of the Company’s wholly-owned operating subsidiaries are qualified subchapter S or disregarded entities which, for federal income tax purposes, are not treated as separate corporations. As of September 30, 2005, the Company’s tax basis in its assets exceeds its book basis by approximately $69.3 million.
Accounts Receivable and Billings in Excess of Costs and Estimated Earnings on Uncompleted Contracts
      Accounts receivable include billed accounts receivable, amounts currently billable and costs and estimated earnings in excess of billings on uncompleted contracts that represent accumulated project expenses and fees which have not been billed or are not currently billable as of the date of the consolidated balance sheet. The costs and estimated earnings in excess of billings on uncompleted contracts are stated at estimated realizable value and aggregated $19.3 million and $14.6 million at September 30, 2005 and 2004, respectively. Costs and estimated earnings in excess of billings on uncompleted contracts at September 30, 2005 include $2.1 million related to costs incurred on projects for which the Company has been requested by the customer to begin work under a new contract or extend work under an existing contract, but for which formal contracts or contract modifications have not been executed. The allowance for doubtful accounts is the Company’s best estimate of the amount of probable losses in the Company’s existing billed and unbilled accounts receivable. The Company determines the allowance using specific identification and historical write-off experience based on the age of the population.
      Billings in excess of costs and estimated earnings and advance collections from customers represent amounts received from or billed to commercial customers in excess of project revenue recognized to date.
Goodwill and Other Intangibles
      The Company has adopted Statement of Financial Accounting Standards (SFAS) No. 142, “Goodwill and Other Intangible Assets”, which requires, among other things, the discontinuance of goodwill

72



 

ALION SCIENCE AND TECHNOLOGY CORPORATION
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS — (Continued)
amortization. Under SFAS 142, goodwill is to be reviewed at least annually for impairment or more frequently if events or changes in circumstances indicates the asset might be impaired; the Company has elected to perform this review annually at the end of each fiscal year. An impairment loss would be recognized to the extent that the carrying amount exceeds the asset’s fair value. This determination consists of two steps. First, the Company estimates its fair value using an estimate of the fair value of its common stock based upon a valuation performed by an independent, third-party firm and compares it to its carrying amount. Second, if the carrying amount exceeds its fair value, an impairment loss is recognized for any excess of the carrying amount of goodwill over the implied fair value of that goodwill. The implied fair value of goodwill is determined by allocating the fair value in a manner similar to a purchase price allocation, in accordance with FASB Statement No. 141, Business Combinations. The residual fair value after this allocation is the implied fair value of the goodwill. The Company completed the fiscal year 2005 annual goodwill impairment analysis in the fourth quarter of fiscal year 2005. Based on this analysis, the Company concluded that no goodwill impairment exists as of September 30, 2005. Intangible assets are amortized over their estimated useful lives, generally three to five years primarily using the straight-line method.
Fixed Assets
      Leasehold improvements, software and equipment are recorded at cost. Expenditures for maintenance and repairs that do not add significant value or significantly lengthen an asset’s useful life are charged to current operations. Software and equipment are depreciated over their estimated useful lives (2 to 15 years for the various classes of software and equipment) generally using the straight-line method. Leasehold improvements are amortized on the straight-line method over the shorter of the assets’ estimated useful life or the life of the lease. Upon sale or retirement of an asset, costs and related accumulated depreciation are deducted from the accounts, and the gain or loss is recognized in the consolidated statements of operations.
Fair Value of Financial Instruments
      The following methods and assumptions were used to estimate the fair value of each class of financial instruments for which it is practicable to estimate fair value. It is impracticable for the Company to estimate the fair value of its subordinated debt because the only market for this financial instrument consists of principal to principal transactions. For all of the following items, the fair value is not materially different than the carrying value.
Cash, cash equivalents, accounts payable and accounts receivable
      The carrying amount approximates fair value because of the short maturity of those instruments.
Marketable securities
      The fair values of these investments are estimated based on quoted or market prices for these or similar instruments.
Senior Long-term debt
      The carrying amount of the Company’s senior debt approximates fair value which is estimated on current rates offered to the Company for debt of the same remaining maturities.
Interest rate cap
      The fair value of the Company’s financial instruments is estimated based on current rates offered to the Company for contracts with similar terms and maturities.

73



 

ALION SCIENCE AND TECHNOLOGY CORPORATION
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS — (Continued)
Redeemable common stock warrants
      The Company uses an option pricing model to estimate the fair value of its redeemable common stock warrants.
Alion Stock
      The estimated fair value price per share is determined based upon a valuation performed by an independent, third-party firm.
(3) Employee Stock Ownership Plan (ESOP) and Stock Ownership Trust
      On December 19, 2001, the Company adopted the Alion Science and Technology Corporation Employee Ownership, Savings and Investment Plan (the “Plan”) and the Alion Science and Technology Corporation Employee Ownership, Savings and Investment Trust (the “Trust”). The Plan, a tax qualified retirement plan, includes an ESOP component and a non-ESOP component. On August 9, 2005, the Internal Revenue Service issued a determination letter that the Trust and the Plan, as amended through the Ninth Amendment, qualify under Sections 401(a) and 501(a) of the Internal Revenue Code of 1986 (the IRC) , as amended. The Company believes that the Plan and Trust have been designed and are currently being operated in compliance with the applicable requirements of the IRC.
(4) Postretirement Benefits
      The Company sponsors a medical benefits plan providing certain medical, dental, and vision coverage to eligible employees and former employees. The Company has a self-insured funding policy with a stop-loss limit under an insurance agreement.
      The Company also provides postretirement medical benefits for employees who meet certain age and service requirements. Retiring employees may become eligible for those benefits at age 55 if they have 20 years of service, or at age 60 with 10 years of service. The plan provides benefits until age 65 and requires employees to pay one-quarter of their health care premiums. A small, closed group of employees is eligible for coverage after age 65. These retirees contribute a fixed portion of the health care premium. The estimated contribution to premiums from retirees is an aggregate of $125,000.
      There were no plan assets as of September 30, 2005 and 2004. The Company uses an October 1 measurement date.
      Following is a reconciliation of the plan’s accumulated postretirement benefit obligation (In thousands):
                 
    2005   2004
         
Accumulated postretirement benefit obligation as of September 30:
               
Retirees
  $ 1,028     $ 1,118  
Fully eligible active plan participants
    814       812  
Other active plan participants
    1,741       1,672  
             
    $ 3,583     $ 3,602  
             

74



 

ALION SCIENCE AND TECHNOLOGY CORPORATION
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS — (Continued)
                 
    2005   2004
         
Reconciliation of beginning and ending benefit obligation:
               
Benefit obligation at beginning of period
  $ 3,602     $ 2,938  
Service cost
    188       119  
Interest cost
    227       178  
Actuarial (gain) loss
    22       579  
Benefits paid
    (456 )     (212 )
             
Benefit obligation at September 30
  $ 3,583     $ 3,602  
             
      Following is a reconciliation of the funded status of the plan (In thousands):
                 
Funded status of the plan:
               
Obligation at September 30
  $ (3,583 )   $ (3,602 )
Unrecognized net loss (gain)
  $ 226     $ 204  
             
Accrued postretirement benefits included in the consolidated balance sheet
  $ (3,357 )   $ (3,398 )
             
      The components of net periodic postretirement benefit cost for the years ended September 30, 2005 and 2004 are as follows (In thousands):
                 
    2005   2004
         
Service cost
  $ 188     $ 119  
Interest cost
    227       178  
Amortization of net (gain) loss
          (6 )
             
Net periodic postretirement benefit cost
  $ 415     $ 291  
             
      The weighted-average assumptions in the following table represent the rates used to develop the actuarial present value of the projected benefit obligation for the year listed and also the net periodic benefit costs.
                 
    2005   2004
         
Accumulated post retirement benefit obligation at September 30
    5.25%       6.00%  
Service and interest cost portions of net periodic postretirement benefit costs
    6.00%       6.25%  
      The following table displays the assumed health care trends used to determine the accumulated postretirement benefit obligation:
                 
    2005   2004
         
Health care cost trend rate assumed for next year
    10.0 %     10.5 %
Rate to which the cost trend rate is assumed to decline (ultimate trend rates)
    5.0 %     5.5 %
Year the rate reaches the ultimate trend rate
    2015       2014  
      A one-percentage-point change in assumed health care cost trend rates would have the following effect (In thousands):
                 
    One-Percentage-   One-Percentage-
    Point Increase   Point Decrease
         
Total interest and service cost
  $ 47     $ (42 )
Accumulated postretirement benefit obligation
    277       (251 )

75



 

ALION SCIENCE AND TECHNOLOGY CORPORATION
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS — (Continued)
      Estimated future benefit payments -fiscal years ending September 30:
         
2006
  $ 256  
2007
    234  
2008
    244  
2009
    279  
2010
    307  
2010 - 2015
  $ 2,070  
      In December 2003, the Medicare Prescription Drug, Improvement and Modernization Act of 2003 (the Act) was signed into law. The Act introduced a prescription drug benefit under Medicare Part D and a federal subsidy to sponsors of retirement health care plans that provide a benefit that is at least actuarially equivalent to Medicare Part D. The Company has elected to defer the recognition of the effect, if any, of the Act until such time when the authoritative guidance is issued. Any measures of the accumulated postretirement benefit obligation or net periodic postretirement benefit cost in the Company’s financial statements do not reflect the effect of the Act. The Company has a small, closed group of retirees covered for medical after age 65, thus the effect of the Act is not expected to be material.
(5) Loss Per Share
      Basic and diluted loss per share is computed by dividing net loss by the weighted average number of common shares outstanding which excludes the impact of warrants and stock appreciation rights described herein as this impact would be anti-dilutive for all periods presented.
(6) Shareholder’s Equity, Subject to Redemption
      The Company’s common stock is owned by the Trust. The Company provides a put option to any participant or beneficiary who receives a distribution of common stock which permits the participant or beneficiary to sell such common stock to the Company during certain periods, at the estimated fair value price per share, which was at $35.89 per share as of September 30, 2005. Accordingly, all of the Company’s equity is classified as subject to redemption in the accompanying consolidated balance sheets. The estimated fair value price per share is determined based upon a valuation performed by an independent, third-party firm. The Company may allow the Trust to purchase shares of common stock tendered to the Company under the put option.
      Certain participants have the right to sell their shares distributed from the participant’s account that were acquired on the closing date of the Transaction at a value per share equal to the greater of the original purchase price or the estimated fair value price per share of the common stock.
(7) Goodwill and Intangible Assets
      The Company accounts for goodwill and other intangible assets in accordance with the provisions of Statement of Financial Accounting Standards (SFAS) No. 142, “Goodwill and other Intangible Assets”, which requires that goodwill be reviewed at least annually for impairment. The Company performs this review at the end of each fiscal year.
      As of September 30, 2005, the Company has recorded goodwill of approximately $163.4 million, which is subject to an annual impairment review. During the fiscal year ended September 30, 2005, goodwill increased by approximately $80.3 million. Approximately $77.6 million related to purchase price allocation, and related adjustments to the initial allocation, for acquisitions that occurred during the year ended September 30, 2005, as described in Note 15 and approximately $2.7 million related to adjustments to the initial purchase price allocation for acquisitions that occurred during the year ended September 30, 2004 and for additional earn-out

76



 

ALION SCIENCE AND TECHNOLOGY CORPORATION
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS — (Continued)
obligations from historical acquisitions. For the acquisitions completed during the year ended September 30, 2005, the purchase price allocations are preliminary and subject to change based upon the completion of the valuation of certain intangible assets and other items.
      As of September 30, 2005, the Company has recorded gross intangible assets of approximately $62.1 million and accumulated amortization of $31.9 million. Approximately $60.5 million of recorded gross intangible assets are comprised of the contracts purchased from acquisitions, approximately $0.7 million for non compete agreements and $0.9 million from software acquired for internal use. The intangible assets have an estimated useful life of one to thirteen years and are primarily being amortized using the straight-line method. The weighted-average remaining amortization of period of intangible assets was approximately 4 years at September 30, 2005. Amortization expense was approximately $13.4 million, $10.6 million, and $8.3 million for the years ended September 30, 2005, 2004, and 2003 respectively. Estimated aggregate amortization expense for each of the next four years and thereafter is as follows:
           
    (In thousands)
For the year ended September 30:
       
 
2006
  $ 7.2  
 
2007
    5.0  
 
2008
    4.7  
 
2009
    4.4  
 
and thereafter
    8.9  
      As of September 30, 2005, the Company has recorded net intangible assets of approximately $30.2 million comprised primarily of contracts purchased in connection with the acquisitions of JJMA, IITRI, IPS and METI of approximately $25.7 million, $2.3 million, $0.7 million, and $0.1 million, respectively; approximately $0.6 million for non-compete agreements and $0.8 million for acquired internal use software.
(8) Long-Term Debt
      To fund the Transaction described in Note 1, the Company entered into various debt agreements (i.e., Senior Credit Agreement, Mezzanine Note, and Subordinated Note) on December 20, 2002. On August 2, 2004, the Company entered into a new Term B senior secured credit facility (the Term B Senior Credit Facility) with a syndicate of financial institutions for which Credit Suisse serves as arranger, administrative agent and collateral agent. LaSalle Bank National Association serves as syndication agent under the Term B Senior Credit Facility. On April 1, 2005, the Company entered into an incremental term loan facility and an amendment to the Term B Senior Credit Facility (Amendment One), which added $72 million in term loans to our total indebtedness under the Term B Senior Credit Facility. Set forth below is a summary of the terms of the Term B Senior Credit Facility, as modified by Amendment One.
      The discussion below describes the Term B Senior Credit Facility and the initial debt agreements used to finance the Transaction.
Term B Senior Credit Facility
      The Term B Senior Credit Facility has a term of five years and consists of:
  •  a senior term loan in the approximate amount of $142.9 million, (which includes the incremental term loan), all of which was drawn down as of September 30, 2005;
 
  •  a senior revolving credit facility, in the amount of $30.0 million, of which approximately $3.0 million was deemed borrowed as of September 30, 2005, through the issuance of letters of credit issued under

77



 

ALION SCIENCE AND TECHNOLOGY CORPORATION
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS — (Continued)
  the Company’s prior senior credit facility which remain outstanding under the Term B Senior Credit Facility and the issuance of one additional letter of credit under the Term B Senior Credit Facility; and
 
  •  an uncommitted incremental term loan “accordion” facility in the amount of $150.0 million.
      On the senior term loan, until the quarter ending December 31, 2008, the Company is obligated to pay quarterly installments of principal in the amount of $360,000. On each of December 31, 2008, March 31, 2009, June 30, 2009 and August 2, 2009, the Company is obligated to pay installments of principal in the amount of $34,650,000.
      Under the senior revolving credit facility, the Company may request the issuance of up to $5.0 million in letters of credit and may borrow up to $5.0 million in swing line loans, a type of loan customarily used for short-term borrowing needs. As of September 30, 2005, approximately $3.0 million in letters of credit have been issued. All principal obligations under the senior revolving credit facility are to be repaid in full no later than August 2, 2009.
      The Company may prepay any of its borrowings under the Term B Senior Credit Facility, in whole or in part, in minimum increments of $1.0 million, in most cases without penalty or premium. The Company is responsible to pay any customary breakage costs related to the repayment of Eurodollar-based loans prior to the end of a designated Eurodollar rate interest period. The Company is required to pay a 1% prepayment premium on the amount of term loans prepaid from future debt proceeds if the interest rate margins of the future debt are lower than applicable interest rate margins then in effect under the Term B Senior Credit Facility and the Company makes the prepayment before April 1, 2006. If, during the term of the Term B Senior Credit Facility, the Company engages in the issuance or incurrence of certain permitted debt or the Company sells, transfers or otherwise disposes of certain of its assets, the Company must use all of the proceeds (net of certain costs, reserves, security interests and taxes) to repay term loan borrowings under the Term B Senior Credit Facility. If the Company engages in certain kinds of issuances of equity or has any excess cash flow for any fiscal year during the term of the Term B Senior Credit Facility, the Company must use 50 percent of the proceeds of the equity issuance (net of certain costs, reserves, security interests and taxes) or 50 percent of excess cash flow for that fiscal year to repay term loan borrowings under the Term B Senior Credit Facility. If the Company’s leverage ratio is less than 2.00 to 1.00 at the applicable time after taking into account the use of the net proceeds (in the case of an equity issuance), then the Company must use 25 percent of those net proceeds or excess cash flow for that fiscal year to repay term loan borrowings under the Term B Senior Credit Facility.
      If the Company borrows under the incremental term loan facility and certain economic terms of the incremental term loan, including applicable yields, maturity dates and average life to maturity, are more favorable to the incremental term loan lenders than the comparable economic terms under the senior term loan or the senior revolving credit facility, then the Term B Senior Credit Facility provides that the applicable interest rate spread will be adjusted upward. The upward adjustment will take place if the yield payable under the incremental term loan exceeds the yield under the senior term loan or senior revolving credit facility by more than 50 basis points. The effect of this provision is that an incremental term loan may make our borrowings under the senior term loan and the senior revolving credit facility more expensive.
      The Term B Senior Credit Facility requires that the Company’s existing subsidiaries and subsidiaries that the Company acquires during the term of the Term B Senior Credit Facility, other than certain insignificant subsidiaries, guarantee the Company’s obligations under the Term B Senior Credit Facility. Accordingly, the Term B Senior Credit Facility is guaranteed by the Company subsidiaries, HFA, CATI, METI, and JJMA.
      Use of Proceeds. On August 2, 2004, the Company borrowed $50.0 million through the senior term loan under the Term B Senior Credit Facility. The Company used the proceeds to retire its then outstanding senior term loan and revolving credit facility administered by LaSalle Bank in the approximate amount of $47.2 million including principal and accrued and unpaid interest and to pay certain transaction fees associated

78



 

ALION SCIENCE AND TECHNOLOGY CORPORATION
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS — (Continued)
with the refinancing in the approximate amount of $3.3 million. In October 2004, the Company borrowed approximately $22.0 million of the senior term loan to retire our existing mezzanine note in the approximate principal amount of $19.6 million and to pay accrued and unpaid interest and prepayment premium in the aggregate amount of approximately $2.4 million. On April 1, 2005, the Company borrowed $72 million in an incremental term loan under the Term B Senior Credit Facility. The Company used approximately $58.7 million of the incremental term loan proceeds to pay a portion of the JJMA acquisition price, and approximately $1.25 million to pay certain transaction fees associated with the incremental term loan. The remaining $12 million has been and will be used for general corporate purposes, which may include financing permitted acquisitions, and funding the Company’s working capital needs, as necessary.
      The Term B Senior Credit Facility permits the Company to use the remainder of its senior revolving credit facility for the Company’s working capital needs and other general corporate purposes, including to finance permitted acquisitions. The Term B Senior Credit Facility permits the Company to use any proceeds from the uncommitted incremental term loan facility to finance permitted acquisitions and to make certain put right payments required under the Company’s existing mezzanine warrant, if those put rights are exercised, and for any other purpose permitted by any future incremental term loan.
      Security. The Term B Senior Credit Facility is secured by a security interest in all of the Company’s current and future tangible and intangible property, as well as all of the current and future tangible and intangible property of the Company’s subsidiaries, HFA, CATI, METI, and JJMA.
      Interest and Fees. Under the Term B Senior Credit Facility, the senior term loan and the senior revolving credit facility can each bear interest at either of two floating rates. The Company was entitled to elect that interest be payable on the Company’s $142.9 million senior term loan at an annual rate equal to the prime rate charged by CSFB plus 125 basis points or at an annual rate equal to the Eurodollar rate plus 225 basis points. The Company was also entitled to elect that interest be payable on the Company’s senior revolving credit facility at an annual rate that varies depending on the Company’s leverage ratio and whether the borrowing is a Eurodollar borrowing or an alternate base rate (“ABR”) borrowing. Under the Term B Senior Credit Facility, if the Company were to elect a Eurodollar borrowing under its senior revolving credit facility, interest would be payable at an annual rate equal to the Eurodollar rate plus additional basis points as reflected in the table below under the column “Eurodollar Spread” corresponding to the Company’s leverage ratio at the time. Under the Term B Senior Credit Facility, if the Company elects an ABR borrowing under its senior revolving credit facility, the Company may elect an alternate base interest rate based on a federal funds effective rate or based on CSFB’s prime rate, plus additional basis points reflected in the table below under the column “Federal Funds ABR Spread” or “Prime Rate ABR Spread” corresponding to the Company’s leverage ratio at the time.
Eurodollar Prime Rate
                           
    Spread   ABR Spread   ABR Spread
Leverage Ratio   (In basis points)   (In basis points)   (In basis points)
             
Category 1
    275       225       175  
 
Greater than or equal to 3.00 to 1.00
                       
Category 2
    250       200       150  
 
Greater than or equal to 2.50 to
                       
 
1.00 but less than 3.00 to 1.00
                       
Category 3
    225       175       125  
 
Greater than or equal to 2.00 to
                       
 
1.00 but less than 2.50 to 1.00
                       
Category 4
    200       150       100  
 
Less than 2.00 to 1.00
                       

79



 

ALION SCIENCE AND TECHNOLOGY CORPORATION
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS — (Continued)
      On April 1, 2005, the Company elected to have the senior term loan bear interest at the Eurodollar rate and the senior revolving credit facility bear interest at the ABR rate (based on CSFB’s prime rate). As of September 30, 2005, the Eurodollar rate on the senior term loan was 6.45 percent (i.e., 4.20 percent plus 2.25 percent Eurodollar spread) and the ABR rate (based on CSFB’s prime rate) on the senior revolving credit facility was 7.50 percent (i.e. 5.75 percent plus 1.75 percent spread).
      Under the Term B Senior Credit Facility, the Company was required to enter into an interest rate hedge agreement acceptable to CSFB to fix or cap the actual interest the Company will pay on no less than 40 percent of the Company’s long-term indebtedness.
      On August 16, 2004, the Company entered into an interest rate cap agreement effective as of September 30, 2004 with one of the Company’s senior lenders. Under this agreement, in exchange for the Company’s payment to the senior lender of approximately $319,000, the Company’s maximum effective rate of interest payable with regard to an approximately $37.3 million portion of the outstanding principal balance of the Term B Senior Credit Facility was not to exceed 6.64 percent (i.e., LIBOR 3.89 percent cap plus maximum 2.75 percent Eurodollar spread) for the period September 30, 2004 through September 29, 2005 and was not to exceed 7.41 percent (i.e., LIBOR 4.66 percent cap plus 2.75 percent maximum Eurodollar spread) for the period September 30, 2005 through September 30, 2007.
      On April 15, 2005, the Company entered into a second interest rate cap agreement which covers an additional $28.0 million of the Company’s long-term indebtedness. The interest on such portion of the Company’s long-term indebtedness is capped at 7.25 percent (i.e., LIBOR 5.00 percent cap plus 2.25 percent Eurodollar spread). For this second cap agreement, the Company paid a senior lender $117,000. The second interest rate cap agreement terminates on September 30, 2007. Further, the Company’s maximum effective rate of interest payable under the first interest rate cap agreement was reset and capped at a maximum interest rate of 6.91 percent (i.e., LIBOR 4.66 percent cap plus maximum 2.25 percent Eurodollar spread). As of September 30, 2005, approximately $65.3 million, or 45.7 percent, of the $142.9 million drawn under the Term B Senior Credit Facility is at a capped interest rate. The maximum effective interest rate on the $65.3 million that is currently under cap agreements is approximately 7.06 percent. The remaining outstanding aggregate balance under the Term B Senior Credit Facility over $65.3 million, which was approximately $77.6 million as of September 30, 2005, is not subject to any interest rate cap agreements or arrangements.
      Subject to certain conditions, the Company may convert a Eurodollar-based loan to a prime rate based loan and the Company may convert a prime rate based loan to a Eurodollar-based loan.
      The Company is obligated to pay on a quarterly basis a commitment fee of 0.50 percent per annum on the daily unused amount in the preceding quarter of the commitments made to the Company under the Term B Senior Credit Facility including the unused portion of the senior term loan and the unused portion of the $30.0 million senior revolving credit facility.
      For fiscal year 2005, as of September 30, 2005, the Company has paid a 0.5 percent commitment fee of approximately $0.2 million dollars and approximately $0.06 million on the unused amounts of the senior term loan and senior revolving credit facility, respectively. As of September 30, 2005, the unused amounts of the senior term loan and senior revolving credit facility were zero and approximately $30.0 million, respectively.
      Each time a letter of credit is issued on the Company’s behalf under the senior revolving credit facility, the Company will pay a fronting fee not in excess of 0.25 percent of the face amount of the letter of credit issued. In addition, the Company will pay quarterly in arrears a letter of credit fee based on the interest rate spread applicable to the revolving credit facility borrowing made to issue the letter of credit. The Company will also pay standard issuance and administrative fees specified from time to time by the bank issuing the letter of credit.

80



 

ALION SCIENCE AND TECHNOLOGY CORPORATION
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS — (Continued)
      In addition to letter of credit fees, commitment fees and other fees payable under the Term B Senior Credit Facility, the Company will also pay an annual agent’s fee.
      Covenants. The Term B Senior Credit Facility requires the Company to meet the following financial tests over the life of the facility:
      Leverage Ratio. The Company’s leverage ratio is calculated by dividing the total outstanding amount of all of the Company’s consolidated indebtedness, but excluding the amount owed under the Company’s subordinated note and the aggregate amount of letters of credit issued on the Company’s behalf other than drawings which have not been reimbursed, by the Company’s consolidated EBITDA for the previous four fiscal quarters on a rolling basis. The maximum total leverage ratio is measured as of the end of each of our fiscal quarters. For purposes of determining the Company’s leverage ratio as of or for the quarters ended on September 30, 2004, December 31, 2004 and March 31, 2005, the Term B Senior Credit Facility deems the Company’s consolidated EBITDA to be $7.5 million for the fiscal quarter ended December 31, 2003, $7.0 million for the fiscal quarter ended March 31, 2004, and $7.7 million for the fiscal quarter ended June 30, respectively. For each of the following time periods, the Company is required to maintain a maximum leverage ratio not greater than the following:
         
Period   Ratio
     
    3.85 to 1.00  
    3.75 to 1.00  
    3.50 to 1.00  
    3.25 to 1.00  
    2.75 to 1.00  
Thereafter
    2.25 to 1.00  
      Interest Coverage Ratio. The Company’s interest coverage ratio is calculated by dividing the Company’s consolidated EBITDA, less amounts the Company spends attributable to property, plant, equipment and other fixed assets, by the Company’s consolidated interest expense. For purposes of determining the Company’s interest coverage ratio as of or for the quarters ended on September 30, 2004, December 31, 2004 and March 31, 2005, the Term B Senior Credit Facility deems the Company’s consolidated EBITDA to be $7.5 million for the fiscal quarter ended December 31, 2003, $7.0 million for the fiscal quarter ended March 31, 2004, and $7.7 million for the fiscal quarter ended June 30, 2004. The Company is required to maintain a minimum fixed charge coverage ratio of at least the following:
         
Date or Period   Ratio
     
    3.75 to 1.00  
Thereafter
    4.00 to 1.00  
      The Term B Senior Credit Facility includes covenants which, among other things, restrict the Company’s ability to do the following without the prior consent of syndicate bank members that have extended 50 percent or more of the then outstanding aggregate senior credit facility:
  •  incur additional indebtedness other than permitted additional indebtedness;
 
  •  consolidate, merge or sell all or substantially all of the Company’s assets;
 
  •  make certain loans and investments including acquisitions of businesses, other than permitted acquisitions;
 
  •  pay dividends or distributions other than distributions needed for the ESOP to satisfy its repurchase obligations, for the Company to satisfy any put right if exercised by mezzanine warrant holders and for certain payments required under the Company’s equity based incentive plans;

81



 

ALION SCIENCE AND TECHNOLOGY CORPORATION
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS — (Continued)
  •  enter into transactions with the Company’s shareholders and affiliates;
 
  •  enter into certain transactions not permitted under ERISA;
 
  •  grant certain liens and security interests;
 
  •  enter into sale and leaseback transactions;
 
  •  change lines of business;
 
  •  repay subordinated indebtedness and redeem or repurchase certain equity; or
 
  •  use the proceeds of the Company’s borrowings other than as permitted by the Term B Senior Credit Facility.
      Events of Default. The Term B Senior Credit Facility contains customary events of default including, without limitation:
  •  payment default;
 
  •  breach of representations and warranties;
 
  •  uncured covenant breaches;
 
  •  default under certain other debt exceeding an agreed amount;
 
  •  bankruptcy and insolvency events;
 
  •  notice of debarment, suspension or termination under a material government contract;
 
  •  certain ERISA violations;
 
  •  unstayed judgments in excess of an agreed amount;
 
  •  failure of the subordinated note to be subordinated to the Term B Senior Credit Facility;
 
  •  failure of the guarantee of the Term B Senior Credit Facility to be in effect;
 
  •  failure of the security interests to be valid, perfected first priority security interests in the collateral;
 
  •  failure of the Company to remain an S-corporation;
 
  •  the Trust is subject to certain taxes in excess of an agreed amount;
 
  •  final negative determination that the ESOP is not a qualified plan; or
 
  •  change of control (as defined below).
      For purposes of the Term B Senior Credit Facility, a change of control generally occurs when, before the Company lists its common stock to trade on a national securities exchange or the NASDAQ National Market quotation system and obtains net proceeds from an underwritten public offering of at least $30,000,000, the Trust fails to own at least 51 percent of the Company’s outstanding equity interests, or, after the Company has such a qualified public offering, any person or group other than IIT or the Trust owns more than 37.5 percent of the Company’s outstanding equity interests. A change of control may also occur if a majority of the seats (other than vacant seats) on the Company’s board of directors shall at any time be occupied by persons who were neither nominated by our board nor were appointed by directors so nominated. A change of control may also occur if a change of control occurs under any of the Company’s material indebtedness including the Company’s subordinated note, the warrants issued with the Company’s subordinated note and the warrants issued with the Company’s retired mezzanine note (which warrants remain outstanding).

82



 

ALION SCIENCE AND TECHNOLOGY CORPORATION
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS — (Continued)
Senior Credit Agreement
      On December 20, 2002, the Company executed a Senior Credit Agreement among LaSalle Bank National Association and other lenders to refinance and replace IITRI’s prior credit arrangements and to finance, in part, the Transaction. The Senior Credit Agreement consisted of a $35.0 million Senior Term Note and a $25.0 million revolving credit facility. All principal obligations under the Senior Credit Agreement were to be repaid in full no later than December 20, 2007. The Senior Credit Agreement was secured by a first priority, perfected security interest in all of the Company’s current and future tangible and intangible property.
      Prior to the CSFB refinancing in August 2004, the Company had approximately $47.2 million in borrowings under the Senior Credit Agreement (approximately $24.0 million under the revolving credit facility and approximately $23.2 million under the Senior Term Note), each of which bore interest at either of two floating rates: a per year rate equal to the Eurodollar rate plus 350 basis points, or LaSalle’s prime rate (base rate) plus 200 basis points. Under the Senior Credit Agreement, balances drawn on the revolving credit facility bore interest at the LaSalle Bank prime rate plus 200 basis points.
      Effective February 14, 2003, the Company elected that the Senior Term Note bear interest at a Eurodollar rate. This election did not affect the interest rate applicable to amounts borrowed under the revolving line of credit. Interest under the Senior Term Note was payable at LaSalle’s prime rate (base rate) plus 200 basis points until February 14, 2003. Thereafter, the Senior Term Note bore interest at the Eurodollar rate plus 350 basis points.
      On August 2, 2004, the revolving credit facility and Senior Term Note were extinguished with proceeds from the Term B Senior Credit Facility. As of August 2, 2004, the Company had approximately $24.0 million borrowed under the revolving credit facility at an interest rate equal to approximately 6.25% (LaSalle Bank prime rate plus 200 basis points).
      The Company had entered into an interest rate cap agreement effective as of February 3, 2003 with one of its senior lenders. Under this agreement, the Company’s maximum effective rate of interest payable on the first $25 million of principal under its term note was not to exceed 6 percent. Any interest the Company paid on the first $25 million of principal in excess of 6 percent was to be reimbursed to the Company semiannually by the senior lender pursuant to the cap agreement. On August 2, 2004, the cap agreement was extinguished and its remaining value was recognized as interest expense.
Mezzanine Note
      On December 20, 2002, the Company issued to IITRI a Mezzanine Note securities purchase agreement (Mezzanine Note) with a face value of approximately $20.3 million. The Mezzanine Note served as part of the consideration for the Transaction. On July 1, 2004, the Illinois Institute of Technology (IIT) acquired all of IITRI’s rights and interests in the Mezzanine Note and the related Warrant Agreement.
      On March 28, 2003, an officer of the Company purchased a portion of the Company’s Mezzanine Note owned by IITRI for $750,000, its face value (as described below in “Other Notes and Agreements”).
      On October 1, 2004, the Company borrowed $22.0 million under the Senior Secured Term B Loan. The Company used the proceeds of the October 1, 2004, borrowing to redeem the Mezzanine Note for approximately $19.6 million, to pay a prepayment penalty of approximately $1.8 million and to pay approximately $0.6 million in accrued interest. The Company recognized an expense of approximately $3.9 million on extinguishment of the Mezzanine Note, including approximately $2.1 million for amortization of original issue discount in addition to the $1.8 million prepayment penalty.

83



 

ALION SCIENCE AND TECHNOLOGY CORPORATION
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS — (Continued)
Subordinated Note
      On December 20, 2002, the Company issued a seller note to IITRI under a seller note securities purchase agreement (Subordinated Note) with a face value of $39.9 million. The Subordinated Note served as part of the consideration for the Transaction. On July 1, 2004, the Illinois Institute of Technology (IIT) acquired all of IITRI’s rights and interests in the Subordinated Note and the related Warrant Agreement. The Subordinated Note bears interest at a rate of 6% per year through December 2008 payable quarterly by the issuance of non-interest bearing notes (paid-in-kind notes or PIK notes) maturing at the same time as the Subordinated Note. The issuance of the PIK notes will have the effect of deferring the underlying cash interest expense on the Subordinated Note, but because the PIK notes will not themselves bear interest, they will not have the effect of compounding any interest on these interest payment obligations. Commencing December 2008, the Subordinated Note will bear interest at 16% per year payable quarterly in cash through the time of repayment in full of the Subordinated Note. Principal on the Subordinated Note will be payable in equal installments of $19.95 million in December 2009 and December 2010; the PIK notes are also due in equal installments of $7.2 million on these same dates.
Other Notes and Agreements
      On December 20, 2002, the Company entered into a $0.9 million deferred compensation agreement with Dr. Bahman Atefi, its President, CEO and Chairman, as a condition to completing the Transaction, with payment terms substantially equivalent to those of the Mezzanine Note, and issued Dr. Atefi detachable warrants representing the right to buy approximately 22,062 shares of Alion common stock at an exercise price of $10.00 per share, with put rights similar to those contained in the warrants accompanying the Mezzanine Note. On October 29, 2004, Dr. Atefi elected to redeem the amount due under his deferred compensation agreement with Alion. Dr. Atefi was paid approximately $0.9 million, plus $0.2 million in accrued interest. The warrants relating to the deferred compensation agreement remain outstanding.
      On March 28, 2003, an officer of the Company purchased a portion of the Company’s Mezzanine Note owned by IITRI for $750,000, its face value, along with warrants to purchase 19,327 shares of Alion’s common stock at an exercise price of $10.00 per share. On November 12, 2003, the Company purchased the portion of the Mezzanine Note and warrants from the officer for an aggregate purchase price of $1,034,020.
      On February 11, 2004, the Company borrowed $750,000 from an officer of the Company. In exchange, on June 7, 2004, the Company issued a promissory note in the principal amount of $750,000 to the officer. The promissory note bore interest at a rate of 15% per year, payable quarterly. The annual interest period was effective beginning February 11, 2004. On December 9, 2004, the Promissory Note was extinguished. An amount of $750,000 plus accrued interest of $21,635 was paid to the officer.
      As of September 30, 2005, for the aforementioned debt agreements, the remaining fiscal year principal repayments (at face amount before debt discount) are as follows:
                                                 
    5-Fiscal Year Period
     
    2006   2007   2008   2009   2010   Total
                         
            ($ In millions)        
Senior Secured Term B Loan(1)
  $ 1.44     $ 1.44     $ 1.44     $ 138.60     $     $ 142.92  
Subordinated Seller Note(2)
                      19.95       19.95       39.90  
Subordinated Paid in Kind Note(3)
                      7.18       7.18       14.36  
                                     
Total principal payments
  $ 1.44     $ 1.44     $ 1.44     $ 165.73     $ 27.13     $ 197.18  
                                     
 
(1)  The Term B Senior Credit Facility requires the Company to repay 1 percent of the principal balance outstanding under the senior term loan during the first four years (i.e., fiscal years 2005 through 2008) of

84



 

ALION SCIENCE AND TECHNOLOGY CORPORATION
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS — (Continued)
the Term B Senior Credit Facility’s term and 96 percent of the principal balance outstanding during the fifth and final year of the term. The table reflects the balance drawn of $142.9 as of September 30, 2005, resulting in expected annual principal payments of approximately $1.4 million in each of fiscal years 2006, 2007, and 2008. During the fifth year, or 2009, we expect to pay principal in the amount of $138.6 million. The Term B Senior Credit Facility also requires the Company to make mandatory prepayments of principal depending upon whether the Company generates certain excess cash flow in a given fiscal year, issue certain equity, issue or incur certain debt or sell certain assets. Due to the uncertainty of these payments, the table does not reflect any such payments. The approximate $142.9 million includes, as of September 30, 2005, approximately $3.6 million of the remaining unamortized debt discount. Approximately $4.6 million of debt issuance costs were recorded as debt discount.
 
(2)  Repayment of $39.9 million for the face value of the Subordinated Seller Note in two equal payments of $19.95 million in years 2009 and 2010. The $39.9 million includes, as of September 30, 2005, approximately $4.8 million of the remaining unamortized debt discount, assigned to fair value of the detachable warrants. At date of issuance, December 20, 2002, approximately $7.1 million was assigned as the fair value of the warrants in accordance with Emerging Issues Task Force Issue No. 00-19, “Accounting for Derivative Financial Instruments Indexed to, and Potentially settled in, a Company’s Own Stock.”
 
(3)  During the eight-year term of the Subordinated Note, approximately $14.4 million of principal accretes to the note through the PIK. These amounts are included in the principal payments in fiscal years 2009 and 2010. In fiscal years 2009 and 2010, interest will be 16% paid quarterly in cash. The principal, together with the outstanding balance of the PIK notes will be paid in equal amounts at the end of fiscal years 2009 and 2010.
(9) Redeemable Common Stock Warrants
      In connection with the issuance of the Mezzanine Note, Subordinated Note, and the Deferred Compensation Agreement described in Note 8, the Company issued 524,229 (an amount which was subsequently reduced by repurchase of 19,327 warrants, as described above), 1,080,437, and 22,062, respectively, detachable redeemable common stock warrants (the Warrants) to the holders of those instruments. As of July 1, 2004, IITRI transferred all of its rights, title and interest in the warrants to the Illinois Institute of Technology. The Warrants have an exercise price of $10 per share and are exercisable until December 20, 2008 for the warrants associated with the Mezzanine Note and the Deferred Compensation Agreement and until December 20, 2010 for the warrants associated with the Subordinated Note. In addition, the Warrants enable the holders to sell the warrants back to the Company, at predetermined times, at the then current fair value of the common stock less the exercise price. Accordingly, the Warrants are classified as debt instruments in accordance with Emerging Issues Task Force Issue No. 00-19, “Accounting for Derivative Financial Instruments Indexed to, and Potentially Settled in, a Company’s Own Stock”. The estimated fair value of the Warrants of approximately $10.3 million on the date of issuance was recorded as a discount to the face value of the notes issued and as a liability in the accompanying consolidated balance sheet. The estimated fair value of the Warrants was $44.6 million as of September 30, 2005. Changes in the estimated fair value of the Warrants are recorded as interest expense in the accompanying consolidated statements of operations.
(10) Leases
      Future minimum lease payments under non-cancelable operating leases for buildings, equipment and automobiles at September 30, 2005 are set out below. Under these operating leases, the Company subleased some excess capacity to subtenants under non-cancelable operating leases.

85



 

ALION SCIENCE AND TECHNOLOGY CORPORATION
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS — (Continued)
      In connection with the IPS, METI, and JJMA acquisitions, the Company assumed operating leases at above-market rates and recorded a loss accrual of approximately $5.2 million based on the estimated fair value of the lease liabilities assumed; which is being amortized over the lease terms. The remaining unamortized accrued loss related to these acquisitions was $3.5 million at September 30, 2005. In connection with the IPS acquisition, the Company also acquired a related sub-lease pursuant to which it receives above-market rates. Based on the estimated fair value of the sublease, the Company recognized an asset of $0.6 million which is being amortized over the lease term. The remaining asset value was $0.4 million at September 30, 2005.
           
Fiscal Years Ending   (In Thousands)
     
2006
  $ 19,035  
2007
    16,698  
2008
    15,415  
2009
    12,292  
2010
    7,888  
and thereafter
    4,493  
       
Gross lease payments
  $ 75,821  
 
Less: non-cancelable subtenant receipts
    8,286  
       
Net lease payments
  $ 67,535  
       
      Rent expense under operating leases was $15.1 million, $10.5 million, and $8.2 million for the years ended September 30, 2005, 2004, and 2003, respectively. Sublease rental income under operating leases was $1.8 million, $0.8 million, and zero for the years ended September 30, 2005, 2004, and 2003, respectively.
(11) Fixed Assets
      Fixed assets at September 30 consisted of the following:
                   
    2005   2004
         
    (In thousands)
Leasehold improvements
  $ 2,302     $ 1,992  
Equipment and software
    17,395       13,358  
             
 
Total cost
    19,697       15,350  
             
Less accumulated depreciation and amortization
    8,523       4,572  
             
 
Net fixed assets
  $ 11,174     $ 10,778  
             
      Depreciation and leasehold amortization expense for fixed assets was approximately $4.4 million and $2.8 million for fiscal years ended September 30, 2005 and 2004, respectively.

86



 

ALION SCIENCE AND TECHNOLOGY CORPORATION
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS — (Continued)
(12) Stock Appreciation Rights
      In November 2002, the board of directors adopted the Alion Science and Technology Corporation 2002 Stock Appreciation Rights (SAR) Plan (the “2002 SAR Plan”), which is administered by the compensation committee of the board or its delegate. On November 9, 2004, the board of directors amended the 2002 SAR Plan to provide that, on or after October 3, 2004, no further grants would be made under the 2002 SAR Plan. Existing grants made under the plan before October 3, 2004, remain in force. The 2002 SAR Plan has a term of ten years. Awards may be granted under the plan to directors, officers, and employees. Outstanding SAR awards cannot exceed the equivalent of 10% of the Company’s outstanding shares of common stock on a fully diluted basis. A grantee has the right to receive payment upon exercise equal to the difference between the appraised value of a share of Alion common stock as of the grant date and the appraised value of a share of Alion common stock as of the exercise date based on the most recent valuation of the shares of common stock held by the ESOP. Under the 2002 SAR Plan, awards vest at 20% per year for employees. Awards to members of the Company’s board of directors, other than Dr. Atefi, vest ratably over each member’s then-current term of office. SARs may be exercised at any time after grant to the extent they have vested. As of September 30, 2005, the Company had granted 236,400 outstanding SARs which may be summarized as follows:
                                         
    Number of   Number of SARs            
    SARs   Granted to           Cumulative
    Granted to   Board   Total Number of   Exercise   Number of
Effective Date of Grant   Employees   of Directors   SARs Granted   Price/Share   SARs Granted
                     
    64,250       29,400       93,650     $ 10.00/share       93,650  
    300             300     $ 11.13/share       93,950  
    300             300     $ 11.13/share       94,250  
    129,550       12,600       142,150     $ 14.71/share       236,400  
      As of September 30, 2005, under this plan, approximately 30,670 SARs had been exercised and 23,760 SARs had been forfeited resulting in approximately 181,970 SARs outstanding.
      On January 13, 2005, the Company’s board of directors adopted a second SAR plan, the Alion Science and Technology Corporation 2004 Stock Appreciation Rights Plan (the “2004 SAR Plan”), to comply with the deferred compensation provisions of the American Jobs Creation Act of 2004.
      The 2004 SAR Plan has a 10-year term. Awards may be granted under the plan to Alion directors, officers, employees and consultants. Under the Plan, the chief executive officer has the authority to grant awards as he deems appropriate; however, awards to executive officers are subject to the approval of the administrative committee of the Plan. Outstanding SAR awards cannot exceed the equivalent of 12% of the Company’s outstanding shares of common stock on a fully diluted basis. Awards to employees vest over four years at 25% per year and awards to directors vest ratably over each director’s term of service. SARs may be exercised at any time after grant to the extent they have vested. The 2004 SAR Plan contains a provision for accelerated vesting in the event of death, disability or a change in control of the Company. SARs are normally paid on the first anniversary of the date the award becomes fully vested, or else upon the SAR holder’s earlier death, disability or termination of service, or change in control. Payments are determined by the number of vested SARs multiplied by the difference between the share price at date of grant and the share price at date of payment; however, for SARs granted before November 9, 2005 and outstanding when a change in control occurs, payment is based on the number of SARs multiplied by the share price at the date of the change in control (or earlier valuation, if higher).
      Upon exercise, a grantee has the right to receive payment equal to the difference between the appraised value of a share of Alion common stock as of the grant date and the appraised value of a share of Alion common stock as of the exercise date per the most recent valuation of the common stock held by the ESOP.

87



 

ALION SCIENCE AND TECHNOLOGY CORPORATION
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS — (Continued)
As of September 30, 2005, under this plan, the Company has granted 214,350 outstanding SARs summarized as follows:
                                         
    Number of   Number of SARs            
    SARs   Granted to           Cumulative
    Granted to   Board   Total Number of   Exercise   Number of
Effective Date of Grant   Employees   of Directors   SARs Granted   Price/Share   SARs Granted
                     
November 2004
          12,600       12,600     $ 19.94/share       12,600  
February 2005
    164,750             164,750     $ 19.94/share       177,350  
March 2005
    2,000             2,000     $ 19.94/share       179,350  
April 2005
    33,000             33,000     $ 29.81/share       212,350  
June 2005
    2,000             2,000     $ 29.81/share       214,350  
      As of September 30, 2005, under this plan, no SARs have been exercised, 12,350 SARs have been forfeited and 202,000 SARs remain outstanding.
      For the years ended September 30, 2005, 2004, and 2003, the Company recognized approximately $3.7 million, $0.7 million, and $0.2 million, respectively, in compensation expense associated with the two SAR plans.
(13) Phantom Stock Program
      Phantom stock refers to hypothetical shares of Alion common stock. Recipients, upon vesting, are generally entitled to receive cash equal to the product of the number of hypothetical shares vested and the then-current value of Alion common stock, based on the most recent valuation of the shares of common stock held by the ESOP. The Company’s phantom stock plans are administered by the compensation committee of the board of directors which may grant key management employees awards of phantom stock.
Initial Phantom Stock Plan
      In February 2003, the compensation committee of Alion’s board of directors approved, and the board of directors subsequently adopted, the Alion Science and Technology Phantom Stock Plan (the “Initial Phantom Stock Plan”).
      The Initial Phantom Stock plan has a term of ten years. The Initial Phantom Stock Plan contains provisions for acceleration of vesting and payouts in connection with an employee’s death, disability, involuntary termination of employment without cause or a change in control of the Company. The phantom stock awards vest according to the following schedule:
                 
    The Vested Amount for
    Grant in
     
    February   November
Anniversary from Grant Date   2003   2003
         
1st
          20 %
2nd
          20 %
3rd
    50 %     20 %
4th
    25 %     20 %
5th
    25 %     20 %

88



 

ALION SCIENCE AND TECHNOLOGY CORPORATION
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS — (Continued)
      As of September 30, 2005, under the Initial Phantom Stock Plan, the Company had 223,685 shares of phantom stock outstanding which may be summarized as follows:
                 
    Shares of   Cumulative
    Phantom Stock   Shares of
    Awarded to   Phantom Stock
Effective Date of Grant   Employees   Awarded
         
    171,000       171,000  
    52,685       223,685  
Second Phantom Stock Plan
      On November 9, 2004, the Company’s compensation committee approved, and the full board adopted, the Alion Science and Technology Corporation Performance Shares and Retention Phantom Stock Plan (the “Second Phantom Stock Plan”) to comply with the requirements of the American Jobs Creation Act.
      The Second Phantom Stock Plan permits awards of retention share phantom stock and performance share phantom stock. A retention award is for a fixed number of shares determined at the date of grant. A performance award is for an initial number of shares subject to change at the vesting date. Performance phantom shares are subject to forfeiture for failure to achieve a specified threshold value for a share of the Company’s common stock as of the vesting date. If the value of a share of the Company’s common stock equals the threshold value but does not exceed the target value, the number of performance shares in a given grant may be decreased by a specified percentage (generally up to 50 percent). If the value of a share of the Company’s common stock exceeds a pre-established target price on the vesting date, the number of performance shares in a given grant may be increased by a specified percentage (generally up to 20%).
      Awards of performance share phantom stock vest three years from date of grant (unless otherwise provided in an individual award agreement) and awards of retention share phantom stock vest in the years specified in the individual award agreement, provided that the grantee is still employed by the Company. Depending on the future financial performance of the Company, grantees may vest in performance phantom shares at a greater (up to 20% more) or lesser (up to 50% less) number of shares than the target number of shares disclosed above. Grants are to be paid out five years and sixty days from the date of grant. Under limited circumstances, a grantee may defer an award payout beyond the original date. The Second Phantom Stock Plan contains provisions for acceleration of vesting and payouts in connection with an employee’s death, disability, involuntary termination of employment without cause or a change in control of the Company.
      As of September 30, 2005, under the Second Phantom Stock Plan, the Company had 311,192 shares of phantom stock outstanding which may be summarized as follows:
                 
    Shares of   Cumulative
    Phantom Stock   Shares of
    Awarded to   Phantom Stock
Effective Date of Grant   Employees   Awarded
         
    207,778 (1)     207,778  
    103,414 (2)     311,192  
 
(1)  Awarded 207,778 shares of performance share phantom stock.
 
(2)  Awarded 103,414 shares of retention share phantom stock.
      For the years ended September 30, 2005, 2004, and 2003, the Company recognized approximately $6.6 million, $1.5 million, and 0.4 million, respectively, in compensation expense associated with the phantom stock plans.

89



 

ALION SCIENCE AND TECHNOLOGY CORPORATION
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS — (Continued)
(14) Segment Information and Customer Concentration
      The Company operates in one segment, delivering a broad array of scientific and engineering expertise to research and develop technological solutions for problems relating to national defense, public health and safety, and nuclear safety and analysis under contracts with the federal government, state and local governments, and commercial customers. The Company’s federal government customers typically exercise independent contracting authority, and even offices or divisions within an agency or department may directly, or through a prime contractor, use the Company’s services as a separate customer so long as that customer has independent decision-making and contracting authority within its organization.
      Contract receivables from agencies of the federal government represented approximately $79.0 million, or 94%, of accounts receivable at September 30, 2005 and $68.6 million, or 96%, of accounts receivable at September 30, 2004. Contract revenues from agencies of the federal government represented approximately 96% and 98% of total contract revenues during the years ended September 30, 2005 and 2004, respectively.
(15) Business Combinations
IITRI Acquisition and Pro Forma Information
      On December 20, 2002, Alion acquired substantially all of the assets and certain of the liabilities of IITRI, excluding the assets and liabilities of IITRI’s Life Sciences Operation, for approximately $127.3 million as described in Note 1. In connection with the acquisition, the Company formed the KSOP, which has an ESOP component. The ESOP trustee, State Street Bank and Trust Company, used the proceeds from the ESOP aggregating approximately $25.8 million to acquire approximately 2.58 million shares or 100% of the Company’s outstanding common stock. The Company used the funds from the sale of common stock to the ESOP and proceeds from the debt instruments described in Note 8, to fund the Transaction. The acquisition was accounted for using the purchase method. The acquisition occurred on the last day of the Company’s first interim period in fiscal year 2003, and accordingly, the accompanying consolidated statements of operations exclude the results of operations of the acquired business prior to the acquisition. The purchase price has been allocated to the acquired assets and assumed liabilities based on their estimated fair values at the date of acquisition. As of September 30, 2005, the Company has recorded approximately $63.0 million of goodwill related to this acquisition. Prior to the Transaction, the Company’s activities had been organizational in nature.
Acquisition of Innovative Technology Solutions Corporation
      On October 31, 2003, Alion acquired 100% of the outstanding stock of ITSC for $4.0 million. The transaction is subject to an earn out provision not-to-exceed $1.5 million. As of September 30, 2005, the Company has recorded approximately $5.0 million of goodwill relating to this acquisition. ITSC’s results of operations are included in Alion’s operations from the date of acquisition.
Acquisition of Identix Public Sector, Inc.
      On February 13, 2004, Alion acquired 100% of the outstanding stock of IPS for $8.0 million in cash. IPS, formerly ANADAC, was a wholly-owned subsidiary of Identix Incorporated. In the three months following the closing, the Company paid Identix approximately $2.6 million for intercompany payables. Subsequent payments totaling approximately $1.7 million for intercompany payables. Per the agreement, the Company placed a payment of $0.5 million in escrow contingent on the Company having the opportunity to compete or bid for services on certain government solicitations. As of September 30, 2005, the Company has recorded approximately $6.1 million of goodwill relating to this acquisition and approximately $0.8 million of intangible assets related to acquired contracts to be amortized over three years. The results of operations for IPS are included in Alion’s operations from the date of acquisition.

90



 

ALION SCIENCE AND TECHNOLOGY CORPORATION
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS — (Continued)
Acquisition of Assets of Countermeasures, Inc.
      On October 28, 2004, Alion purchased substantially all of the assets of Countermeasures, Inc. for approximately $2.4 million. At the time of acquisition, Countermeasures, Inc. had two employees and was located in Hollywood, Maryland. As of September 30, 2005, the Company has recorded approximately $1.4 million in goodwill relating to this acquisition. The results of operations for Countermeasures, Inc. are included in Alion’s operations from the date of acquisition. The pro forma impact of this acquisition was not significant.
Acquisition of ManTech Environmental Technology, Inc.
      On February 11, 2005, Alion acquired 100 percent of the outstanding stock of METI, an environmental and life sciences research and development company for approximately $7.0 million in cash. METI was headquartered in Research Triangle Park, NC. As of September 30, 2005, the Company has recorded $5.5 million in goodwill related to this acquisition and has remaining approximately $0.2 million of purchased contracts being amortized over three years. The results of operations for METI are included in Alion’s operations from the date of acquisition. The allocation of purchase price is preliminary as the Company completes its valuation of assets acquired and liabilities assumed. The pro forma impact of this acquisition was not significant.
Acquisition of Carmel Applied Technologies, Inc.
      On February 25, 2005 Alion acquired 100 percent of the outstanding stock of CATI, a flight training software and simulator development company, for approximately $7.3 million in cash. The transaction is subject to an earn-out provision not-to-exceed a cumulative amount of $9.0 million based on attaining certain cumulative revenue goals for fiscal years 2005, 2006, and 2007, and a second earn-out provision not-to-exceed $1.5 million for attaining certain revenue goals in the commercial aviation industry. As of September 30, 2005, the Company has recorded $12.9 million in goodwill related to this acquisition. The results of operations for CATI are included in Alion’s operations from the date of acquisition The allocation of purchase price is preliminary as the Company completes its valuation of assets acquired and liabilities assumed. The pro forma impact of this acquisition was not significant.
Investment in VectorCommand Ltd.
      On March 22, 2005, Alion acquired approximately 12.5 percent of the A ordinary shares in VectorCommand Ltd. for $1.5 million which investment is accounted for at cost.
Acquisition of John J. McMullen Associates, Inc. and Pro Forma Information
      On April 1, 2005, the Company acquired 100% of the issued and outstanding stock of JJMA pursuant to a Stock Purchase Agreement (the “Agreement”) by and among Alion, JJMA, Marshall & Ilsley Trust Company N.A. as trustee of the JJMA Employee Stock Ownership Trust, and holders of JJMA stock options and JJMA stock appreciation rights. The Company paid the equity holders of JJMA approximately $51.9 million, issued 1,347,197 shares of Alion common stock to the JJMA Trust valued at approximately $37.3 million, and agreed to make $8.3 million in future payments. The Company valued its common stock issued to the JJMA Trust at $27.65 per share, which price was determined based on an independent valuation. The acquisition was accounted for using the purchase method. The estimated total purchase price is as follows.

91



 

ALION SCIENCE AND TECHNOLOGY CORPORATION
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS — (Continued)
         
Form of Consideration   Fair Value
     
    (In millions)
Cash paid, net of cash acquired
  $ 52.9  
Stock issued
    37.3  
Future payments
    8.3  
Acquisition costs
    1.3  
       
Total consideration
  $ 99.8  
      The Company has allocated the purchase price of JJMA to the estimated fair value of the assets acquired and liabilities assumed in the purchase. The purchase price allocation is preliminary as the Company completes its determination of the fair values of the assets acquired and liabilities assumed and is as follows (in millions):
         
Accounts receivable
  $ 21.5  
Property and equipment
    1.0  
Other assets
    1.4  
Identifiable intangible assets
    29.6  
Goodwill
    57.8  
Accounts payable and other accrued liabilities
    (11.5 )
      Identifiable intangible assets include $28.0 million for contracts acquired, $0.9 million for software and $1.3 million for non-compete agreements. The intangible asset for contracts acquired has an estimated useful life of five years and the intangible asset for non-compete agreements will be amortized over the term of the agreements, which are two years.
      The table below sets out the unaudited pro forma effects of the JJMA acquisition on the Company’s revenue, net income and earnings per share as though the JJMA acquisition had taken place on the first day of each fiscal year presented. The unaudited pro forma information disclosed below for JJMA includes historical operating results and pro forma adjustments to reflect the effects of Alion’s acquisition of JJMA. The JJMA pro forma results for the year ended September 30, 2005, includes approximately $10.1 million of stock-based compensation expensed and recorded by JJMA due to accelerated vesting directly associated with this acquisition. The unaudited pro forma information does not purport to be indicative of the results of operations that would have actually been achieved if the transaction had occurred on the date indicated or the results of operations that will be reported in the future.
                                                 
    Twelve Months Ended September 30, 2005   Twelve Months Ended September 30, 2004
         
        JJMA Pro   Alion Pro       JJMA Pro   Alion Pro
    Alion   Forma   Forma   Alion   Forma   Forma
                         
Pro Forma Revenue
  $ 369,231     $ 51,103     $ 420,334     $ 269,940     $ 101,418     $ 371,358  
Pro Forma Loss
  $ (40,238 )   $ (17,524 )   $ (57,762 )   $ (15,111 )   $ (4,705 )   $ (19,816 )
Weighted Average Shares Outstanding
    4,235,947       671,753       4,907,700       3,074,709       1,347,197       4,421,906  
Loss Per Share
  $ (9.50 )   $     $ (11.77 )   $ (4.91 )   $     $ (4.33 )
                                     
(16) Related Party Transactions
      On March 28, 2003, an officer of the Company purchased a portion of the Company’s Mezzanine Note owned by IITRI for $750,000, its face value, along with warrants to purchase 19,327 shares of Alion’s common stock at an exercise price of $10.00 per share. On November 12, 2003, the Company purchased the Mezzanine Note and warrants from the officer for an aggregate purchase price of $1,034,020.

92



 

ALION SCIENCE AND TECHNOLOGY CORPORATION
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS — (Continued)
      On February 11, 2004, the Company borrowed $750,000 from an officer of the Company and, in exchange, the Company issued a Promissory Note in the principal amount of $750,000 with interest at a rate of 15% per annum, to be paid quarterly, until March 31, 2009 when the principal amount becomes due. The annual interest period was effective beginning February 11, 2004. On December 9, 2004, the Promissory Note with officer was extinguished. An amount of $750,000 plus accrued interest of $21,635 was paid to the officer.
      On October 29, 2004, Dr. Atefi elected to redeem the amount due under his Deferred Compensation Agreement with Alion. The Company paid Dr. Atefi approximately $1.1 million including accrued interest of approximately $0.2 million. Dr. Atefi’s related warrants remain outstanding.
(17) Commitments and Contingencies
Earn Out Commitments
      The Company has earn out commitments related to the following acquisitions:
      AB Technologies (AB Tech) — Earn out is based on an agreed-upon formula applied to net income of the business units that formerly comprised AB Tech. The earn out obligation continues through February 7, 2005, the fifth anniversary of the original acquisition date. As of September 30, 2005, approximately $1.4 million of earn-out has been recorded for fiscal year 2005. See below regarding the settlement of the Company’s dispute with the former shareholders of AB Tech.
      ITSC — Earn out is based on a portion of the gross revenue of the business units that formerly comprised ITSC. As of September 30, 2005, $1.8 million of earn-out has been recorded from the date of the acquisition, of which approximately $1.5 million was recorded in fiscal year 2005.
      CATI — Earn-out is based on the performance of the business units that formerly comprised CATI. The transaction is subject to an earn -out provision not-to-exceed a cumulative amount of $9.0 million based on attaining certain revenue goals for fiscal years 2005, 2006, and 2007, and a second earn-out provision not-to-exceed $1.5 million for attaining certain revenue goals in the commercial aviation industry. As of September 30, 2005, no earn-out obligation has been recorded for fiscal year 2005. The obligation continues through February 25, 2007.
      In the opinion of management, the realization of the amounts due under these arrangements will not have a material adverse effect upon the financial position, results of operations, or the liquidity of the Company.
Legal Proceedings
AB Tech Settlement
      On September 12, 2002, the former owners of AB Technologies, Inc. (“AB Tech”) filed a lawsuit (“AB Tech Lawsuit”) against IITRI in Circuit Court for Fairfax County, Virginia. The complaint alleges breach of the AB Tech asset purchase agreement (“Asset Purchase Agreement”), and claims damages of $8.2 million. The former owners of AB Tech (“Former Owners”) asked the court to order an accounting of their earn out.
      On September 16, 2002, IITRI filed a lawsuit against the Former Owners which asked the court to compel the Former Owners to submit disputed issues to an independent accounting firm in accordance with the requirements of the Asset Purchase Agreement, make a declaratory judgment concluding that IITRI is entitled to an approximately $1.1 million downward adjustment of the purchase price paid under the Asset Purchase Agreement, and conclude that IITRI properly computed the earnout in accordance with the earnout formula in the Asset Purchase Agreement.
      Upon the closing of the Transaction, Alion assumed responsibility for and acquired all claims under these lawsuits.

93



 

ALION SCIENCE AND TECHNOLOGY CORPORATION
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS — (Continued)
      On July 22, 2005, the Company settled the ongoing dispute between the Company and AB Tech. Under the terms of the settlement, the Company paid $3.4 million to the former shareholders of AB Tech, and has a remaining obligation to pay $0.7 million to the former shareholders of AB Tech within fifteen days following the date that the Company’s fiscal 2005 year-end audited financial statement report by the Company’s auditor is issued and made publicly available by the Company.
Joseph Hudert vs. Alion; Frank Stotmeister vs. Alion
      On December 23, 2004, the estate of Joseph Hudert filed an action against Grunley-Walsh Joint Venture, L.L.C. (Grunley-Walsh) and the Company in the District of Columbia Superior Court for damages in excess of $80 million. On January 6, 2005, the estate of Frank Stotmeister filed an action against the Company in the same court on six counts, some of which are duplicate causes of action, claiming $30 million for each count. Several other potential defendants may be added to these actions in the future.
      The suits arose in connection with a steam pipe explosion that occurred on or about April 23, 2004 on a construction site at 17th Street, N.W. in Washington, D.C. The plaintiffs died, apparently as a result of the explosion. They were employees of the prime contractor on the site, Grunley-Walsh, and the subcontractor, Cherry Hill Construction Company Inc., respectively. Grunley-Walsh had a contract with the U.S. General Services Administration (GSA) for construction on 17th Street N.W. near the Old Executive Office Building in Washington, D.C. Sometime after the award of Grunley-Walsh’s construction contract, Alion was awarded a separate contract by GSA. Alion’s responsibilities on this contract were non-supervisory monitoring of Grunley-Walsh’s activities and reporting to GSA of any deviations from contract requirements.
      The Company intends to defend these lawsuits vigorously based on the facts currently known to the Company. The Company’s management does not believe that these lawsuits will have a materially adverse effect upon the Company, its operations or its financial condition.
      Alion’s primary provider of general liability insurance, St. Paul Travelers, has assumed defense of these lawsuits subject to a reservation of rights to deny coverage. American International Group, the Company’s excess insurance carrier, has also been notified regarding these lawsuits.
      Other than the foregoing action, the Company is not involved in any legal proceeding other than routine legal proceedings occurring in the ordinary course of business. The Company believes that these routine legal proceedings, in the aggregate, are not material to its financial condition and results of operations.
      The Company is involved in various claims and legal actions arising in the ordinary course of business. In the opinion of management, the ultimate disposition of these matters will not have a material adverse effect upon the financial position, results of operations, or liquidity of the Company.
Government Audits
      The amount of federal government contract revenue and expense reflected in the consolidated financial statements attributable to cost reimbursement contracts is subject to audit and possible adjustment by the Defense Contract Audit Agency (DCAA). The federal government considers the Company to be a major contractor and DCAA maintains an office on site to perform its various audits throughout the year. DCAA has concluded its audits of the Company’s indirect expense rates and cost accounting practices through fiscal year 2003. There were no significant cost disallowances for the fiscal years ended September 30, 2000 and 2001. Final rates on fiscal years ended September 2002 and 2003 are being negotiated with the Defense Contract Management Agency and are not expected to have a material effect on the results of future operations. The result of the audit for 2004 is not expected to have a material effect on the results of future operations. The fiscal year 2005 indirect expense rate submittal is scheduled to be provided to the federal government for review on or about March 30, 2006. Contract revenues on federal government contracts have been recorded in amounts that are expected to be realized upon final settlement.

94



 

ALION SCIENCE AND TECHNOLOGY CORPORATION
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS — (Continued)
(18) Interim Period Information (Unaudited, in thousands)
                                 
    2005 Quarters
     
    1st   2nd   3rd   4th
                 
Revenue
  $ 69,221     $ 80,691     $ 110,795     $ 108,524  
Net loss
  $ (5,964 )   $ (17,366 )   $ (10,763 )   $ (6,145 )
Loss per share
  $ (1.77 )   $ (5.21 )   $ (2.21 )   $ (1.18 )
                                 
    2004 Quarters
     
    1st   2nd   3rd   4th
                 
Revenue
  $ 58,591     $ 64,712     $ 69,808     $ 76,829  
Net loss
  $ (4,292 )   $ (3,386 )   $ (2,805 )   $ (4,628 )
Loss per share
  $ (1.45 )   $ (1.16 )   $ (0.87 )   $ (1.45 )
(19) Subsequent Event
  Joint Spectrum Center Contract
      During the year ended September 30, 2005, the support services contract to the Joint Spectrum Center underwent a full and open competition for the follow-on support contract that was to commence beginning October 2005. In August 2005, we were notified that we were not the successful bidder for these services. The JSC contract represented approximately 12%, 18%, and 21% of our revenue for the years ended September 30, 2005, 2004, and 2003, respectively. The Company filed a formal bid protest before the Government Accountability Office (GAO) with respect to the JSC contract award. The Company’s principal argument was that the successful bidder had an organizational conflict of interest with respect to its performance of the contract. In it’s decision dated January 9, 2006, the GAO sustained the protest and recommended that the contracting agency take certain corrective action in order to address the awardee’s organizational conflict of interest. The Company is awaiting further action from the contracting agency. In the meantime, the Company expects to continue to generate revenue from its existing JSC contract until the issues involved in its protest are fully resolved.
Consolidated Financial Statement Schedule
      Schedule II — Valuation and Qualifying Accounts (in thousands)
                                                 
    Balance at   Charged to   Charged to            
Allowance for Doubtful   Beginning of   Costs and   Contract           Balance at
Accounts Receivable   Year   Expenses   Revenue   Deductions(2)   Acquisitions(3)   End of Year
                         
Fiscal year ended
2003(1)
  $ 3,414     $ (525 )   $ (18 )   $ (387 )   $     $ 2,484  
Fiscal year ended
2004
  $ 2,484     $ 659     $     $ (791 )   $ 544 (3)   $ 2,896  
Fiscal year ended
2005
  $ 2,896     $ 700     $     $ (970 )   $ 913 (4)   $ 3,539  
 
(1)  Beginning balance recorded pursuant to allocation of purchase price to assets acquired and liabilities assumed in Alion’s acquisition of the Selected Operations of IITRI.
 
(2)  Accounts receivable written off against the allowance for doubtful accounts.
 
(3)  Adjustments pursuant to the allocation of purchase price to assets acquired and liabilities assumed in Alion’s acquisitions of ITSC and IPS.

95



 

ALION SCIENCE AND TECHNOLOGY CORPORATION
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS — (Continued)
(4)  Adjustments pursuant to the allocation of purchase price to assets acquired and liabilities assumed in Alion’s acquisitions of CATI, METI, and JJMA.

96



 

INDEPENDENT AUDITORS’ REPORT
The Board of Governors
IIT Research Institute:
      We have audited the accompanying consolidated balance sheets of Selected Operations of IIT Research Institute as of September 30, 2001 and 2002, and the related consolidated statements of income, changes in owner’s net investment, and cash flows for each of the years in the three-year period ended September 30, 2002. These consolidated financial statements are the responsibility of Selected Operations of IIT Research Institute’s management. Our responsibility is to express an opinion on these consolidated financial statements based on our audits.
      We conducted our audits in accordance with auditing standards generally accepted in the United States of America. Those standards require that we plan and perform the audit to obtain reasonable assurance about whether the financial statements are free of material misstatement. An audit includes examining, on a test basis, evidence supporting the amounts and disclosures in the financial statements. An audit also includes assessing the accounting principles used and significant estimates made by management, as well as evaluating the overall financial statement presentation. We believe that our audits provide a reasonable basis for our opinion.
      In our opinion, the consolidated financial statements referred to above present fairly, in all material respects, the financial position of Selected Operations of IIT Research Institute as of September 30, 2001 and 2002, and the results of their operations and their cash flows for each of the years in the three-year period ended September 30, 2002, in conformity with accounting principles generally accepted in the United States of America.
  /s/ KPMG LLP
Chicago, Illinois
December 6, 2002 except as to note 13,
  which is as of December 20, 2002

97



 

SELECTED OPERATIONS OF IIT RESEARCH INSTITUTE
CONSOLIDATED BALANCE SHEETS
As of September 30, 2002 and 2001
                     
    September 30,
     
    2002   2001
         
    (In thousands)
ASSETS
Current assets:
               
 
Cash
  $ 396     $  
 
Restricted cash
    512       2,396  
 
Accounts receivable, less allowance of $3,613 at September 30, 2002 and $3,260 at September 30, 2001
    49,051       56,095  
 
Other current assets
    2,965       1,619  
             
   
Total current assets
    52,924       60,110  
Fixed assets, net
    8,388       5,835  
Goodwill, less accumulated amortization
    8,931       9,511  
Other assets
    853       853  
             
   
Total assets
  $ 71,096     $ 76,309  
             
 
LIABILITIES AND OWNER’S NET INVESTMENT
Current liabilities:
               
 
Bank overdraft
  $     $ 2,156  
 
Current portion of long-term debt
    3,330       141  
 
Trade accounts payable and accrued liabilities
    9,890       8,965  
 
Accrued payroll and related liabilities
    12,058       8,722  
 
Advance payments
    512       2,396  
 
Billings in excess of costs and estimated earnings on uncompleted contracts
    1,703       3,699  
 
Due to the Illinois Institute of Technology
    72       775  
 
Current portion of deferred gain on sale of building to the Illinois Institute of Technology
    487       493  
             
   
Total current liabilities
    28,052       27,347  
 
Long-term debt, excluding current portion
    1,654       11,886  
 
Accrued post-retirement benefit obligation
    1,520       1,345  
 
Long-term deferred gain on sale of building to the Illinois Institute of Technology excluding current portion
    3,523       4,054  
             
   
Total liabilities
    34,749       44,632  
Owner’s net investment
    36,347       31,677  
             
   
Total liabilities and owner’s net investment
    71,096       76,309  
             
See accompanying notes to consolidated financial statements.

98



 

SELECTED OPERATIONS OF IIT RESEARCH INSTITUTE
CONSOLIDATED STATEMENTS OF INCOME
For the Years Ended September 30, 2002, 2001, and 2000
                             
    Year Ended September
     
    2002   2001   2000
             
    (In thousands)
Contract revenue
  $ 201,738     $ 193,152     $ 156,137  
Direct contract expenses
    147,377       140,555       111,122  
                   
   
Excess of contract revenue over direct contract expenses
    54,361       52,597       45,015  
                   
Operating expenses:
                       
 
Indirect contract expenses
    11,153       13,145       12,348  
 
Research and development
    575       435       547  
 
General and administrative
    25,363       16,352       15,132  
 
Rental and occupancy expense
    7,796       7,083       7,536  
 
Depreciation and amortization
    3,447       3,488       3,754  
 
Bad debt expense
    154       1,223       324  
                   
 
Total operating expense
    48,488       41,726       39,641  
                   
   
Operating income
    5,873       10,871       5,374  
Other income (expense):
                       
 
Interest income
    40       50       105  
 
Interest expense
    (563 )     (895 )     (1,389 )
 
Equity in loss of affiliate
                (498 )
 
Gain on sale of land
                1,319  
 
Other
    (63 )     (277 )     (231 )
                   
   
Income before income taxes
    5,287       9,799       4,680  
 
Income tax expense
    (589 )     (302 )     (398 )
                   
   
Net income
  $ 4,698     $ 9,497     $ 4,282  
                   
See accompanying notes to consolidated financial statements.

99



 

SELECTED OPERATIONS OF IIT RESEARCH INSTITUTE
CONSOLIDATED STATEMENTS OF CHANGES IN OWNER’S NET INVESTMENT
For the Years Ended September 30, 2000, 2001, and 2002
         
    Owner’s Net
    Investment
     
    (In thousands)
  $ 26,787  
Net Income
    4,282  
Distributions to the Illinois Institute of Technology
    (1,315 )
Unreimbursed losses and capital funding of Life Sciences Operation
    (2,135 )
       
    27,619  
Net Income
    9,497  
Distributions to the Illinois Institute of Technology
    (1,585 )
Unreimbursed losses and capital funding of Life Sciences Operation
    (3,854 )
       
    31,677  
Net income
    4,698  
Distributions to the Illinois Institute of Technology
    (887 )
Unreimbursed losses and capital funding from Life Sciences Operation
    859  
       
  $ 36,347  
       
See accompanying notes to consolidated financial statements.

100



 

SELECTED OPERATIONS OF IIT RESEARCH INSTITUTE
CONSOLIDATED STATEMENTS OF CASH FLOW
For the Years Ended September 30, 2002, 2001, and 2000
                                 
    Year Ended September 30,
     
    2002   2001   2000
             
    (In thousands)
Cash flows from operating activities:
                       
 
Net Income (loss)
  $ 4,698     $ 9,497     $ 4,282  
 
Adjustments to reconcile net income loss to net cash provided by (used in) operating activities:
                       
   
Depreciation and amortization
    3,447       3,488       3,754  
   
Gain in investments
    (77 )            
   
Equity in loss of affiliate
                498  
   
Amortization of deferred gain on sale of building to the Illinois Institute of Technology
    (486 )     (379 )      
   
Gain on sale of land
                (1,319 )
   
Loss on disposal of fixed assets
          84        
   
Changes in assets and liabilities, net of effect of acquisitions:
                       
     
Accounts receivable, net
    5,927       378       (8,369 )
     
Other assets
    (654 )     (365 )     1,088  
     
Trade accounts payable and accrued liabilities
    4,384       (1,696 )     (136 )
     
Other liabilities
    (2,526 )     (3,100 )     (5,104 )
                   
       
Net cash provided by (used in) operating activities
    14,713       7,907       (5,306 )
                   
Net cash flows from investing activities:
                       
 
Proceeds from sale of land
                2,328  
 
Proceeds from sale of building to the Illinois Institute of Technology, net
          12,181        
 
Capital expenditures
    (3,643 )     (1,940 )     (2,795 )
 
Cash paid for acquisition of net assets of AB Tech
          (378 )     (2,500 )
 
Cash paid for Daedalic
    (823 )            
                   
       
Net cash provided by (used in) investing activities
    (4,466 )     9,863       (2,967 )
                   
Cash flows from financing activities:
                       
 
Increase in (repayment of) bank overdraft
    (2,156 )     2,156       855  
 
Net borrwoings (repayments) under revolving bank credit agreement
    (7,526 )     (10,838 )     14,373  
 
Payments under notes payable
    (141 )     (3,649 )     (6,817 )
 
Distributions to the Illinois Institute of Technology
    (887 )     (1,585 )     (1,315 )
 
Unreimbursed losses and capital funding (of) from Life Sciences Operation
    859       (3,854 )     (2,135 )
   
Cash transferred to Alion in conjunction with the sale of the Business to Alion
                 
                   
       
Net cash provided by (used in) financing activities
    (9,851 )     (17,770 )     4,961  
                   
       
Net increase (decrease) in cash
    396             (3,312 )
Cash at beginning of period
                3,312  
                   
Cash at end of period
  $ 396     $     $  
                   
Supplement disclosure of cash flow information:
                       
 
Cash paid for interest
  $ 776     $ 1,561     $ 1,318  
 
Cash paid for income taxes
    489       570        
Supplemental disclosure of noncash financing activities:
                       
 
Debt incurred related to earnout provisions of acquisitions
  $ 624     $ 579     $ 2,952  
                   
See accompanying notes to consolidated financial statements.

101



 

SELECTED OPERATIONS OF IIT RESEARCH INSTITUTE
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
(1) Nature of Organization and Business
      IIT Research Institute (IITRI) is a not-for-profit membership corporation working for the advancement of knowledge and the beneficial application of science and engineering to meet the needs of society. IITRI’s articles of incorporation provide that in addition to its primary purpose, it will support and assist the Illinois Institute of Technology and, in the event of dissolution, IITRI’s assets are to be distributed to the Illinois Institute of Technology. In addition to its Chicago facilities, IITRI maintains offices in, amongst other places, McLean and Alexandria, Virginia; Lanham, Annapolis, and Waldorf, Maryland; Rome, New York; West Conshohocken, Pennsylvania; and Huntsville, Alabama.
      In October 2001, Alion Science and Technology Corporation, (formerly known as Beagle Holdings, Inc.) (Alion), a for-profit S Corporation, was incorporated in the state of Delaware for the purpose of purchasing substantially all of the assets and liabilities of IITRI (Selected Operations of IIT Research Institute or the Business). The Business includes substantially all of the assets and liabilities of IITRI with the exception of those assets and liabilities associated with IITRI’s Life Sciences Operation.
      As described in Note 13, on December 20, 2002 Alion purchased the Business.
(2) Basis of Presentation and Principles of Consolidation
      The consolidated financial statements of the Business have been carved out from the consolidated financial statements of IITRI using the historical results of operations and bases of the assets and liabilities of the transferred operations and give effect to certain allocations of expenses from IITRI to Life Sciences Operation. Such expenses represent costs related to general and administrative services that IITRI has provided to Life Sciences Operation including interest, accounting, tax, legal, human resources, information technology, and other corporate and infrastructure services. The costs of these services have been allocated to Life Sciences Operation using relative percentages of revenues, operating expenses and headcount, and other reasonable methods, and have been excluded in preparing the Business’ financial statements. Allocations of expenses are estimates based on management’s best assessment of actual expenses incurred by Life Sciences Operation. It is management’s opinion that the expenses charged to Life Sciences Operation and the underlying assumptions used to determine the expenses are reasonable. These allocations and estimates are not necessarily indicative of the costs and expenses that would have resulted had the Business been operated as a separate entity in the past, or of the costs the Business may incur in the future.
      The consolidated financial statements are prepared on the accrual basis of accounting and include the accounts of the Business and its wholly owned subsidiary Human Factors Applications, Inc. (HFA). All significant intercompany accounts have been eliminated in consolidation.
      The consolidated financial statements may not be indicative of the Business’ financial position, operating results, or cash flows in the future or what the Business’ financial position, operating results, and cash flows would have been had the Business been a separate, stand-alone entity during the periods presented. The consolidated financial statements do not reflect any changes that will occur in the Business’ funding or operations as a result of the Business becoming a stand-alone entity.
(3) Summary of Significant Accounting Policies
Use of Estimates
      The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosures of contingent assets and liabilities at the date of financial statements and the reported amounts of revenue and expenses during the reporting period.

102



 

SELECTED OPERATIONS OF IIT RESEARCH INSTITUTE
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS — (Continued)
      Actual results are likely to differ from those estimates, but the Business’ management does not believe such differences will materially affect the Business’ financial position, results of operations, or cash flows.
Fiscal and Interim Periods
      The Business’ fiscal years end on September 30 and consist of 52 weeks. Interim periods were determined based upon the Business’ thirteen internal period closings, each of which ends on a Friday. During the fiscal year ended September 30, 2000, the interim periods ended on December 24, 1999, and March 17, July 7, and September 30, 2000. During the fiscal year ended September 30, 2001, the interim periods ended on December 22, 2000, and March 16, July 6, and September 30, 2001. During the fiscal year ended September 30, 2002, the interim periods ended on December 21, 2001, March 15, July 5, and September 30, 2002. For the fiscal year ending September 30, 2003, the first interim period ended on December 20, 2002. While the actual number of days within each interim period will vary from fiscal year to year, the first, second, and fourth interim periods will include approximately 12 weeks while the third interim period will include approximately 16 weeks. Accordingly, comparisons between interim periods will need to consider the differing length of the third interim period.
Unaudited Financial Information
      The interim period information included in the consolidated financial statements and Note 12 has been prepared by the Business and are unaudited. In the opinion of management, this financial information has been prepared in conformity with accounting principles generally accepted in the United States of America and reflects all adjustments necessary for a fair statement of the Business’ results of operations. All such adjustments are of a normal recurring nature.
Revenue Recognition
      The Business’ revenue results from contract research and other services under a variety of contracts, some of which provide for reimbursement of cost plus fees and others which are fixed-price or time-and-material type contracts. The Business generally recognizes revenue when a contract has been executed, the contract price is fixed or determinable, delivery of the services or products has occurred and collectibility of the contract price is considered probable.
      Revenue on cost-reimbursement contracts is recognized as costs are incurred and include a proportionate share of the fees earned.
      The percentage of completion method is used to recognize revenue on fixed-price contracts generally based on costs incurred in relation to total estimated costs. From time to time, facts develop that require the Business to revise its estimated total costs or revenues expected. The cumulative effect of revised estimates is recorded in the period in which the facts requiring revisions become known. The full amount of anticipated losses on any type of contract are recognized in the period in which they become known.
      Under time-and-material contracts, labor and related costs are reimbursed at negotiated, fixed hourly rates. Revenue on time-and-material contracts is recognized at contractually billable rates as labor hours and direct expenses are incurred.
      Contracts with agencies of the federal government are subject to periodic funding by the contracting agency concerned. Funding for a contract may be provided in full at inception of the contract or ratably throughout the term of the contract as the services are provided. If funding is not assessed as probable, revenue recognition is deferred until realization is probable.
      Contract costs on U.S. Government contracts, including indirect costs, are subject to audit by the federal government and adjustment pursuant to negotiations between the Business and government representatives.

103



 

SELECTED OPERATIONS OF IIT RESEARCH INSTITUTE
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS — (Continued)
      All of the Business’ federal contract indirect costs have been audited and agreed upon through fiscal year 2000. Contract revenue on U.S. Government contracts have been recorded in amounts that are expected to be realized upon final settlement.
      The Business recognizes revenue on unpriced change orders as expenses are incurred only to the extent that the Business expects it is probable that such costs will be recovered. The Business recognizes revenue in excess of costs on unpriced change orders only when management can also reliably estimate the amount of excess and experience provides a sufficient basis for recognition. The Business recognizes revenue on claims as expenses are incurred only to the extent that the Business expects it is probable that such costs will be recovered and the amount of recovery can be reliably estimated.
Restricted Cash
      Restricted cash represents short-term restricted cash received from a customer as an advance payment on a contract. This short-term restricted cash is utilized as work is performed in accordance with the contract.
Costs and Estimated Earnings in Excess of Billings and Billings in Excess of Costs and Estimated Earnings
      Costs and estimated earnings in excess of billings on uncompleted contracts represent accumulated project expenses and fees which have not been invoiced to customers as of the date of the consolidated balance sheet. These amounts, which are included in accounts receivable, are stated at estimated realizable value and aggregated $24.2 million and $12.5 million at September 30, 2001 and 2002, respectively. Billings in excess of costs and estimated earnings and advance collections from customers represent amounts received from or billed to commercial customers in excess of project revenue recognized to date. Costs and estimated earnings in excess of billings on uncompleted contracts at September 30, 2001 and 2002 include $0.6 million and $2.9 million, respectively, related to costs incurred on projects for which the Business has been requested by the customer to begin work under a new contract or extend work under an existing contract, but for which formal contracts or contract modifications have not been executed. In addition, billed receivables at September 30, 2001 and 2002 include $0.6 million of final bills that are not expected to be collected within one year.
Goodwill
      Goodwill, which represents the excess of purchase price over fair value of net assets acquired, is amortized on a straight-line basis over the expected periods to be benefited, generally 7 years. The Business assesses the recoverability of this intangible asset by determining whether the amortization of the goodwill balance over its remaining life can be recovered through undiscounted future operating cash flows of the acquired operation. The amount of goodwill impairment, if any, is measured based on projected discounted future operating cash flows using a discount rate commensurate with the risks involved. The assessment of the recoverability of goodwill will be impacted if estimated future operating cash flows are not achieved.
Property, Plant, and Equipment
      Buildings, leasehold improvements, and equipment are recorded at cost. Expenditures for maintenance and repairs are charged to current operations. Buildings and equipment are depreciated over their estimated useful lives (40 years for buildings and 3 to 15 years for the various classes of equipment) generally using the straight-line method. Leasehold improvements are amortized on the straight-line method over the shorter of the assets’ estimated useful life or the life of the lease. Upon sale or retirement of an asset, costs and related accumulated depreciation are deducted from the accounts, and the gain or loss is recognized in the consolidated income statement.

104



 

SELECTED OPERATIONS OF IIT RESEARCH INSTITUTE
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS — (Continued)
Income Taxes
      Under Subchapter S of the Internal Revenue Code, the stockholder of the Company will include the Company’s income in its own income for federal and most state income tax purposes. Accordingly, the Company is not subject to federal and most state income taxes.
      IITRI has received a determination letter from the Internal Revenue Service which indicates it is exempt from income taxes under Section 501(c)(3) of the Internal Revenue Code except for taxes pertaining to unrelated business income. Accordingly, the accompanying consolidated financial statements do not include provisions for income taxes except as described below.
      HFA, the Business’ for-profit subsidiary, accounts for income taxes under the asset and liability method. HFA recognizes deferred tax assets and liabilities based on the differences between financial statement carrying amounts and the tax bases of assets and liabilities. HFA uses the enacted tax rates expected to apply to taxable income in the years in which these temporary differences are expected to be recovered or settled. The effect of a change in tax rates on deferred tax assets and liabilities is recognized in income in the period that includes the enactment date.
Earnings per Common Share
      The Business’ historical structure is not indicative of its prospective capital structure and, accordingly, historical earnings per share information has not been presented.
Derivative Financial Instruments
      During 2000, the Business entered into forward contracts as a hedge against certain foreign currency commitments on a contract in the United Kingdom. The total amount of the contracts was approximately $0.4 million with the final contract maturing on May 7, 2002. No contracts were outstanding at September 30, 2002. The contracts were marked to market, with gains and losses recognized in the consolidated statements of income. The Business does not use derivatives for trading purposes.
Segment Information and Customer Concentration
      The FASB issued SFAS No. 131, Disclosures about Segments of an Enterprise and Related Information, in February 1998. SFAS No. 131 establishes standards for the way that public business enterprises report information about operating segments in annual financial statements. This statement also requires companies that have a single reportable segment to disclose information about products and services, geographic areas, and major customers. This statement requires the use of the management approach to determine the information to be reported. The management approach is based on the way management organizes the enterprise to assess performance and make operating decisions regarding the allocation of resources. It is management’s opinion that, at this time, the Business has one reportable segment.
      The Business provides technical services and products through contractual arrangements as either prime contractor or subcontractor to other contractors, primarily for departments and agencies of the U.S. Government. U.S. Government contracts are subject to specific regulatory accounting and contracting guidelines including the Cost Accounting Standards and Federal Acquisition Regulations. The Business also provides technical services and products to foreign, state, and local governments, as well as customers in commercial markets. During the years ended September 30, 2000, 2001, and 2002, revenues from foreign countries were not significant.
      Revenues from services provided to various agencies of the U.S. Government represented $137.5 million or 88%, $180.7 million or 94% and $198.8 million or 98% of revenues for the years ended September 30, 2000, 2001 and 2002, respectively. Contract receivables from agencies of the U.S. Government represented

105



 

SELECTED OPERATIONS OF IIT RESEARCH INSTITUTE
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS — (Continued)
$54.3 million or 94% and $48.7 million or 94% of accounts receivable at September 30, 2001 and 2002, respectively.
Recently Issued Accounting Pronouncements
      In June 2001, the Financial Accounting Standards Board issued SFAS No. 141, Business Combinations, and SFAS No. 142, Goodwill and Other Intangible Assets. SFAS 141 requires the purchase method of accounting to be used for all business combinations initiated after June 30, 2001. SFAS 141 also specifies criteria that intangible assets acquired in a business combination must meet to be recognized and reported apart from goodwill. As the Business is a not-for-profit, SFAS No. 141 is not applicable.
      SFAS 142 is effective for fiscal years beginning after December 15, 2001. SFAS 142 will not be applied to previously recognized goodwill and intangible assets arising from the acquisition of a for-profit business enterprise by a not-for-profit organization until interpretive guidance related to the application of the purchase method to those transactions is issued. SFAS 142 will be required to be adopted by Alion in connection with the proposed acquisition of the Business discussed in Note 13. SFAS No. 142 changes the accounting for goodwill from an amortization method to an impairment-only approach. Goodwill and other intangible assets that have an indefinite life will not be amortized, but rather will be tested for impairment annually or whenever an event occurs indicating that the asset may be impaired.
      In June 2001, the FASB issued SFAS No. 143, Accounting for Asset Retirement Obligations. SFAS 143 addresses financial accounting and reporting for obligations associated with the retirement of tangible long-lived assets and for the associated asset retirement costs. SFAS 143 must be applied starting with fiscal years beginning after June 15, 2002. Management is currently evaluating the impact that the adoption of SFAS 143 will have on the consolidated financial statements.
      In August 2001, the FASB issued SFAS No. 144, Accounting for the Impairment or Disposal of Long-Lived Assets. SFAS No. 144 addresses financial accounting and reporting for the impairment or disposal of long-lived assets. While SFAS No. 144 supersedes SFAS No. 121, Accounting for the Impairment of Long-Lived Assets and for Long-Lived Assets to Be Disposed Of, it retains many of the fundamental provisions of that Statement. SFAS No. 144 also supersedes the accounting and reporting provisions of APB Opinion No. 30, Reporting the Results of Operations — Reporting the Effects of Disposal of a Segment of a Business, and Extraordinary, Unusual, and Infrequently Occurring Events and Transactions, for the disposal of a segment of a business. It retains, however, the requirement in APB Opinion No. 30 to report separately discontinued operations, and extends that reporting to a component of an entity that either has been disposed of (by sale, abandonment, or in a distribution to owners) or is classified as held for sale. SFAS No. 144 is effective for fiscal years beginning after December 15, 2001, and interim periods within those fiscal years. Management does not believe that the adoption of SFAS 144 will have a significant impact on its consolidated financial statements.
      During June 2002, the FASB issued SFAS No. 146, Accounting for Costs Associated with Exit or Disposal Activities. Such standard requires costs associated with exit or disposal activities (including restructurings) to be recognized when the costs are incurred, rather than at a date of commitment to an exit or disposal plan. SFAS No. 146 nullifies Emerging Issues Task Force (“EITF”) Issue No. 94-3, Liability Recognition for Certain Employee Termination Benefits and Other Costs to Exit an Activity (including Certain Costs Incurred in a Restructuring). Under SFAS No. 146, a liability related to an exit or disposal activity is not recognized until such liability has actually been incurred whereas under EITF Issue No. 94-3 a liability was recognized at the time of a commitment to an exit or disposal plan. The provisions of this standard are effective for disposal activities initiated after December 31, 2002.

106



 

SELECTED OPERATIONS OF IIT RESEARCH INSTITUTE
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS — (Continued)
Reclassifications
      Certain amounts in the prior years financial statements have been reclassified to conform to the current year’s presentation.
(4) Business Combinations
      Effective September 30, 1998, the Business completed the acquisition of Human Factors Applications, Inc. (HFA) for $3.0 million. HFA is a U.S. supplier of ordnance and explosive waste remediation with core competencies in the areas of demilitarization, demining, environmental remediation, explosion sciences, sensor and software integration, and training. The Business purchased all the outstanding shares of HFA’s common stock. The Business allocated a portion of the purchase price to the assets acquired and liabilities assumed at the date of acquisition based upon their estimated fair values and recorded the balance of $1.5 million as goodwill. The results of HFA’s operations are included in the Business’ consolidated financial statements beginning on October 1, 1998.
      Effective May 31, 1999, the Business acquired EMC Science Center, Inc. (EMC) for $3.0 million. EMC has technical expertise in electromagnetic environmental effects testing, standards and training, and operates a certified test laboratory. The Business acquired all the assets and assumed all the liabilities of EMC. The Business allocated a portion of the purchase price to the assets acquired and liabilities assumed at the date of acquisition based upon their estimated fair values and recorded the balance of $2.3 million as goodwill. The results of operations of EMC are included in the Business’ consolidated financial statements beginning on June 1, 1999.
      On June 12, 1999, the Business acquired 25% of the outstanding common stock of AB Technologies, Inc. (AB) for $6.0 million. AB Technologies specializes in modeling and simulation related to training exercises, education and training support, complex problem analysis and systems, and military policy development for the U.S. Government and other customers. A portion of the purchase price was allocated to the estimated fair value of the net assets acquired while the balance of $4.2 million was recorded as goodwill. The Business used the equity method to account for its initial common stock purchase. At September 30, 1999, the Business’ investment in AB Technologies reflected its proportionate share of net losses from June 13, 1999. At September 30, 1999, the Business owed the previous owners of AB Technologies $2.0 million under notes payable. AB Technologies reported revenue of approximately $28.5 million for the nine months ended September 30, 1999.
      Effective February 7, 2000, the Business acquired the remaining assets and liabilities from the other shareholders of AB Technologies for approximately $5.4 million. The acquisition was accounted for as a step acquisition. The Business allocated a portion of the purchase to the assets acquired and liabilities assumed at the date of acquisition based upon their estimated fair values. The Business recorded the remaining balance of $4.3 million as goodwill. The purchase agreement contains an earnout provision under which the Business could be required to make additional payments to the other former shareholders of AB Technologies. These payments cannot exceed $11.5 million and are based on the future net income of AB Technologies’ operations through February 7, 2005. For the years ended September 30, 2001 and 2002, the Business accrued contingent consideration obligations of $0.6 million and $0.6 million, respectively, under this purchase agreement. Such amounts are included in long-term debt in the accompanying consolidated balance sheets.
      From June 12, 1999 through February 7, 2000, the Business provided management and accounting services to AB Technologies under an administrative agreement. The Business recovered expenses under this agreement of $1.5 million for the period ended September 30, 1999 and an additional $2.8 million through February 7, 2000.

107



 

SELECTED OPERATIONS OF IIT RESEARCH INSTITUTE
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS — (Continued)
      The following unaudited pro forma summary information presents the results of operations as if the AB Technologies acquisition had been completed at the beginning of the period presented and is not necessarily indicative of the results of operations of the Business that might have occurred had the acquisition been completed at the beginning of the period specified, nor is it necessarily indicative of future operating results:
         
    2000
     
    (In thousands)
Revenue
  $ 169,268  
Net income
  $ 5,698  
      In May 2002, the Business acquired the assets of Daedalic, Inc. for $0.8 million in a business combination to be accounted for as a purchase. The Business allocated the purchase price to the assets acquired and recorded the balance of $0.4 million as goodwill. The pro forma impact of this acquisition was not significant.
      Aggregate goodwill amortization expense related to the aforementioned business combinations was $1.5 million, $1.8 million, and $2.0 million during the years ended September 30, 2000, 2001, and 2002, respectively.
(5) Property, Plant, and Equipment
                   
    2002   2001
         
    (In thousands)
Buildings and building improvements
  $ 15,925     $ 15,780  
Leasehold improvements
    922       469  
Equipment and software
    28,647       25,201  
             
 
Total cost
    45,494       41,450  
Less accumulated depreciation and amortization
    37,106       35,615  
             
 
Net property, plant, and equipment
  $ 8,388     $ 5,835  
             
      Depreciation and leasehold improvement amortization expense for property, plant and equipment was $2.3 million, $1.7 million, and $1.5 million in the fiscal years ended September 30, 2000, 2001, and 2002, respectively.
      In May 2000, the Business sold land in Annapolis, Maryland for $2.3 million, and recognized a gain of $1.3 million during fiscal year 2000.
      In December 2000, the Business sold its Chicago research tower, engineering buildings, and related assets for $12.5 million to the Illinois Institute of Technology. The Business leased back six of the 19 floors in the tower under a 10-year operating lease agreement. The Business applied sale/leaseback accounting and deferred recognition of the $4.9 million gain arising from this transaction. The Business recognized $0.4 million and $0.5 million of the gain in fiscal years 2001 and 2002, respectively, and the deferred balance at September 30, 2002 was $4.0 million. The deferred gain is being recognized over the remaining life of the lease. See Note 9 for further discussion regarding lease commitments.
      In fiscal year 2002, the Business completed the implementation of PeopleSoft’s human resource software. The Business capitalized $1.9 million of costs associated with the implementation including software license and consultant expenses. The Business accounted for the costs of the implementation in accordance with AICPA Statement of Position 98-1, Accounting for the Costs of Computer Software Developed or Obtained for Internal Use.

108



 

SELECTED OPERATIONS OF IIT RESEARCH INSTITUTE
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS — (Continued)
(6) Debt
      The Business maintains a revolving bank credit agreement with First Union Bank that is secured by qualifying billed and unbilled accounts receivable and allows borrowings of up to $25.0 million. The maximum amount available is calculated monthly using a borrowing base formula based on percentages of eligible billed and unbilled accounts receivable. Advances under the agreement bear interest, at the Business’ election, at either the prime rate (4.75% at September 30, 2002) or the London Interbank Offering Rate (LIBOR) plus a fee. Historically, the Business has elected the prime rate. The agreement extends through December 22, 2002. The Business also had $0.5 million in standby letters of credit outstanding at September 30, 2002 with First Union Bank.
      Long-term debt at September 30 consisted of the following:
                   
    2002   2001
         
    (In thousands)
Note payable to First Union Bank, due in December 2002
  $ 3,330     $ 10,820  
Other notes payable, primarily to previous owners of EMC and AB Tech
    1,654       1,207  
             
 
Total long-term debt
    4,984       12,027  
Less current portion
    3,330       141  
             
 
Long-term debt, excluding current portion
    1,654       11,886  
             
      The Business is subject to certain debt covenants relating to the revolving bank credit agreement with First Union Bank. As of September 30, 2002, all debt covenants had been met.
      IITRI incurred interest expense of $1.8 million, $1.6 million, and $0.9 million and the Business was allocated interest expense of $1.4 million, $0.9 million, and $0.6 million for the years ended September 30, 2000, 2001, and 2002, respectively.
(7) Income Taxes
      For fiscal year 2000, the Business recorded an income tax provision of $0.2 million for unrelated business income arising from the AB Technologies acquisition.
      For the years ended September 30, 2000, 2001 and 2002, HFA had an operating income of $0.5 million, $1.0 million and $1.6 million, respectively. The Business recorded an income tax provision of $0.4 million, $0.3 million, and $0.6 million for the years ended September 30, 2000, 2001 and 2002, respectively, related to HFA. Deferred taxes were not significant at September 30, 2001 and 2002.
(8) Pensions and Postretirement and Other Benefits
      The Business sponsors two defined contribution retirement plans that cover substantially all full-time employees. The plans are funded by contributions from the Business and its employees. The employer’s contributions under the plans were $1.5 million, $3.5 million, and $4.2 million for the years ended September 30, 2000, 2001 and 2002, respectively.
      The Business also sponsors a medical benefits plan providing certain medical, dental, and vision coverage to eligible employees and former employees. The Business has a self-insured funding policy with a stop-loss limit under an insurance agreement. Certain funds are set aside in a trust fund from which the medical benefit claims are paid. At September 30, 2001 and 2002, the trust fund balance was $0.9 million and $0.04 million, respectively.
      The Business also provides post retirement medical benefits for employees who meet certain age and service requirements. Retiring employees may become eligible for those benefits at age 55 if they have

109



 

SELECTED OPERATIONS OF IIT RESEARCH INSTITUTE
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS — (Continued)
20 years of service, or at age 60 with 10 years of service. The plan provides benefits until age 65 and requires employees to pay one-quarter of their health care premiums. A small, closed group of employees is eligible for coverage after age 65. These retirees contribute a fixed portion of the health care premium.
      Following is a reconciliation of the plan’s funded status with the accrued benefit cost shown on the consolidated balance sheets at September 30:
                 
    2002   2001
         
    (In thousands)
Accumulated postretirement benefit obligation:
               
Retirees
  $ 287     $ 358  
Fully eligible active plan participants
    739       508  
Other active plan participants
    1,296       1,144  
             
    $ 2,322     $ 2,010  
             
Reconciliation of beginning and ending benefit obligation:
               
Benefit obligation at October 1
  $ 2,010     $ 1,780  
Service cost
    112       61  
Interest cost
    253       152  
Actuarial loss
    158       135  
Benefits paid
    (211 )     (118 )
             
Benefit obligation at September 30
  $ 2,322     $ 2,010  
             
Change in fair value of plan assets:
               
Fair value of plan assets at October 1
           
Funded status of the plan:
               
obligation at September 30
    (2,322 )     (2,010 )
Unrecognized net transition obligation
    953       900  
Unrecognized prior service cost
    (156 )     (153 )
Unrecognized net loss (gain)
    5       (82 )
             
Accrued postretirement benefits recognized in the consolidated balance sheets
  $ (1,520 )   $ (1,345 )
             
      The components of net periodic postretirement benefit cost for the years ended September 30 are as follows:
                           
    2002   2001   2000
             
Service cost
  $ 112     $ 61     $ 112  
Interest cost
    253       152       253  
Amortization of unrecognized net transition obligation
    94       94       94  
Amortization of unrecognized prior-service cost
    (19 )     (19 )     (19 )
                   
 
Net periodic postretirement benefit cost
  $ 440     $ 288     $ 440  
                   
      The health care cost trend rates used to determine the accumulated postretirement benefit obligation are 11.5% in fiscal year 2002, decreasing each year to an ultimate of 5.5% per year in fiscal 2014. Based on the number of employees currently participating in these plans, it is estimated that a 1% increase each year in the health care cost trend rates would result in increases of $0.014 million in the service and interest cost

110



 

SELECTED OPERATIONS OF IIT RESEARCH INSTITUTE
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS — (Continued)
components of the net periodic postretirement benefit cost and $0.24 million in the accumulated postretirement benefit obligation. Similarly, a 1% decrease each year in the health care cost trend rates would result in decreases of $0.013 million in the service and interest cost components of the net periodic postretirement benefit cost and $0.2 million in the accumulated postretirement benefit obligation. The discount rate used to measure the accumulated postretirement benefit obligation at September 30, 2001 and 2002 was 7.5% and 7.0%, respectively.
      The Business provides other deferred compensation and participation in a flexible option plan for certain key executives. Aggregate amounts granted under the flexible option plan were $0.3 million and $2.0 million as of September 30, 2001 and 2002, respectively. These amounts vest over a five-year period from the original date of grant and vesting accelerates upon a change in control. No amounts have vested as of September 30, 2002. Funds granted under the plan are invested in a limited variety of mutual funds selected by the grantee. These assets are owned by the Business and subject to the claims of general creditors of the Business. The deferred compensation liability to the participants is recorded over the service period as compensation expense.
(9) Leases
      Future minimum lease payments under non-cancelable operating leases for buildings, equipment, and automobiles at September 30, 2002, are as follows:
         
Fiscal Years Ending:   (In Thousands)
     
2003
  $ 8,544  
2004
    7,913  
2005
    7,511  
2006
    5,637  
2007
    5,664  
and thereafter
    11,040  
       
    $ 46,309  
       
      Rent expense under operating leases was $2.5 million, $6.3 million, and $8.3 million for the years ended September 30, 2000, 2001, and 2002, respectively.
      The Business periodically enters into other lease obligations which are directly chargeable to current contracts. These obligations are covered by current available contract funds or are cancelable upon termination of the related contracts.
(10) Transactions Between the Business and the Illinois Institute of Technology
      Except as noted in the following paragraph, the Business recognizes as operating expense amounts assessed by the Illinois Institute of Technology primarily for lease payments and utility costs related to shared facilities, including steam and electricity charges, and for shared grounds maintenance and security costs. For the fiscal years ended September 30, 2000, 2001, and 2002, such amounts totaled $1.8 million, $3.2 million, and $3.6 million, respectively.
      Distributions from the Business to the Illinois Institute of Technology are determined by and made on a voluntary basis and at the direction of IITRI’s Board of Governors. For fiscal years 2000, 2001, 2002, distributions amounted to $1.3 million, $1.6 million, and $0.9 million, respectively.
      The accompanying consolidated statements of changes in owner’s net investment include adjustments that represent changes in net assets of Life Sciences Operation which included the period’s net loss and capital

111



 

SELECTED OPERATIONS OF IIT RESEARCH INSTITUTE
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS — (Continued)
funding requirements. Such amounts will not be reimbursed to or refunded by the Business subsequent to the acquisition by Alion described in Note 13.
      See Note 5 for a discussion of the Business’ sale of assets to the Illinois Institute of Technology.
(11) Commitments and Contingencies
Legal Proceedings
      The Business is involved in various claims and legal actions arising in the ordinary course of business. In the opinion of management, the ultimate disposition of these matters will not have a material adverse effect upon the financial position, results of operations, or liquidity of the Business.
AB Technologies Lawsuit
      On September 12, 2002, the former owners of AB Technologies (Former Owners) filed a lawsuit (AB Tech Lawsuit) against IITRI in Circuit Court for Fairfax County, Virginia. The complaint alleges breach of the AB Technologies asset purchase agreement (Asset Purchase Agreement), and claims damages of $8.2 million. The Former Owners asked the court to order an accounting of their earn out. IITRI has filed a Notice of Removal, asking the United States District Court for the Eastern District of Virginia to remove the AB Tech Lawsuit from the state court and assume jurisdiction over it in federal court.
      On September 16, 2002, IITRI filed a lawsuit against the Former Owners which asks the court to compel the Former Owners to submit disputed issues to an independent accounting firm in accordance with the requirements of the Asset Purchase Agreement, make a declaratory judgment concluding that IITRI is entitled to an approximately $1.1 million downward adjustment of the purchase price paid under the Asset Purchase Agreement, and conclude that IITRI properly computed the earnout in accordance with the earnout formula in the Asset Purchase Agreement.
      Upon the closing of the proposed acquisition of the Business by Alion, Alion assumed responsibility for and acquired all claims under these lawsuits.
      IITRI has accrued its estimate of the earnout liability based on the earnout formula in the Asset Purchase Agreement.
Government Audits
      The amount of U.S. Government contract revenue and expense reflected in the consolidated financial statements attributable to cost reimbursement contracts is subject to audit and possible adjustment by the Defense Contract Audit Agency (DCAA). The government considers the Business a major contractor and DCAA maintains an office on site to perform its various audits throughout the year. DCAA has concluded its audits of the Business’ indirect expense rates and cost accounting practices through fiscal year 2000. There were no significant cost disallowances for the fiscal years ended September 30, 1999 and 2000.
      IITRI, as a not-for-profit organization receiving federal funds, is required to have an annual compliance audit in accordance with the provisions of OMB Circular A-133, Audits of States, Local Governments, and Non-profit Organizations. Accordingly, for purposes of these financial statements, the Business is subject to similar audit requirements. Although DCAA has completed its incurred cost audit for the Business’ year ended September 30, 2000, the Business’ A-133 audit for the year ended September 30, 2001, has not been completed. It is the opinion of management that unallowable costs, if any, associated with this audit will be insignificant.

112



 

SELECTED OPERATIONS OF IIT RESEARCH INSTITUTE
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS — (Continued)
(12) Interim Period Information (Unaudited)
      See Note 1 for a description of the Business’ interim periods.
                                                                 
    2002   2001
         
    1st   2nd   3rd   4th   1st   2nd   3rd   4th
                                 
Revenue
  $ 43,701     $ 44,853     $ 64,485     $ 48,699     $ 40,700     $ 44,465     $ 59,611     $ 48,376  
Net income (loss)
  $ 1,390     $ 1,037     $ 745     $ 745     $ 1,772     $ 2,090     $ 2,236     $ 3,399  
(13) Sale of Business (Unaudited)
      On December 20, 2002, Alion purchased the Business from IITRI for total aggregate proceeds of $127,879 consisting of:
  •  $58,571 cash, consisting of $56,721 paid to IITRI and $1,517 paid for certain transaction expenses on behalf of IITRI, and $333 paid for other transaction expenses;
 
  •  $39,900 in seller notes to IITRI with detachable warrants representing approximately 26% of the outstanding common of stock of Alion (on a fully diluted basis) attached. The seller notes bear a weighted average interest rate of 6.7% per annum;
 
  •  $20,343 in mezzanine notes to the IITRI with detachable warrants representing 12% of the outstanding common stock of Alion (on a fully diluted basis) attached. The mezzanine notes bear interest at 12% per annum;
 
  •  transaction costs of $2,300, less the $1,517 noted above;
 
  •  assumption of debt from Wachovia (formerly First Union) of $6,188; and
 
  •  amounts due to IITRI of $2,094.

113



 

Item 9. Changes in and Disagreements with Accountants on Accounting and Financial Disclosure
      There are no changes in or disagreements with our accountants.
Item 9a. Controls and Procedures
      Disclosure Controls and Procedures. The Company’s management, with the participation of the Company’s Chief Executive Officer and Chief Financial Officer, has evaluated the effectiveness of the Company’s disclosure controls and procedures (as such term is defined in Rule 15d — 15(e) under the Securities Exchange Act of 1934, as amended (the “Exchange Act”)) as of the end of the period covered by this report. Based on such evaluation, the Company’s Chief Executive Officer and Chief Financial Officer have concluded that, as of the end of such period, the Company’s disclosure controls and procedures are effective in recording, processing, summarizing and reporting, on a timely basis, information required to be disclosed by us in the reports that the Company is required to file or submit under the Exchange Act.
      Internal Control Over Financial Reporting. There have not been any changes in the Company’s internal control over financial reporting (as such term is defined in Rule 15d — 15(f) under the Exchange Act) during the fiscal fourth quarter ended September 30, 2005 that have materially affected, or are reasonably likely to materially affect, the Company’s internal control over financial reporting.
Item 9b. Other Information
Sales of Unregistered Securities
      The Company has reported all other information required to be disclosed in a report on Form 8-K during the quarter ended September 30, 2005.

114



 

PART III
Item 10. Directors and Executive Officers of the Registrant
      Information Regarding the Directors of the Registrant
      The names, ages and positions of our directors, as of September 30, 2005, are set forth below:
                             
            Term   Director
Name   Age   Position   Expires   Since
                 
    52     President, Chief Executive Officer and Chairman     2008       2001  
Edward C. “Pete” Aldridge
    67     Director     2006       2003  
    37     Director     2007       2002  
    67     Director     2007       2002  
Admiral (Ret.) Harold W. Gehman, Jr. 
    62     Director     2007       2002  
    74     Director     2006       2002  
    62     Director     2006       2002  
General (Ret.) George A. Joulwan
    65     Director     2008       2002  
General (Ret.) Michael E. Ryan
    63     Director     2008       2002  
      Our directors are divided into three classes. The first class of directors consists of three directors — Donald E. Goss, Edward C. Aldridge, and Robert L. Growney. Their term expires on the date of the annual meeting of Alion’s shareholder(s) in 2006. The second class of directors consists of three directors — Leslie Armitage, Lewis Collens and Admiral Harold W. Gehman, Jr. Their term expires on the date of the annual meeting of Alion’s shareholder(s) in 2007. The third class of directors consists of three directors — Bahman Atefi, General George A. Joulwan and General Michael E. Ryan. The term of the third class of directors expires on the date of the annual meeting of Alion’s shareholder(s) in 2008. Under the terms of the subordinated note and warrants, subject to certain requirements, IITRI may nominate two directors for election to Alion’s board. Messrs. Collens and Growney are IITRI’s board appointees.
      The following sets forth the business experience, principal occupations and employment of each of the directors.
      Bahman Atefi was appointed chief executive officer of Alion in December 2001. He is also chairman of Alion’s board of directors. Dr. Atefi also serves as chairman of the ESOP committee. Dr. Atefi served as president of IITRI from August 1997, and as its chief executive officer from October 2000 until December 20, 2002, the closing date of the Transaction. Dr. Atefi has also been chairman of the board of directors of Human Factors Applications, Inc. since February 1999. From June 1994 to August 1997, Dr. Atefi served as manager of the energy and environmental group at Science Applications International Corporation. In this capacity, he was responsible for operation of a 600-person business unit, with annual revenues in 1997 of approximately $80 million, which provided scientific and engineering support to the U.S. Department of Energy, Nuclear Regulatory Commission, Environmental Protection Agency, U.S. Department of Defense, as well as commercial and international customers. Dr. Atefi is a member of the board of trustees of the Illinois Institute of Technology. Dr. Atefi received a BS in Electrical Engineering from Cornell University, a master’s degree in nuclear engineering and a doctor of science in nuclear engineering from the Massachusetts Institute of Technology.
      Edward C.“Pete” Aldridge has served as a director of Alion since November 2003. Mr. Aldridge retired from government service in May 2003 as the Under Secretary of Defense for Acquisition, Technology, and Logistics, a position he held since May 2001. In this position, Mr. Aldridge was responsible for all matters relating to U.S. Department of Defense (DoD) acquisition, research and development, advanced technology, international programs, and the industrial base. From March 1991 to May 2001, Mr. Aldridge also served as president and CEO of the Aerospace Corporation, president of McDonnell Douglas Electronic Systems,

115



 

Secretary of the Air Force, and numerous other positions within the U.S. Department of Defense. He is currently a director of Lockheed Martin Corporation and Global Crossing, Ltd.
      Leslie Armitage has served as a director of Alion since May 2002. Ms. Armitage served as a Partner of The Carlyle Group from January 1999 until May 2005. In June 1997, Ms. Armitage became a founding member of Carlyle Europe. Ms. Armitage also served on the board of directors of Vought Aircraft Industries, Inc., Honsel International Technologies, and United Component, Inc.
      Lewis Collens has served as a director of Alion since May 2002. Since 1990, Mr. Collens has served as president of the Illinois Institute of Technology. Mr. Collens has also served as chief executive officer of IITRI from 1990 to October 2000. Mr. Collens also serves as chairman of the board for IITRI and as a director for Dean Foods Company, Taylor Capital, Amsted Industries and Colson Group. Mr. Collens is one of the two members of the board of directors designated by the holders of the subordinated note and the warrants.
      Admiral (Ret.) Harold W. Gehman, Jr. has served as a director of Alion since September 2002. Admiral Gehman retired from over 35 years of active duty in the U.S. Navy in October 2000. While in the U.S. Navy, Admiral Gehman served as NATO’s Supreme Allied Commander, Atlantic and as the Commander in Chief of the U.S. Joint Forces Command from September 1997 to September 2000. Since his retirement in November 2000, Admiral Gehman has served as an independent consultant to the U.S. Government from October 2000 to present and Science Applications International Corporation from January 2002 to present. Admiral Gehman currently serves on the board of directors of Maersk Lines, Ltd., Transystems Corp., and Burdeshaw Associates, Ltd. He also currently serves as a member of the board of advisors for Anser Institute for Homeland Security, Old Dominion University Research Foundation, and Old Dominion University College of Engineering. In addition, Admiral Gehman is a senior fellow at the National Defense University and is chairman of the Government of Virginia’s Advisory Commission for Veterans Affairs. Most recently, Admiral Gehman agreed to chair the Space Shuttle Mishap Interagency Investigation Board, which will provide an independent review of the events and activities that led up to the loss of seven astronauts on February 1, 2003 on board the Space Shuttle Columbia.
      Donald E. Goss has served as a director of Alion since May 2002. Mr. Goss has served as trustee and chairman of the audit committee for the Illinois Institute of Technology since 1982, as well as the chairman of the audit committee and a member of the board of governors for IITRI since 1985. Mr. Goss has also served on the Finance Council and as chair of the audit committee for the Catholic Archdiocese of Chicago, Illinois since 1985. Mr. Goss has also served as a member of the board of governors for the Chicago Zoological Society at Brookfield Zoo since 1998. Mr. Goss retired from Ernst & Young as partner, after 37 years of service, in March 1990, and he has remained retired since that date.
      Robert L. Growney has served as a director of Alion since May 2002. Up until his retirement from Motorola in April 2002, Mr. Growney had served as a member of the board of directors for Motorola since January 1997 and as vice chairman of Motorola’s board of directors since January 2002. From January 1997 to January 2002, Mr. Growney served as president and chief operating officer for Motorola. Mr. Growney currently serves as a trustee for the Illinois Institute of Technology as well as serves as a member of its executive committee. Since May 2002, Mr. Growney has been a venture partner with Edgewater Funds. Mr. Growney is one of the two members of the board of directors designated by the holders of the subordinated note and the warrants.
      General (Ret.) George A. Joulwan has served as a director of Alion since May 2002. General Joulwan retired from 36 years of service in the military in September 1997. While in the military, General Joulwan served as commander in chief for the U.S. Army, for U.S. Southern Command in Panama from 1990-1993 and served as commander in chief of the U.S. European Command and NATO Supreme Allied Command from 1993-1997. From 1998 to 2000, General Joulwan served as an Olin Professor at the U.S. Military Academy at West Point. General Joulwan has also served as an adjunct professor at the National Defense University from 2001 to 2002. Since 1998, General Joulwan has served as president of One Team, Inc., a strategic consulting company. General Joulwan also currently serves as a director for General Dynamics Corporation.

116



 

      General (Ret.) Michael E. Ryan has served as a director of Alion since May 2002. General Ryan retired from the military in 2001 after 36 years of service. He served his last four years as the 16th Chief of Staff of the Air Force, responsible for organizing, training and equipping over 700,000 active duty, reserve and civilian members. He is president of the consulting firm, Ryan Associates, focusing on national defense issues. He is chairman of the board of CAE USA, Inc. and the Air Force Village Charitable Foundation. He serves on the board of directors of United Services Automobile Association, Circadence Corporation, VT Griffin, Inc., and Selex Sensor Airborne Systems (US) Inc. He is a senior trustee of the Air Force Academy Falcon Foundation.
Compensation of Directors
      Our non-employee directors receive an annual retainer of $25,000, payable in quarterly installments, for their services as members of the board of directors. These services include preparation for and attendance in person at four board meetings per year and all committee meetings that take place on the same day as a full board meeting. In addition, each director receives a fee of $1,000 for in-person attendance at each additional board meeting, and $250 for telephone attendance at each additional board meeting. Each chairman of a board committee receives $2,500 per year for each year he or she serves in such capacity. All board committee members receive $1,000 per committee meeting if the committee meeting occurs on a day other than the day of a full Alion board meeting. Alion reimburses directors for reasonable travel expenses in connection with attendance at board of directors and board committee meetings.
      Each director is eligible for a one-time award under our stock appreciation rights, or SAR, plan at the beginning of each board term that he or she serves. For more information about our SAR plan, please read “Executive Compensation — Stock Appreciation Rights Plan.” A director’s SAR awards will vest on a schedule coincident with his or her term on our board. With the exception of Dr. Atefi, each of our initial directors, irrespective of their terms, was awarded 4,200 SARs in December 2002. Each future class of directors will be elected for a three-year term and will receive 4,200 SAR awards upon the commencement of each three-year term. Our directors also have the option to participate in a deferred compensation plan for tax deferral of their annual compensation and/or payments to be made upon exercise of their SAR awards.
      Our employee directors will not receive any additional compensation for their services as members of the board.
Establishment of Committees
      The Board of Directors has established three committees. As of September 30, 2005, each committee was comprised of the following members:
         
Committee   Chairperson   Members
         
Audit and Finance Committee
  Donald Goss   Leslie Armitage, Robert Growney, Harold Gehman, Michael Ryan
Compensation Committee
  Lewis Collens   Pete Aldridge, Leslie Armitage, Harold Gehman, George Joulwan
Governance and Compliance Committee
  Bahman Atefi   George Joulwan, Michael Ryan, Harold Gehman
      The Board of Directors has determined that Mr. Donald E. Goss qualifies as “audit committee financial expert” as defined in Item 401(h) of Regulation S-K, and that he is “independent” as the term is used in Item 7(d)(3)(iv) of Schedule 14A under the Securities Exchange Act.
Compensation Committee Interlocks and Insider Participation
      In October 2003, the Board of Directors established a Compensation Committee. As indicated above, the members of the Committee are Lewis Collens (Chairman), Leslie Armitage, Harold Gehman,

117



 

George Joulwan, and Pete Aldridge. Dr. Atefi is a member of the board of trustees of the Illinois Institute of Technology where Mr. Collens is the President.
Information Regarding the Executive Officers of the Registrant
      The names, ages and positions of our executive officers as of September 30, 2005, and the dates from which these positions have been held are set forth below.
                     
Name   Age   Office   Position Since
             
    52     President,
Chief Executive Officer and
Chairman of the Board(1)
    December 2001  
Randy Crawford
    54     Sector Senior Vice President(1)     May 2002  
Rob Goff
    59     Sector Senior Vice President     February 2004  
Scott Fry
    56     Sector Senior Vice President     October 2005  
John (Jack ) Hughes
    53     Executive Vice President, Chief Financial Officer and Treasurer(1)     September 2005  
Stacy Mendler
    42     Executive Vice President and Chief Administrative Officer(1)     September 2005  
James Fontana
    47     Senior Vice President, General Counsel and Secretary     January 2004  
 
(1)  Member of the ESOP committee
      The following sets forth the business experience, principal occupations and employment of each of the current executive officers who do not serve on the board. Please read “Information Regarding the Directors of the Registrant” above for the information with respect to Dr. Atefi.
      Randy Crawford has served as Sector Senior Vice President and Sector Manager for Alion’s Engineering and Information Technology Sector since September 2005. Mr. Crawford served as Sector Senior Vice President and Sector Manager for Alion’s Spectrum Engineering Sector from May 2002 until September 2005. He is also a member of Alion’s ESOP committee. Mr. Crawford has been a member of the board of directors of Human Factors Applications, Inc. since September 2000. Mr. Crawford served IITRI as spectrum engineering sector senior vice president and manager from October 2000 through December 20, 2002, the date of completion of the Transaction. From January 1997 to October 2000, Mr. Crawford served as group manager of IITRI’s spectrum engineering group. Mr. Crawford received a BSEE from Virginia Tech and an MSE from The George Washington University.
      Rob Goff has served as Sector Senior Vice President and Sector Manager for Alion’s Defense Operations Integration Sector since February 2004. He has also served as a member of Alion’s ESOP committee since January 2005. Mr. Goff served as Vice President and Operations Manager for IITRI from July 1999 until September 2001. From December 20, 2002 (the closing date of the Transaction) until February 2004, Mr. Goff was Senior Vice President and Group Manager for Alion; he held this same position for IITRI from September 2001 until December 20, 2002. Prior to working for IITRI, Mr. Goff served on active duty for 30 years, retiring at the rank of Major General from the United States Army. Mr. Goff received a BS from the U.S. Army Military Academy at West Point, followed by a Masters degree in Spanish Language and Literature from Middlebury College, and a MBA from Long Island University.
      Scott Fry has served as Senior Vice President and Sector Manager for Alion’s JMS Maritime Sector since October 2005. Mr. Fry served as Senior Vice President and Deputy Sector Manager for the JMS Maritime Sector from April 2005 to October 2005. Prior to joining Alion, Mr. Fry served in the U.S. Navy for

118



 

32 years retiring in the rank of Vice Admiral. His career included command and staff positions both at sea and ashore with the Navy, NATO, and Joint Chiefs of Staff. In his last active duty assignment he commanded the United States Sixth Fleet during Operation Iraqi Freedom and the Global War on Terrorism. Mr. Fry received a B.S from the United States Naval Academy in Annapolis, Maryland.
      John Hughes has served as Executive Vice President, Chief Financial Officer and Treasurer of Alion since September 2005. He served as Senior Vice President, Chief Financial Officer and Treasurer from October 2002 until September 2005. From July 1998 to September 2002, Mr. Hughes served as co-founder and principal of Phoenix Financial & Advisory Services LLC, responsible for providing strategic planning, operations, financing, merger/acquisition, marketing/communications and business development support to small and mid-sized companies in the technology, media and entertainment industries. Mr. Hughes has also served as principal consultant of HKSBS, LLC from July 2002 to September 2002 and currently serves on the HKSBS advisory board. In his position as a principal consultant, Mr. Hughes functioned as the team leader for the financial advisory services division. From November 1992 to May 1998, Mr. Hughes served as senior vice president and chief financial officer of BTG Inc., responsible for business and operations management, strategic planning, mergers and acquisitions, and arranging financing for a $600 million business with 1,650 employees. Mr. Hughes received a BS in Economics and Business from Frostburg State University and has performed graduate coursework in contract formation, government procurement and financial management.
      Stacy Mendler has served as Executive Vice President and Chief Administrative Officer of Alion since September 2005. She served as Senior Vice President and Chief Administrative Officer of Alion from May 2002 until September 2005. She is also a member of Alion’s ESOP committee. Ms. Mendler served IITRI as senior vice president and director of administration from October 1997 until December 20, 2002, the closing date of the Transaction. As of May 2002, Ms. Mendler was IITRI’s chief administrative officer, as well as senior vice president. She also served as IITRI’s assistant corporate secretary from November 1998 through completion of the Transaction and has been a member of the board of directors of Human Factors Applications, Inc. since February 1999. From February 1995 to October 1997, Ms. Mendler was vice president and group contracts manager for the energy and environment group at Science Applications International Corporation where she managed strategy, proposals, contracts, procurements, subcontracts and accounts receivable. Ms. Mendler received a BBA in Marketing from James Madison University and a MS in Contracts and Acquisition Management from Florida Institute of Technology.
      James Fontana has served as Senior Vice President, General Counsel and Secretary of Alion since January 2004. He has 20 years of experience as an attorney specializing in government contracts and technology law, and possesses a wide range of legal subject matter expertise. From February 2003 to January 2004, Mr. Fontana was in private practice as the principal of the Law Offices of James C. Fontana, and from April 1997 to January 2003 he served as General Counsel of Getronics Government Solutions, LLC (formerly Wang Federal) and Vinnell Corporation, and was Senior Corporate Counsel to BDM International, Inc., Vinnell’s parent company. Mr. Fontana is a graduate of Temple University School of Law. He received his undergraduate degree from The American University, where he majored in economics.
Code of Ethics
      The Company adopted a Code of Ethics, Conduct, and Responsibility (the “Code”) on December 21, 2001 that applies to all employees, executive officers and directors of the Company. The Code also serves as a code of ethics for the Company’s chief executive officer, chief financial officer, director of finance, controller, or any person performing similar functions. Alion provides access to a telephone hotline so that employees can report suspected instances of improper business practices such as fraud, waste, and violations of the Alion Code of Ethics, Conduct and Responsibility.
      In 2004, the Company completed an examination of the Code to determine whether it fully met the definitional requirements of a code of ethics as set forth in the rules and regulations of the Securities and Exchange Commission. On September 15, 2004, the Company adopted a revised Code applicable to all Alion employees, including Alion’s CEO and CFO, and meeting such definitional requirements set forth in the rules and regulations of the Securities and Exchange Commission. A copy of the Code is posted for all employees

119



 

on the Company’s external website at www.alionscience.com The Company intends to post on its website any amendments to, or waiver of, its Code.
Item 11. Executive Compensation
      The following table sets forth all compensation with respect to our chief executive officer and our other most highly paid executive officers (the “Named Executive Officers”), whose total salary and bonus exceeded $100,000 for the fiscal years ended September 30, 2005, 2004, and 2003. During the fiscal year ended September 30, 2003, the acquired Selected Operations of IITRI paid all compensation for the named executive officers earned or paid prior to December 20, 2002.
                                                   
        Long-Term    
    Annual Compensation   Compensation    
             
        Other Annual       All Other
Name and Principal Position   Year   Salary   Bonus   Compensation(1)   LTIP Payouts(2)   Compensation
                         
    2005       438,609       425,000 (4)           (3)     1,081,488 (5)
Chief Executive Officer
    2004       406,156       410,000                   16,445 (5)
      2003       387,115       365,000                   873,078 (5),(13)
Stacy Mendler
    2005       262,450       215,000 (4)           (6)     249,003 (7)
Executive VP, Chief
    2004       216,243       105,000                   14,655 (7)
 
Administrative Officer
    2003       196,238       90,000                   227,930 (7),(13)
Randy Crawford
    2005       286,982       125,000 (4)           (8)     18,799 (9)
Spectrum Engineering and
    2004       257,752       90,000                   13,825 (9)
 
Information Technology Sector
                                               
 
Senior VP and Sector Manger
    2003       245,475       90,000                   285,441 (9),(13)
Rob Goff
    2005       284,169 (10)     235,000 (4)           (15)     19,533 (14)
Defense Operations
    2004       243,271 (10)     200,000                   14,261 (14)
 
Integration Sector Senior VP
    2003       221,349       60,000                   15,999 (14)
 
and Sector Manager
                                               
Jack Hughes
    2005       280,771       215,000 (4)           (11)     18,494 (12)
Executive VP, Chief Financial
    2004       245,195       135,000                   14,957 (12)
 
Officer and Treasurer
    2003       220,677       65,000                   11,675 (12)
Thomas Diamant(16)
    2005       223,114 (17)                       210,196 (18)
Senior Consultant to the CEO
                                               
 
(1)  Unless otherwise indicated, no executive officer named in this summary compensation table received personal benefits or perquisites with an aggregate value equal to or exceeding the lesser of $50,000 or 10% of his or her aggregate salary and bonus.
 
(2)  See the “Long Term Incentive Plan — Awards in Last Fiscal Year” table, set forth below, for details related to phantom stock grants. See the “SAR Grants in Last Fiscal Year” and “Aggregate SAR Exercises in Last Fiscal Year and Fiscal Year End SAR Values” tables, set forth below, for details related to SAR grants.
 
(3)  In February 2005, Dr Atefi was awarded 65,926 shares of performance-base phantom stock and 43,951 shares of retention-based phantom stock under the Second Phantom Stock Plan. In November 2003 and February 2003, Dr. Atefi was awarded 18,695 shares and 65,000 shares, respectively, of phantom stock under the Initial Phantom Stock Plan. Each phantom stock plan is described more fully below.
 
(4)  Bonus amounts for fiscal year 2005 were paid in December 2005.

120



 

(5)  2005 includes $1,051,005 paid to Dr. Atefi for the redemption of the amount due under his Deferred Compensation Agreement, Company matching contributions of $25,970 under Alion’s KSOP, $3,800 in club membership dues, and $673 in term life insurance premiums paid by Alion.
  2004 includes Company matching contributions of $11,817 under Alion’s KSOP. Includes $648 in term life insurance premiums and $3,980 in club membership dues paid by Alion.
 
  2003 includes Company matching contribution of $11,000 under Alion’s KSOP. Includes $857,000 vested under a deferred compensation arrangement with the Company. See below, “Deferred Compensation Arrangement for Bahman Atefi. Includes $648 in term life insurance premiums and $4,430 in club membership dues paid by Alion.
(6)  In February 2005, Ms. Mendler was awarded 24,151 shares of performance-base phantom stock and 36,227 shares of retention-based phantom stock under the Second Phantom Stock Plan. In November 2003 and February 2003, Ms. Mendler was awarded 6,798 shares and 28,500 shares, respectively, of phantom stock under the Initial Phantom Stock Plan. Each phantom stock plan is described more fully below.
 
(7)  2005 includes $241,016 paid to Ms. Mendler for the redemption of the amount due her under the Executive Deferred Compensation Plan, Company matching contributions of $7,415 under Alion’s KSOP plan, and $572 in term life insurance premiums paid by Alion.
  2004 includes Company matching contributions of $14,185 under Alion’s KSOP plan. Includes $470 in term life insurance premiums paid by Alion.
 
  2003 includes Company matching contributions of $3,001 under IITRI’s 401(a) plan. These contributions cover the period October 1, 2002 to December 20, 2002, prior to the Transaction. Includes Company matching contribution of $9,504 under Alion’s KSOP. Includes $215,000 vested under a Retention Incentive Agreement. Includes $425 in term life insurance premiums paid by Alion.
(8)  In February 2005, Mr. Crawford was awarded 25,075 shares of performance-based phantom stock under the Second Phantom Stock Plan. In November 2003 and February 2003, Mr. Crawford was awarded 6,798 shares and 33,000 shares, respectively, of phantom stock under the Initial Phantom Stock Plan. Each phantom stock plan is described more fully below.
 
(9)  2005 includes Company matching contributions of $18,198 under Alion’s KSOP. Includes $601 in term life insurance premiums paid by Alion.
  2004 includes Company matching contributions of $13,291 under Alion’s KSOP. Includes $534 in term life insurance premiums paid by Alion.
 
  2003 includes Company matching contributions of $1,175 and $2,350 under IITRI’s 403(b) and 401(a) plans, respectively. These contributions cover the period October 1, 2002 to December 20, 2002, prior to the Transaction. Includes Company matching contribution of $11,404 under Alion’s KSOP. Includes $270,000 vested under a Retention Incentive Agreement. Includes $512 in term life insurance premiums paid by Alion.
(10)  In February 2004, Mr. Goff was promoted to Sector Senior Vice President and Sector Manager.
 
(11)  In February 2005, Mr. Hughes was awarded 30,297 shares performance-base phantom stock and 45,445 shares of retention-based phantom stock under the Second Phantom Stock Plan. In November 2003 and February 2003, Mr. Hughes was awarded 10,000 shares and 6,798 shares, respectively, of phantom stock under the Initial Phantom Stock Plan. Each phantom stock plan is described more fully below.
 
(12)  2005 includes Company matching contributions of $17,315 under Alion’s KSOP, $534 in term life insurance premiums, and $645 in club membership dues paid by Alion.
  2004 includes Company matching contributions of $14,423 under Alion’s KSOP and $611 in term life insurance premiums paid by Alion.
 
  2003 includes Company matching contribution of $10,687 under Alion’s KSOP. Includes $488 in term life insurance premiums paid by Alion. Includes $500 in club membership dues.

121



 

(13)  Retention Incentive Agreements. In September 2001, IITRI entered into and funded retention incentive agreements with Bahman Atefi, Stacy Mendler and Randy Crawford for $550,000, $295,000 and $270,000, respectively, via a non-qualified deferred compensation agreement. Alion’s acquisition of IITRI’S assets constituted a change in control of IITRI and these retention incentive awards vested fully upon closing of the Transaction.
 
(14)  2005 includes Company matching contributions of $18,509 under Alion’s KSOP, $425 in health club membership fees, and $599 in term life insurance paid by Alion.
  2004 includes Company matching contributions of $13,753 under Alion’s KSOP and $508 in term life insurance paid by Alion.
 
  2003 includes Company matching contributions of $1,967 and $3,358 under IITRI’s 403(b) and 401(a) plans, respectively. These contributions cover the period October 1, 2002 to December 20, 2002, prior to the Transaction. Includes Company matching contribution of $10,213 under Alion’s KSOP. Includes $461 in term life insurance premiums paid by Alion.
(15)  In February 2005, Mr. Goff was awarded 25,075 shares of performance-based phantom stock under the Second Phantom Stock Plan. In February 2003, Mr. Goff was awarded 3,999 shares of phantom stock under the Initial Phantom Stock Plan. Each phantom stock plan is described more fully below. In 2004, Mr. Goff received an award of 2,500 SARs. In 2003, Mr. Goff received an award of 1,200 SARs.
 
(16)  In September 2005, Mr. Diamant separated from the Company.
 
(17)  The amount paid directly by Alion for the six-month period subsequent to the purchase of JJMA by Alion (i.e. April 1, 2005 through September 30, 2005) of $223,114.
 
(18)  Includes $205,071 for settlement of employment agreement between Mr. Diamant and Alion. Includes Company matching contributions of $5,125 under Alion’s KSOP.
Stock Appreciation Rights Plans
      In November 2002, the board of directors adopted the Alion Science and Technology Corporation 2002 Stock Appreciation Rights (SAR) Plan, which is administered by the compensation committee of the board of directors or its delegate. The purpose of the 2002 SAR Plan was to attract, retain, reward and motivate employees responsible for the Company’s continued growth and development and its future financial success. On November 9, 2004, the board of directors amended the 2002 SAR Plan to provide that, on or after October 3, 2004, no further grants would be made under the 2002 SAR Plan. Existing grants made under the plan before October 3, 2004, remain in force.
      A SAR award provides a grantee with the right to receive payment for the increase in appraised value of a share of Alion common stock from the grant date to the exercise date. The 2002 SAR Plan contains a provision to prevent an award to a person who is or would become (if the award were made) a “disqualified person”. For this purpose, “disqualified person” means any individual who directly or beneficially holds at least 10% of Alion equity, including outstanding common stock and “synthetic equity”, such as SARs or phantom stock. Any award that violates this provision is void.
      Under the 2002 SAR Plan, awards to employees vest over five years, at a rate of 20% per year. Awards to directors under the plan vest ratably over each director’s term of service. The 2002 SAR Plan contains a provision for accelerated vesting in the event of death, disability or a change in control of the Company. Under the 2004 amendment to the 2002 SAR Plan, SARs are normally paid at the time the award becomes fully vested, or else upon the SAR holder’s earlier death, disability or termination of service. However, a grantee may request payment for any portion of an SAR that was vested on or before December 31, 2004 at any time, and can continue to hold such unexercised SARs for up to 60 days after the date at which a grant becomes completely vested. Payments are determined by the number of SARs vested multiplied by the difference between the share price at date of grant and the share price at date of payment.
      As of September 30, 2005, the Company had granted under the 2002 SAR Plan, 236,430 SARs, of which approximately 30,670 SARs had been exercised and 23,760 SARs had been forfeited resulting in approximately 181,970 SARs outstanding.

122



 

      On January 13, 2005, the Company’s board of directors adopted a second SAR plan, the Alion Science and Technology Corporation 2004 Stock Appreciation Rights Plan (the “2004 SAR Plan”), to comply with the deferred compensation provisions of the American Jobs Creation Act of 2004.
      The 2004 SAR Plan is administered by the compensation committee of the board of directors or its delegate and has a 10-year term. Awards may be granted under the plan to Alion directors, officers, employees and consultants. Under the Plan, the chief executive officer has the authority to grant awards as he deems appropriate; however, awards to executive officers are subject to the approval of the administrative committee of the Plan. The shares of Company common stock that may be used for reference purposes with respect to awards granted under the 2004 SAR Plan may not exceed 12% of the shares of Company common stock outstanding on a fully diluted basis (assuming the exercise of any outstanding options, warrants and rights including, without limitation, SARs, and assuming the conversion into stock of any outstanding securities convertible into stock), which amount may be adjusted in the event of a merger or other significant corporate transaction.
      Awards to employees vest over four years, at 25% per year. Awards to directors vest ratably over each director’s term of service. The 2004 SAR Plan contains a provision for accelerated vesting in the event of death, disability or a change in control of the Company. SARs are normally paid on the first anniversary of the date the award becomes fully vested, or else upon the SAR holder’s earlier death, disability or termination of service, or change in control. Payments are determined by the number of vested SARs multiplied by the difference between the share price at date of grant and the share price at date of payment; however, for SARs granted before November 9, 2005 and outstanding when a change in control occurs, payment is based on the number of SARs multiplied by the share price at the date of the change in control (or earlier valuation, if higher).
      The board of directors most recently amended both the 2002 SAR Plan and the 2004 SAR Plan in November 2005 to permit SAR holders to elect, prior to December 31, 2005, to have SARs paid immediately, as amounts under the award become vested. (This election does not apply to awards vested on or before December 31, 2004.) The SAR Plans permit the compensation committee to defer payments if it determines that payment is administratively impracticable or would jeopardize the solvency of the Company (provided that such impracticability or insolvency was unforeseeable as of the grant), or if the payment would violate a loan covenant or similar contract, or not be deductible under Section 162(m) of the Internal Revenue Code. Under the 2004 SAR Plan, a SAR holder may elect to defer the proceeds of the SAR into the Alion Science and Technology Corporation Executive Deferred Compensation Plan for a 5-year period, if he or she is eligible for such plan, by filing a deferral election with the Company at least one year in advance of the payment event.
      As of September 30, 2005, the Company had granted, under the 2004 SAR Plan, 214,350 SARs of which no SARs had been exercised and approximately 12,350 SARs had been forfeited resulting in approximately 202,000 SARs outstanding.
      Our board of directors may amend or terminate either SAR plan at any time.

123



 

      The following table sets forth information regarding grants of SARs to the Named Executive Officers pursuant to the SAR plan in fiscal year 2005. This table does not include warrants purchased from the Company described elsewhere in this Annual Report. The only Named Executive Officer who held warrants to purchase Alion common stock at September 30, 2005 was Dr. Atefi (22,062 shares).
SAR Grants in Last Fiscal Year*
                                         
        Percent of            
        SARs Granted   Exercise of       Grant Date
    No. of SARs   to Employees in   Base       Present
Name   Granted   FY   Price   Expiration Date   Value
                     
            (In dollars)       (In dollars)
                                       
Stacy Mendler(1)
                                       
Randy Crawford(1)
                                       
Jack Hughes(1)
                                       
Rob Goff(1)
                                       
Thomas Diamant(1)(2)
                                       
 
* Refers to the “Alion Science and Technology Corporation 2002 Stock Appreciation Rights (SAR) Plan” and “Alion Science and Technology Corporation 2004 Stock Appreciation Rights Plan” (see above, “Stock Appreciation Rights Plans” for more information regarding the SAR Plans).
 
(1)  No SAR awards during the fiscal year ended September 30, 2005.
 
(2)  In September 2005, Mr. Diamant separated from the Company.
      The following table sets forth information regarding the exercise of SARs during fiscal year 2005 by the Named Executive Officers and SARs held by them at September 30, 2005.
Aggregated SAR Exercises in Last Fiscal Year and Fiscal Year End/ SAR Values*
                                 
            Number of Securities   Value of Unexercised
            Underlying Unexercised   In-The-Money
    Shares       Options/SARs at Fiscal   Options/SARs at Fiscal
    Acquired   Value   Year End (Number)   Year End (Dollars)
Name   on Exercise   Realized   Exercisable/Unexercisable(4)   Exercisable/Unexercisable(5)
                 
            (In dollars)*    
                               
Stacy Mendler(1)
                               
Randy Crawford(1)
                               
Jack Hughes(1)
                               
Rob Goff(1)(2)
                    480/720     $ 12,427/$18,640  
             (3)
                    500/2000     $ 10,590/$42,360  
Thomas Diamant(1)(6)
                               
 
* Refers to the “Alion Science and Technology Corporation 2002 Stock Appreciation Rights (SAR) Plan” and “Alion Science and Technology Corporation 2004 Stock Appreciation Rights Plan” (see above, “Stock Appreciation Rights Plans” for more information regarding the SAR Plans).
 
(1)  No SAR awards during the fiscal year ended September 30, 2005.
 
(2)  In 2003, Mr. Goff was awarded 1,200 SARs at the exercise price of $10.00 per share. As of September 30, 2005, the value of Alion common stock is $35.89 per share.
 
(3)  In 2004, Mr. Goff was awarded 2,500 SARs at the exercise price of $14.71 per share. As of September 30, 2005, the value of Alion common stock is $35.89 per share.
 
(4)  The number of exercisable and unexercisable SARs is dependent on the plan vesting schedule. For example, as of September 30, 2005, for Mr. Goff, only 40% of the 1,200 SARs awarded in 2003 have vested, resulting in 480 exercisable SARs. As of September 30, 2005, the remaining SARs are unexercisable.

124



 

(5)  The value of exercisable and unexercisable SARs is dependent on the difference between the exercise price per share and the current fair value per share of Alion common stock. For example, as of September 30, 2005, for Mr. Goff, the exercise price for his SARs awarded in 2003 was $10 per share and the current value per share of Alion common stock is $35.89. The value of the exercisable SARs is $12,247 (480 shares multiplied by the difference between the current fair value per share of Alion stock, $35.89, and the exercise price per share, $10.00).
 
(6)  In September 2005, Mr. Diamant separated from the Company.
Phantom Stock Plans
      Phantom stock refers to hypothetical shares of Alion common stock. Each recipient of a phantom stock award receives a grant for a specified number of shares. Recipients, upon vesting, are generally entitled to receive an amount of money equal to the product of the number of hypothetical shares vested and the then current value of our common stock, based on the most recent valuation of the shares of common stock held by the ESOP. Phantom stock may increase, or decrease, in value over time, resulting in cash payments under the phantom stock awards that may be greater, or less than, the value of the phantom stock at the date of grant.
Initial Phantom Stock Plan
      In February 2003, the compensation committee of Alion’s board of directors approved, and the board of directors subsequently adopted, the Alion Science and Technology Phantom Stock Plan (the “Initial Phantom Stock Plan”). The Initial Phantom Stock Plan has a term of ten years. The Plan is administered by the board of directors (or its delegate) which may grant key management employees awards of phantom stock. Under the Initial Phantom Stock Plan, awards vest according to the following schedule:
                 
    Vested Amount
    for Grant in
     
    February   November
Anniversary from Grant Date   2003   2003
         
1st
          20 %
2nd
          20 %
3rd
    50 %     20 %
4th
    25 %     20 %
5th
    25 %     20 %
      As of September 30, 2005, the Company had 223,685 shares of phantom stock outstanding under the Initial Phantom Stock Plan.
      The Initial Phantom Stock Plan contains provisions for acceleration of vesting in the event of the employee’s death, disability, or a change in control of the Company. Terminated employees will usually forfeit their rights to all unvested phantom stock. In certain instances, however, an employee may receive a pro rata portion of his or her unvested phantom stock upon termination. For awards made prior to November 9, 2005, when an employee voluntarily terminates for good reason or is involuntarily terminated for any reason other than cause or just cause, as defined in his or her employment agreement with us, then that employee will receive a pro rata portion of his or her unvested phantom stock based on a ratio:
  •  the numerator of which is the number of months from the date of grant of the
 
  •  phantom stock through the end of the month of such termination; and
 
  •  the denominator of which is 60.
      For awards made on or after November 9, 2005, when an employee voluntarily terminates for good reason or is involuntarily terminated for any reason other than cause or just cause, as described above, then that employee will receive a pro rata portion of his or her phantom stock equal to the greater of (i) the amount vested under the award’s normal vesting schedule, or (ii) the number of shares of phantom stock (both vested and unvested) multiplied by the ratio set forth above.

125



 

      Phantom stock awards issued under the Initial Phantom Stock Plan are normally paid at the time the award becomes fully vested, or else upon the employee’s earlier death, disability or termination of service. However, a grantee may request payment for any portion of a phantom stock award that was vested on or before December 31, 2004, by filing a written election to exercise with the committee at least 6 months before the requested exercise date and at least 3 months in advance of the ESOP valuation date that will apply to such exercise, and can continue to hold such unexercised phantom stock awards until the award becomes completely vested.
Second Phantom Stock Plan
      On November 9, 2004, the Company’s compensation committee approved, and the full board adopted, The Alion Science and Technology Corporation Performance Shares and Retention Phantom Stock Plan (the “Second Phantom Stock Plan”) to comply with the requirements of the American Jobs Creation Act.
      The Second Phantom Stock Plan permits awards of retention share phantom stock and performance share phantom stock. A retention award is for a fixed number of shares determined at the date of grant. A performance award is for an initial number of shares subject to change at the vesting date. Performance phantom shares are subject to forfeiture for failure to achieve a specified threshold value for a share of the Company’s common stock as of the vesting date. If the value of a share of the Company’s common stock equals the threshold value but does not exceed the target value, the number of performance shares in a given grant may be decreased by a specified percentage (generally up to 50 percent). If the value of a share of the Company’s common stock exceeds a pre-established target price on the vesting date, the number of performance shares in a given grant may be increased by a specified percentage (generally up to 20%).
      Awards under the Second Phantom Stock Plan vest three years from date of grant (unless otherwise provided in an individual award agreement), provided that the grantee is still employed by the Company. Accelerated vesting is provided in the event of death, disability, involuntary termination without cause, or upon a change in control of the company, unless the individual award agreement provides otherwise. Grants are to be paid out on the “payment date” specified in the award agreement, which is generally five years and sixty days from the date of grant, unless the award holder elects to accelerate payment by filing an election no later than December 31, 2005, or to defer the proceeds of phantom stock into the Alion Science and Technology Corporation Executive Deferred Compensation Plan, as described below.
      As of September 30, 2005, under the Second Phantom Stock Plan, the Company had granted 125,623 shares of retention incentive phantom stock and 183,062 shares of performance incentive phantom stock to executive officers of the Company pursuant to the Second Phantom Stock Plan. Depending on the future financial performance of the Company, grantees may vest in performance incentive phantom shares at a greater (up to 20% more) or lesser (up to 50% less) number of shares than the target number of shares disclosed above.
      Under the plans, members of our compensation committee who are eligible to receive phantom stock or who have been granted phantom stock may vote on any matters affecting the administration of the plan or the grant of phantom stock, except that a member cannot act upon the granting of phantom stock to himself or herself. These voting provisions also apply to members of our board of directors when the board resolves to act under the plans.
      When granted, phantom stock provides the employee with the right to receive payment upon exercise of the phantom stock. The terms of each phantom stock grant are evidenced in a phantom stock agreement which determines the:
  •  Date of grant;
 
  •  Number of shares of the phantom stock awarded; and
 
  •  Provisions governing vesting of the phantom stock awarded.
      The plans also provide that phantom stock awarded at different times need not contain similar provisions.

126



 

      Under the plans, the payment that the Company will make upon the vesting of phantom stock is intended to be made in one lump sum within 60 days of the date of vesting unless a later date is set forth in an individual award agreement. The compensation committee, or our board of directors, if it resolves to do so, may delay payment for five years. If the payment is delayed, it will include interest accrued at the prime rate as of the date of vesting until the payment date. In general, we expect that the compensation committee, or the board if it resolves to do so, will examine our available cash and anticipated cash needs in determining whether to delay payment. Under limited circumstances, payments from the exercise of phantom stock may be rolled over into any non-qualified deferred compensation plan available to the employee.
      The board of directors amended both Phantom Stock Plans in November 2005. Under this amendment, phantom stock holders may elect, prior to December 31, 2005, to have phantom stock awards paid immediately, as amounts under the award become vested. This election does not apply to awards vested before December 31, 2004 under the Initial Phantom Stock Plan, because the phantom stock holder may already exercise such awards at any time. An award holder who does not make an acceleration election as described above may elect to defer the proceeds of phantom stock into the Alion Science and Technology Corporation Executive Deferred Compensation Plan for a 5 year period, if he or she is eligible for the plan, by filing a deferral election with the Company at least one year in advance of the payment event. A 180 day election period applies for phantom stock awards vested on or before December 31, 2004.
      No voting or other rights associated with ownership of our common stock is given to phantom stockholders. References to shares of common stock under the plan are for accounting and valuation purposes only. As a result, an employee who receives phantom stock does not have any of the rights of a stockholder as a result of a grant of phantom stock.
      Both Phantom Stock Plans permit the administrative committee to defer payments if it determines that payment is administratively impracticable or would jeopardize the solvency of the company (provided that such impracticability or insolvency was unforeseeable as of the grant), or if the payment would violate a loan covenant or similar contract, or not be deductible under Section 162(m) of the Internal Revenue Code.
      Both Phantom Stock Plans contain a provision to prevent an award to a person who is or would become (if the award were made) a “disqualified person” for as long as we maintain the ESOP. For this purpose, “disqualified person” means any individual who directly or beneficially (such as under the Alion ESOP) holds at least 10% of Alion equity, including outstanding common stock and “synthetic equity”, such as SARs or phantom stock. Any award that violates this provision is void.
      Subject to adjustments for merger or other significant corporate transactions, the shares of common stock that may be used for awards under all phantom stock plans of the company, including the Alion Science and Technology Corporation Board of Directors Phantom Stock Plan and the Alion Science and Technology Corporation Performance Shares and Retention Phantom Stock Plan and the Alion Science and Technology Corporation Phantom Stock Plan, shall not exceed 2,000,000 shares (whether or not such awards have expired, terminated unexercised, or become unexercisable, or have been forfeited or otherwise terminated, surrendered or cancelled).
      The number of shares of our common stock used for reference purposes with respect to grants of phantom stock under the plans is as follows:
                         
            Cumulative Shares
    Shares Issued   Cumulative Shares   Authorized Under
Date of Issuance   by Plan   Issued by Plan   all Plans
             
    171,000 (1)     171,000 (1)     173,000 (1)
    52,685 (1)     223,685 (1)     225,000 (1),
    311,645 (2)     311,645 (2)     2,000,000 (2),
 
(1)  Number of shares authorized under the Initial Phantom Stock Plan as periodically amended and approved by the compensation committee of Alion’s board of directors.

127



 

(2)  Number of shares authorized under the Second Phantom Stock Plan as periodically amended and approved by the compensation committee of Alion’s board of directors.
      The following table sets forth information regarding phantom stock granted to the Named Executive Officers pursuant to the phantom stock plan.
                         
    Number of        
    Shares, Units,   Full Vesting   Period Until
Name   or Rights   Period   Payout
             
    65,500 (1)     February 2008(2)       February 2008(3)  
      18,695 (1)     November 2008(2)       November 2008(3)  
      65,926 (4)     February 2008(5)       February 2010(5)  
      43,951 (4)     February 2010(5)       February 2010(5)  
Stacy Mendler
    28,500 (1)     February 2008(2)       February 2008(3)  
      6,798 (1)     November 2008(2)       November 2008(3)  
      24,151 (6)     February 2008(5)       February 2010(5)  
      36,227 (6)     February 2010(5)       February 2010(5)  
Randy Crawford
    33,000 (1)     February 2008(2)       February 2008(3)  
      6,798 (1)     November 2008(2)       November 2008(3)  
      25,075 (7)     February 2008(5)       February 2010(5)  
Jack Hughes
    10,000 (1)     February 2008       February 2008(3)  
      6,798 (1)     November 2008       November 2008(3)  
      30,297 (8)     February 2008(5)       February 2010(5)  
      45,445 (8)     February 2010(5)       February 2010(5)  
Robert Goff
    3,399 (1)     November 2008(3)       November 2008(3)  
      18,695 (1)     November 2008(4)       November 2008(5)  
      25,075 (9)     February 2008(5)       November 2008(5)  
 
(1)  The initial set of awards made in February 2003 was made solely to Alion’s executive management team. The awards made in November 2003 were made to executive and senior management of Alion.
 
(2)  Pursuant to the Initial Phantom Stock Plan, recipients will become fully vested on the fifth year from the grant date, or approximately February 2008 and November 2008.
 
(3)  Pursuant to the Initial Phantom Stock plan, or applicable award agreement, recipients will be paid commencing on the fifth year from the date of grant.
 
(4)  Pursuant to the Second Phantom Stock Plan, in February 2005, Dr. Atefi was awarded 65,926 shares of performance-based phantom stock and 43,951 shares of retention-based phantom stock.
 
(5)  Pursuant to the Second Phantom Stock Plan, recipients may be awarded performance-based or retention-based phantom stock. Under this plan, performance-based phantom stock will become fully vested one third from the date of grant, or approximately February 2008; retention-based phantom stock will become fully vested as specified in the individual agreements. To date, all individual retention-based agreements made have specified that phantom stock will become fully vested on the fifth year from date of grant, or approximately February 2010. Under this plan, recipients of performance-based and retention-based phantom stock will be paid commencing on the fifth year from date of grant, or approximately February 2010.
 
(6)  Pursuant to the Second Phantom Stock Plan, in February 2005, Ms. Mendler was awarded 24,151 shares of performance-based phantom stock and 36,227 shares of retention-based phantom stock.
 
(7)  Pursuant to the Second Phantom Stock Plan, in February 2005, Mr. Crawford was awarded 25,075 shares of performance-based phantom stock.
 
(8)  Pursuant to the Second Phantom Stock Plan, in February 2005, Mr. Hughes was awarded 30,297 shares of performance-based phantom stock and 45,445 shares of retention-based phantom stock.

128



 

(9)  Pursuant to the Second Phantom Stock Plan, in February 2003, Mr. Goff was awarded 25,075 shares of performance-based phantom stock.
Employment Agreements
      Alion has entered into employment agreements with Bahman Atefi, Stacy Mendler, Randy Crawford, John Hughes and Robert Goff, the terms of which are set forth below.
      Under his employment agreement, Dr. Atefi will serve as President and Chief Executive Officer of Alion for a term of 60 months, commencing on December 20, 2002 and ending on December 20, 2007. He will receive a base annual salary of $490,000 for fiscal year 2006 and will be eligible for a performance-based annual incentive bonus. Dr. Atefi is also eligible to participate in Alion’s Deferred Compensation Plan, Stock Appreciation Rights Plan, and Phantom Stock Plan. Under the terms of his employment agreement, Dr. Atefi will be given an allowance for a company car. In addition, his initiation fee and membership dues for a country club for business entertainment purposes are provided for under Dr. Atefi’s employment agreement. Dr. Atefi may terminate his employment agreement with 30 days advance written notice. If he does so, however, he will forfeit any incentive payments which might otherwise have been due him. Alion may terminate Dr. Atefi’s employment agreement for just cause, which includes, amongst others, theft or embezzlement of our material property, gross negligence, willful misconduct or neglect by Dr. Atefi of his duties. Alion may also terminate Dr. Atefi’s employment agreement without cause, although if Alion does so, it will have to make a lump sum severance payment to Dr. Atefi equal to the greater of
  •  Dr. Atefi’s annual base salary at the time of termination, for the unexpired term of the employment agreement up to a maximum of three years; or
 
  •  an amount equal to Dr. Atefi’s base salary plus $100,000.
      Under his employment agreement, Dr. Atefi is entitled to terminate his employment and receive the same lump sum severance payment described above, if he terminates his employment for any of the following reasons within 24 months following a change of control event:
  •  his authority or responsibility is materially diminished;
 
  •  he is assigned duties inconsistent with his position, responsibility and status;
 
  •  there is an adverse change in his title or office;
 
  •  his base pay or incentive compensation is reduced; and
 
  •  his principal work location is more than ten miles away from his principal work location immediately prior to the change of control event.
      For a minimum of one year after termination of Dr. Atefi’s employment, he is not permitted, in any way, to compete with Alion or solicit our employees.
      Under her employment agreement, Ms. Mendler will serve as Executive Vice President and Chief Administrative Officer for Alion for a term of 60 months, commencing on December 20, 2002 and ending December 20, 2007. She will receive a base annual salary of $300,000 and will be eligible for a performance-based annual incentive bonus. Ms. Mendler is also eligible to participate in Alion’s deferred compensation plan, stock appreciation rights plan, and phantom stock plan. Under the terms of her employment agreement, Ms. Mendler will be given an allowance for a company car. Ms. Mendler may terminate her employment agreement with 30 days notice. If she does so, however, she will forfeit any incentive payments which might otherwise have been due her. Alion may terminate Ms. Mendler’s employment agreement for cause, which includes, amongst others, fraud, theft or embezzlement, reckless, willful or criminal misconduct, or gross negligence, in Ms. Mendler’s performance of her duties. Alion may also terminate Ms. Mendler’s employment without cause, although if Alion does so, it will have to make a lump sum severance payment to Ms. Mendler equal to the greater of

129



 

  •  Ms. Mendler’s annual base salary at the time of termination for the unexpired term of the employment agreement up to a maximum of two years; or
 
  •  an amount equal to Ms. Mendler’s base salary.
      Under her employment agreement, Ms. Mendler is entitled to terminate her employment and receive the same lump sum severance payment described above, if she terminates his employment for any of the following reasons within 24 months following a change of control event:
  •  her authority or responsibility is materially diminished;
 
  •  she is assigned duties inconsistent with her position, responsibility and status;
 
  •  there is an adverse change in her title or office;
 
  •  her base pay or incentive compensation is reduced; and
 
  •  her principal work location is more than ten miles away from her principal work location immediately prior to the change of control event.
      For a minimum of one year after termination of Ms. Mendler’s employment she is not permitted, in any way, to compete with Alion or solicit our employees.
      Under his employment agreement, Mr. Crawford will serve as Senior Vice President and Sector Manager of the Engineering and Information Technology Sector for Alion for a term of 60 months, commencing on December 20, 2002 and ending on December 20, 2007. He will receive a base annual salary of $280,000 for fiscal year 2005 and will be eligible for a performance-based annual incentive bonus. Mr. Crawford is eligible to participate in Alion’s Deferred Compensation Plan, Stock Appreciation Rights Plan, and Phantom Stock Plan. Under the terms of his employment agreement, Mr. Crawford will be given an allowance for a company car. Mr. Crawford may terminate his employment agreement with 30 days notice. If he does so, however, he will forfeit any incentive payments which might otherwise have been due him. Alion may terminate Mr. Crawford’s employment agreement for cause, which includes, amongst others, commission of a crime involving fraud, theft or embezzlement, reckless, willful or criminal misconduct, or gross negligence in Mr. Crawford’s performance of his duties. Alion may also terminate Mr. Crawford’s employment without cause, although if Alion does so, it will have to make a lump sum severance payment to Mr. Crawford equal to the greater of
  •  Mr. Crawford’s annual base salary at the time of termination for the unexpired term of the employment agreement up to a maximum of two years; or
 
  •  an amount equal to Mr. Crawford’s base salary.
      Under his employment agreement, Mr. Crawford is entitled to terminate his employment and receive the same lump sum severance payment described above, if he terminates his employment for any of the following reasons within 24 months following a change of control event:
  •  his authority or responsibility is materially diminished;
 
  •  he is assigned duties inconsistent with his position, responsibility and status;
 
  •  there is an adverse change in his title or office;
 
  •  his base pay or incentive compensation is reduced; and
 
  •  his principal work location is more than ten miles away from his principal work location immediately prior to the change of control event.
      For a minimum of one year after termination of Mr. Crawford’s employment he is not permitted, in any way, to compete with Alion or solicit our employees.
      Under his employment agreement, Mr. Hughes will serve as Executive Vice President and Chief Financial Officer of Alion for a term of 60 months, commencing on December 20, 2002 and ending on

130



 

December 20, 2007. He will receive a base annual salary of $300,000 for fiscal year 2005 and will be eligible for a performance-based annual incentive bonus. Mr. Hughes is also eligible to participate in Alion’s Deferred Compensation Plan, Stock Appreciation Rights Plan, and Phantom Stock Plan. Under the terms of his employment agreement, Mr. Hughes will be given an allowance for a company car. Mr. Hughes may terminate his employment agreement with 30 days notice. If he does so, however, he will forfeit any incentive payments which might otherwise have been due him. Alion may terminate Mr. Hughes’ employment agreement for cause, which includes, amongst others, fraud, theft or embezzlement, reckless, willful or criminal misconduct, or gross negligence in Mr. Hughes’ performance of his duties. Alion may also terminate Mr. Hughes’ employment without cause, although if Alion does so, it will have to make a lump sum severance payment to Mr. Hughes equal to the greater of Mr. Hughes’ annual base salary at the time of termination for the unexpired term of the employment agreement up to a maximum of two years; or an amount equal to Mr. Hughes base salary.
      Under his employment agreement, Mr. Hughes is entitled to terminate his employment and receive the same lump sum severance payment described above, if he terminates his employment for any of the following reasons within 24 months following a change of control event:
  •  his authority or responsibility is materially diminished;
 
  •  he is assigned duties inconsistent with his position, responsibility and status;
 
  •  there is an adverse change in his title or office;
 
  •  his base pay or incentive compensation is reduced; and
 
  •  his principal work location is more than ten miles away from his principal work location immediately prior to the change of control event.
      For a minimum of one year after termination of Mr. Hughes employment he is not permitted, in any way, to compete with Alion or solicit our employees.
      Under his employment agreement, Mr. Goff will serve Senior Vice President and Sector Manager of the Defense Operations Integration Sector for Alion, effective February 14, 2004. He will receive a base annual salary of $300,000 for the fiscal year 2005. Mr. Goff is also eligible to participate in Alion’s Deferred Compensation Plan, Stock Appreciation Rights Plan, and Phantom Stock Plan. Mr. Goff will be given an allowance for the lease of a company car. Mr. Goff may terminate his employment agreement with 30 days notice. If he does so, however, he will forfeit any incentive payments which might otherwise have been due him. Alion may terminate Mr. Goff’s employment agreement for cause, which includes, amongst others, commission of a crime involving fraud, theft or embezzlement, reckless, willful or criminal misconduct, or gross negligence in Mr. Goff’s performance of his duties. Within two years from the effective date, Alion may also terminate Mr. Goff’s employment without cause, although if Alion does so, it will have to make a lump sum severance payment to Mr. Goff equal to one year of annual base salary as of the date of termination.
      Under his employment agreement, Mr. Goff is entitled to terminate his employment and receive the same lump sum severance payment described above, if he terminates his employment for any of the following reasons within 24 months following a change of control event:
  •  his authority or responsibility is materially diminished;
 
  •  he is assigned duties inconsistent with his position, responsibility and status;
 
  •  there is an adverse change in his title or office;
 
  •  his base pay or incentive compensation is reduced; and his principal work location is more than ten miles away from his principal work location immediately prior to the change of control event.
Deferred Compensation Arrangement for Bahman Atefi
      Dr. Atefi entered into a Deferred Compensation Agreement with Alion as a condition to completing the acquisition, pursuant to which he has forgone an aggregate of approximately $1.0 million in deferred

131



 

compensation under his retention incentive agreement with IITRI and under an Executive Deferred Compensation Plan entered into between IITRI and Dr. Atefi in 1997. Alion used this amount to decrease the principal amount of the Mezzanine Note and warrants issued to IITRI at closing. On December 20, 2002, Alion entered into an agreement with Dr. Atefi, the payment terms of which resemble those of the Mezzanine Note, which entitle Dr. Atefi to payment by Alion of approximately $857,000 in principal amount on December 20, 2008, plus 12% cash interest per year. Under this Agreement, Dr. Atefi was also granted warrants which entitle him to purchase approximately 22,062 shares of Alion’s common stock at an exercise price of $10 per share. On October 29, 2004, Dr. Atefi elected to redeem the amount due under his Deferred Compensation Agreement. Dr. Atefi was paid $857,000 plus $193,682 in accrued interest. Dr. Atefi’s warrants remained outstanding.
Deferred Compensation Plans
      We maintain two Deferred Compensation Plans. One plan, the Executive Deferred Compensation Plan, covers members of management and other highly compensated officers of the Company. The other plan, the Directors Deferred Compensation Plan, covers members of our board of directors.
      Each plan permits an individual to make a qualifying election to forego current payment and defer a portion of his or her compensation. Officers may defer up to 50% of their annual base salary and up to 100% of their bonus, SAR and/or phantom stock payments. Directors may defer up to 100% of their fees and up to 100% of their SAR payments.
      Each Plan permits an individual to defer payment to a specified future date and to specify whether deferrals are to be paid in a lump sum or installments. Under certain limited circumstances, deferrals may be paid out early or further deferred. In general, individuals may make only one qualifying deferral election per year.
Item 12. Security Ownership of Certain Beneficial Owners and Management and Related Stockholders Matters
      The following table sets forth certain information as of September 30, 2005, regarding the beneficial ownership of the Company’s common stock by certain beneficial owners and all directors and Named Executive Officers, both individually and as a group. The Company knows of no other person not disclosed herein beneficially owning more than 5% of the Company’s Common Stock. The address of the beneficial owner (as required) and the dates applicable to the beneficial ownership indicated are set forth in the footnotes below.
                         
        Amount and Nature    
        of Beneficial   Percentage
Name of Beneficial Owner   Title of Class   Ownership   of Class(1)
             
Five Percent Security Holders:
                       
Illinois Institute of Technology(2)
    Common stock       1,585,339 (3)     23.5  
Directors(4) and Executive Officers:
                       
    Common stock       88,298 (5)     1.7  
Jack Hughes
    Common stock       6,379 (6)     *  
Stacy Mendler
    Common stock       71,452 (7)     1.4  
Randy Crawford
    Common stock       47,980 (8)     *  
Rob Goff
    Common stock       9,281 (9)     *  
All Directors and Officers as a Group
(5 Persons)
    Common stock       223,390 (10)     4.4  
 
  * less than 1%.
(1)  Applicable percentages based on 5,149,840 shares outstanding on September 30, 2005, and also includes shares of Common Stock subject to warrants that may be exercised within 60 days of September 30,

132



 

2005. Such shares are deemed to be outstanding for the purposes of computing the percentage ownership of the individual or entity holding the shares, but are not deemed outstanding for purposes of computing the percentage of any other person shown in the table. This table is based upon information in the Company’s possession and believed to be accurate. Unless indicated in the footnotes to this table and subject to community property laws where applicable, the Company believes that each of the shareholders named in this table has sole voting and investment power with respect to the shares indicated as beneficially owned.
 
(2)  Illinois Institute of Technology’s address is 3300 South Federal Street, Chicago, IL 60616.
 
(3)  The number of shares deemed to be beneficially held by IIT represents currently exercisable warrants held by IIT under the Mezzanine Warrant and the Subordinated Warrant for an aggregate of 1,585,339 shares of Common Stock.
 
(4)  No directors (other than Dr. Atefi) are believed by us to be beneficial owners of our common stock.
 
(5)  Includes warrants to purchase 22,062 shares of common stock pursuant to Dr. Atefi’s Deferred Compensation Arrangement with Alion and interests to purchase 66,236 shares of Alion’s common stock pursuant to The Alion Science and Technology Corporation Employee Ownership, Savings and Investment Plan, which we refer to as the KSOP.
 
(6)  Includes interests to purchase 6,379 shares of Alion’s common stock pursuant to the KSOP.
 
(7)  Includes interests to purchase 71,452 shares of Alion’s common stock pursuant to the KSOP.
 
(8)  Includes interests to purchase 47,980 shares of Alion’s common stock pursuant to the KSOP.
 
(9)  Includes interests to purchase 9,281 shares of Alion’s common stock pursuant to the KSOP.
(10)  Includes 223,390 shares of KSOP interests beneficially owned by the Named Executive Officers as of September 30, 2005, and warrants to purchase 22,062 shares of common stock held by Dr. Atefi.
     Changes in Control
      We do not know of any agreements, the operation of which may at a subsequent date result in a change in control of the Company.
Item 13. Certain Relationships and Related Transactions
      Since the beginning of our last fiscal year, including any currently proposed transactions, no directors, executive officers or immediate family members of such individuals were engaged in transactions with us or any subsidiary involving more than $60,000, other than the arrangements described in the section “Executive Compensation.”
Item 14. Principal Accountant Fees and Services
      Consistent with the charter of Audit and Finance Committee, the Committee is responsible for engaging the Company’s independent auditors. Beginning with the year ended September 30, 2003, all audit and permitted non-audit services require pre-approval by the Audit and Finance Committee. The full Committee approves proposed services and fee estimates for these services. During fiscal years 2005 and 2004 all services performed by the auditors were pre-approved.

133



 

      The following table summarizes the fees of KPMG LLP, our independent auditors, billed to the Company for each of the last two fiscal years for audit services and billed to the Company in each of the last two fiscal years for other services:
                 
Fee Category   2005   2004
         
Audit Fees(1)
  $ 728,334     $ 536,772  
Audit-Related Fees(2)
  $ 65,988     $ 382,661  
Tax fees and other
  $     $  
             
Total Fees
  $ 794,322     $ 919,433  
             
 
(1)  Audit fees consist of fees for the audit of the Company’s financial statements, the review of the interim financial statements included in the Company’s quarterly reports on Form 10-Q, and other professional services provided in connection with statutory and regulatory filings or engagements.
 
(2)  Audit-related fees consist of fees for assurance and related services that are reasonably related to the performance of the audit and the review of our financial statements and which are not reported under “Audit Fees”. In fiscal years 2005 and 2004, these services related primarily to audit services provided in conjunction with acquisitions, accounting consultations, and audits of employee benefit plans. In fiscal 2005, these services related primarily to audit of employee benefit plan and Sarbanes-Oxley Section 404 assistance. These services were approved by the Audit and Finance Committee.

134



 

PART IV
Item 15. Exhibits and Financial Statement Schedules
      The following documents are filed as part of the Annual Report on Form 10-K:
           
Consolidated Financial Statements of Alion Science and Technology Corporation
       
Report of Independent Registered Public Accounting Firm
    63  
Consolidated Financial Statements:
       
 
Consolidated Balance Sheets as of September 30, 2005 and 2004
    64  
 
Consolidated Statements of Operations for the years ended September 30, 2005, 2004 and 2003
    65  
 
Consolidated Statements of Shareholder’s Equity (Deficit), Subject to Redemption, for the years ended September 30, 2005, 2004 and 2003
    66  
 
Consolidated Statements of Cash Flows for the years ended September 30, 2005, 2004 and 2003
    67  
 
Notes to Consolidated Financial Statements
    69  
Consolidated Financial Statement Schedule
       
 
Schedule II — Valuation and Qualifying Accounts
    94  
Consolidated Financial Statements of Selected Operations of IIT Research Corporation
       
Report of Independent Auditors’ Report
    95  
Consolidated Financial Statements:
       
 
Consolidated Balance Sheets as of September 30, 2002 and 2001
    96  
 
Consolidated Statements of Income for the years ended September 30, 2002, 2001, and 2000
    97  
 
Consolidated Statements of Changes in Owner’s Net Investment for the years ended September 30, 2002, 2001, and 2000
    98  
 
Consolidated Statements of Cash Flows for the years ended September 30, 2002, 2001, and 2000
    99  
Notes to Consolidated Financial Statements
    100  
      (b) The following exhibits required by Item 601 of Regulation 8-K
         
Exhibit    
No.   Description
     
  2 .1   Stock Purchase Agreement by and among Identix Public Sector, Inc. Identix Incorporated and Alion Science and Technology Corporation, dated February 13, 2004.(4)
 
  3 .1   Third Amended and Restated Certificate of Incorporation of Alion Science and Technology Corporation.(16)
 
  3 .2   Amended and Restated By-laws of Alion Science and Technology Corporation.
 
  4 .1   Amended and Restated Alion Science and Technology Corporation Employee Ownership, Savings and Investment Plan.(1)
 
  4 .2   First Amendment to The Alion Science and Technology Corporation Employee Ownership, Savings and Investment Plan.(2)
 
  4 .3   Second Amendment to The Alion Science and Technology Corporation Employee Ownership, Savings and Investment Plan.(3)
 
  4 .4   Third Amendment to The Alion Science and Technology Corporation Employee Ownership, Savings and Investment Plan.(3)
 
  4 .5   Fourth Amendment to The Alion Science and Technology Corporation Employee Ownership, Savings and Investment Plan.(3)
 
  4 .6   Fifth Amendment to The Alion Science and Technology Corporation Employee Ownership, Savings and Investment Plan.(5)
 
  4 .7   Sixth Amendment to The Alion Science and Technology Corporation Employee Ownership, Savings and Investment Plan.(5)

135



 

         
Exhibit    
No.   Description
     
 
  4 .8   Seventh Amendment to The Alion Science and Technology Corporation Employee Ownership, Savings and Investment Plan.(5)
 
  4 .9   Eighth Amendment to The Alion Science and Technology Corporation Employee Ownership, Savings and Investment Plan.(5)
 
  4 .10   Ninth Amendment to The Alion Science and Technology Corporation Employee Ownership, Savings and Investment Plan.(9)
 
  4 .11   Tenth Amendment to The Alion Science and Technology Corporation Employee Ownership, Savings and Investment Plan.
 
  4 .12   Eleventh Amendment to The Alion Science and Technology Corporation Employee Ownership, Savings and Investment Plan.
 
  10 .5   Seller Note Securities Purchase Agreement by and between IITRI and Alion Science and Technology Corporation.(2)
 
  10 .8   Rights Agreement.(2)
 
  10 .9   First Amendment to The Alion Science and Technology Corporation 2002 Stock Appreciation Rights Plan.(3)*
 
  10 .14   Employment Agreement between Alion Science and Technology Corporation and Bahman Atefi.(2)*
 
  10 .15   Employment Agreement between Alion Science and Technology Corporation and Stacy Mendler.(2)*
 
  10 .16   Employment Agreement between Alion Science and Technology Corporation and Randy Crawford.(2)*
 
  10 .17   Employment Agreement between Alion Science and Technology Corporation and Barry Watson.(2)*
 
  10 .18   Employment Agreement between Alion Science and Technology Corporation and John Hughes.(2)*
 
  10 .23   Alion Executive Deferred Compensation Plan.(2)*
 
  10 .24   Alion Director Deferred Compensation Plan.(2)*
 
  10 .25   First Amendment to The Alion Science and Technology Corporation Director Deferred Compensation Plan.(3)*
 
  10 .26   Alion Science and Technology Corporation Phantom Stock Plan.(2)*
 
  10 .27   First Amendment to The Alion Science and Technology Corporation Employee Phantom Stock Plan.(9)*
 
  10 .29   First Amendment to the Credit Agreement by and among LaSalle Bank National Association as agent, various lenders and Alion Science and Technology Corporation.(6)
 
  10 .30   Second Amendment to the Credit Agreement by and among LaSalle Bank National Association as agent, various lenders and Alion Science and Technology Corporation.(8)
 
  10 .31   Agreement between Alion Science and Technology Corporation and James Fontana.(8)*
 
  10 .32   Employment Agreement between Alion Science and Technology Corporation and Leroy R. Goff III.(8)*
 
  10 .33   Third Amendment to the Credit Agreement by and among LaSalle Bank National Association as agent, various lenders and Alion Science and Technology Corporation.(7)
 
  10 .34   Addendum to Employment Agreement between Alion Science and Technology Corporation and James Fontana.(7)*
 
  10 .35   Second Amendment to the Alion Science and Technology Corporation Phantom Stock Plan.(7)*
 
  10 .36   Senior Secured Credit facility that includes a revolving credit facility and Term B note, by and among Credit Suisse First Boston as arranger, various lenders, and Alion Science and Technology Corporation.(9)
 
  10 .37   First Amendment to the Mezzanine Warrant Agreement.(9)
 
  10 .38   First Amendment to the Seller Warrant Agreement.(9)

136



 

         
Exhibit    
No.   Description
     
 
  10 .39   First Amendment to the Alion Mezzanine Warrant Agreement between Alion Science and Technology Corporation, Alion Science and Technology Corporation Employee Ownership, Savings and Investment Trust, and Bahman Atefi. (9)*
 
  10 .40   Third Amendment to the Alion Science and Technology Corporation Phantom Stock Plan.(10)*
 
  10 .41   Alion Science and Technology Corporation Performance Shares and Retention Phantom Stock Plan. (10)*
 
  10 .42   Second Amendment to the Alion Science and Technology Corporation 2002 Stock Appreciation Rights Plan. (10)*
 
  10 .43   Alion Science and Technology Corporation 2004 Stock Appreciation Rights Plan. (10)*
 
  10 .44   Second Amendment to the Alion Science and Technology Corporation Directors’ Deferred Compensation Plan. (10)*
 
  10 .45   Second Amendment to the Alion Science and Technology Corporation Executive Deferred Compensation Plan. (10)*
 
  10 .46   Second Amendment to the Seller Warrant Agreement.(10)
 
  10 .47   Second Amendment to the Mezzanine Warrant Agreement.(10)
 
  10 .48   Second Amendment to the Alion Mezzanine Warrant Agreement between Alion Science and Technology Corporation, Alion Science and Technology Corporation Employee Ownership, Savings and Investment Trust, and Bahman Atefi.(10)
 
  10 .49   Commitment letter by and between Alion Science and Technologies, Inc. and Credit Suisse First Boston for the $72 million Term Loan Facility, for Amendment One to existing Term Loan Facility. (11)
 
  10 .50   Third Amendment to the Seller Warrant Agreement.(12)
 
  10 .51   Third Amendment to Mezzanine Warrant Agreement.(12)
 
  10 .52   Third Amendment to the Alion Mezzanine Warrant Agreement between Alion Science and Technology Corporation, Alion Science and Technology Corporation Employee Ownership, Savings and Investment Trust, and Bahman Atefi.(12)
 
  10 .53   Stock Purchase Agreement by and among Alion Science and Technology, Inc, John J. Mc Mullen Associates, Inc., Marshall and Ilsley Trust Company, N.A. as Trustee to the John J. McMullen, Inc. Employee Stock Ownership Trust and P. Thomas Diamant, Anthony Serro, and David Hanafourde.(13)
 
  10 .54   Incremental Term Loan Assumption Agreement and Amendment Number One to existing Term Loan Facility with Credit Suisse First.(14)
 
  10 .55   Employment Agreement between Alion Science and Technology, Inc. and Anthony Serro. (15)*
 
  10 .56   Employment Agreement between Alion Science and Technology, Inc. and P. Thomas Diamant. (15)*
 
  10 .57   Alion Science and Technology Corporation Board of Directors Phantom Stock Plan. (16)*
 
  10 .58   Amended and Restated Alion Science and Technology Corporation Phantom Stock Plan. (16)*
 
  10 .59   Amended and Restated Alion Science and Technology Corporation Performance Shares and Retention Phantom Stock Plan. (16)*
 
  10 .60   Amended and Restated Alion Science and Technology Corporation 2002 Stock Appreciation Rights Plan. (16)*
 
  10 .61   Amended and Restated Alion Science and Technology Corporation 2004 Stock Appreciation Rights Plan. (16)*
 
  10 .62   Amended and Restated Alion Science and Technology Corporation Executive Deferred Compensation Plan. (16)*
 
  10 .63   Amended and Restated Alion Science and Technology Corporation Director Deferred Compensation Plan. (16)*

137



 

         
Exhibit    
No.   Description
     
 
  21     Subsidiaries of Alion Science and Technology Corporation:(i) Human Factors Applications, Inc., incorporated in the Commonwealth of Pennsylvania, (ii) Innovative Technology Solutions Corporation, incorporated in the State of New Mexico, (iii) Alion-IPS Corporation, incorporated in the Commonwealth of Virginia, (iv) Alion-METI Corporation, incorporated in the Commonwealth of Virginia, (v) Alion- CATI Corporation, incorporated in the State of California, (vi) Alion-JJMA Corporation, incorporated in the State of New York, (vii) Alion Technical Services Corporation, incorporated in the Commonwealth of Virginia, (viii) Alion Canada (U.S.), Inc., incorporated in the State of Delaware, and (ix) Alion Science and Technology (Canada) Corporation, incorporated in the Province of Nova Scotia, are wholly-owned (either directly or indirectly) by Alion Science and Technology Corporation.
 
  23 .1   Independent Auditor’s Consent.
 
  23 .2   Consent of Independent Registered Public Accounting Firm.
 
  31 .1   Certification of Chief Executive Officer of Alion Science and Technology Corporation pursuant to Rule 15d-14(a) promulgated under the Securities Exchange Act of 1934, as amended.
 
  31 .2   Certification of Chief Financial Officer of Alion Science and Technology Corporation pursuant to 15d-14(a) promulgated under the Securities Exchange Act of 1934, as amended.
 
  32 .1   Certification of Chief Executive Officer of Alion Science and Technology Corporation, pursuant to 18 U.S.C. Section 1350 as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.
  32 .2   Certification of Chief Financial Officer of Alion Science and Technology Corporation, pursuant to 18 U.S.C. Section 1350 as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.
 
(1)  Incorporated by reference to the corresponding exhibit previously filed as an exhibit to the Company’s Pre-Effective Amendment No. 3 to the Registration Statement on Form S-1 filed with the Securities and Exchange Commission on October 7, 2002 (File no. 333-89756).
 
(2)  Incorporated by reference to the corresponding exhibit previously filed as an exhibit to the Company’s Post-Effective Amendment No. 3 to the Registration Statement on Form S-1 filed with the Securities and Exchange Commission on March 24, 2003 (File no. 333-89756).
 
(3)  Incorporated by reference to the corresponding exhibit previously filed as an exhibit to the Company’s quarterly report on Form 10-Q for the quarterly period ended July 4, 2003, filed with the Securities and Exchange Commission on August 15, 2003 (File no. 333-89756).
 
(4)  Incorporated by reference to the corresponding exhibit previously filed as an exhibit to Company’s current report on Form 8-K/ A, filed with the Securities and Exchange Commission on March 5, 2004 (File no. 333-89756).
 
(5)  Incorporated by reference to the corresponding exhibit previously filed as an exhibit to the Company’s Registration Statement on Form S-8 filed with the Securities and Exchange Commission on April 28, 2004 (File no. 333-89756).
 
(6)  Incorporated by reference to the corresponding exhibit previously filed as an exhibit to the Company’s quarterly report on Form 10-Q for the quarterly period ended December 31, 2003, filed with the Securities and Exchange Commission on February 17, 2004 (File no. 333-89756).
 
(7)  Incorporated by reference to the corresponding exhibit previously filed as an exhibit to the Company’s quarterly report on Form 10-Q for the quarterly period ended June 30, 2004, filed with the Securities and Exchange Commission on August 13, 2004 (File no. 333-89756).
 
(8)  Incorporated by reference to the corresponding exhibit previously filed as an exhibit to the Company’s quarterly report on Form 10-Q for the quarterly period ended March 31, 2004, filed with the Securities and Exchange Commission on May 17, 2004 (File no. 333-89756).
 
(9)  Incorporated by reference to the corresponding exhibit previously filed as an exhibit to the Company’s annual report on Form 10-K for the fiscal year ended September 30, 2004, filed with the Securities and Exchange Commission on December 28, 2004 (File no. 333-89756).

138



 

(10)  Company’s Post-effective Amendment No. 5 to the Registration Statement on Form S-1 filed with the Securities and Exchange Commission on January 24, 2005 (File no. 333-89756).
 
(11)  Incorporated by reference to the corresponding exhibit previously filed as an exhibit to the Company’s Form 8-K filed with the Securities and Exchange Commission on March 9, 2005 (File no. 333-89756).
 
(12)  Incorporated by reference to the corresponding exhibit previously filed as an exhibit to the Company’s Form 8-K filed with the Securities and Exchange Commission on March 14, 2005 (File no. 333-89756).
 
(13)  Incorporated by reference to the corresponding exhibit previously filed as an exhibit to the Company’s Form 8-K filed with the Securities and Exchange Commission on April 6, 2005 (File no. 333-89756).
 
(14)  Incorporated by reference to the corresponding exhibit previously filed as an exhibit to the Company’s Form 8-K filed with the Securities and Exchange Commission on April 6, 2005 (File no. 333-89756).
 
(15)  Incorporated by reference to the corresponding exhibit previously filed as an exhibit to the Company’s Form 8-K filed with the Securities and Exchange Commission on April 7, 2005 (File no. 333-89756).
 
(16)  Incorporated by reference to the corresponding exhibit previously filed as an exhibit to the Company’s quarterly report on Form 10-Q for the quarterly period ended March 31, 2005, filed with the Securities and Exchange Commission on May 13, 2005 (File no. 333-89756).
 
(17)  Incorporated by reference to the corresponding exhibit previously filed as an exhibit to the Company’s Form 8-K filed with the Securities and Exchange Commission on December 2, 2005, 2005 (File no. 333-89756).
  * Denotes management contract and/or compensatory plan/arrangement.

139



 

SIGNATURES
      Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, as amended, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
  Alion Science and Technology Corporation
  (Registrant)
  By:  /s/ Bahman Atefi
 
 
  Bahman Atefi
  Chairman, Chief Executive Officer and Director
Date: January 31, 2006
      Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, this report has been signed below by the following persons on behalf of the registrant and in the capacities and on the dates indicated.
             
Signature   Title   Date
         
 
/s/ Bahman Atefi

Bahman Atefi
  Chairman, Chief Executive Officer and Director   January 31, 2006
 
/s/ John M. Hughes

John M. (“Jack”) Hughes
  Chief Financial Officer (Principal Financial Officer)   January 31, 2006
 
/s/ Gary N. Amstutz

Gary N. Amstutz
  Senior Vice President and Executive Director of Finance   January 31, 2006
 
/s/ Leslie Armitage

Leslie Armitage
  Director   January 31, 2006
 
/s/ Lewis Collens

Lewis Collens
  Director   January 31, 2006
 


Harold Gehman
  Director    
 
/s/ Donald E. Goss

Donald E. Goss
  Director   January 31, 2006
 
/s/ Robert L. Growney

Robert L. Growney
  Director   January 31, 2006
 


George A. Joulwan
  Director    
 
/s/ Michael E. Ryan

Michael E. Ryan
  Director   January 31, 2006
 
 

Edward C. Aldridge, Jr.
  Director    

140



 

      Supplemental Information to be Furnished with Reports Filed Pursuant to Section 15(d) of the Act by Registrants which Have Not Registered Securities Pursuant to Section 12 of the Act
      No annual report or proxy material has been sent to security holders.

141


Dates Referenced Herein   and   Documents Incorporated by Reference

This ‘10-K’ Filing    Date    Other Filings
12/20/108-K
9/30/1010-K,  10-K/A,  11-K,  8-K
12/20/09
9/30/0910-K,  11-K,  8-K
8/2/09
6/30/0910-Q
3/31/0910-Q,  8-K
12/31/0810-Q
12/20/08
9/30/0810-K,  11-K,  8-K/A
3/31/0810-Q,  8-K,  8-K/A
12/20/07
9/30/0710-K,  10-K/A,  8-K,  8-K/A
9/29/07
4/1/07
3/31/0710-Q,  8-K,  8-K/A
2/25/07
9/30/0610-K,  11-K,  8-K/A
4/1/06
3/31/0610-Q,  8-K,  8-K/A
3/30/06
Filed on:1/31/06
1/9/06
1/1/06
12/31/0510-Q
12/2/058-K
11/9/05
For Period End:9/30/058-K,  8-K/A
9/29/05
8/9/058-K/A
7/22/05
5/13/0510-Q,  8-K/A
4/15/05
4/7/058-K
4/6/058-K,  8-K/A
4/1/058-K,  8-K/A
3/31/0510-Q,  10-Q/A,  8-K,  8-K/A
3/22/05
3/14/058-K
3/9/058-K
2/25/05
2/11/05
2/7/05
2/1/05424B3
1/24/058-K,  POS AM
1/13/05
1/6/05
12/31/0410-Q,  NT 10-Q
12/28/0410-K
12/23/04
12/9/048-K
11/9/04
10/29/04
10/28/04
10/3/04
10/1/048-K
9/30/0410-K,  11-K,  424B3
9/15/04
8/16/04
8/13/0410-Q,  8-K/A
8/2/04
7/1/04
6/30/0410-Q
6/7/04
5/17/0410-Q
4/28/04S-8
4/23/04
3/31/0410-Q
3/5/048-K/A
2/17/0410-Q
2/14/04
2/13/048-K,  8-K/A
2/11/04
12/31/0310-Q
12/21/03
11/12/03
11/11/03
10/31/03
9/30/0310-K,  11-K
8/15/0310-Q
7/4/0310-Q
6/5/03
5/15/03
3/28/03
3/24/03POS AM
2/14/03
2/11/03
2/3/0310-Q
2/1/03
12/31/02
12/23/02
12/22/02
12/21/02
12/20/0210-Q,  10-Q/A,  8-K
12/6/02
10/7/02S-1/A
10/1/02
9/30/0211-K,  NT 11-K
9/16/02
9/12/02
6/15/02
5/7/02
12/21/01
12/19/01
12/15/01
10/11/01
10/10/01
10/1/01
9/30/01
6/30/01
12/22/00
9/30/00
2/7/00
12/24/99
9/30/99
6/13/99
6/12/99
6/1/99
5/31/99
10/1/98
9/30/98
 List all Filings 


6 Subsequent Filings that Reference this Filing

  As Of               Filer                 Filing    For·On·As Docs:Size             Issuer                      Filing Agent

 3/15/07  SEC                               UPLOAD10/07/17    1:20K  Alion Science & Technology Corp.
 3/14/07  SEC                               UPLOAD10/07/17    1:33K  Alion Science & Technology Corp.
 2/15/07  SEC                               UPLOAD10/07/17    1:44K  Alion Science & Technology Corp.
 7/25/06  SEC                               UPLOAD10/07/17    1:24K  Alion Science & Technology Corp.
 7/25/06  SEC                               UPLOAD10/07/17    1:23K  Alion Science & Technology Corp.
 3/29/06  SEC                               UPLOAD10/07/17    1:8K   Alion Science & Technology Corp.
Top
Filing Submission 0000950133-06-000416   –   Alternative Formats (Word / Rich Text, HTML, Plain Text, et al.)

Copyright © 2024 Fran Finnegan & Company LLC – All Rights Reserved.
AboutPrivacyRedactionsHelp — Fri., Apr. 19, 10:21:46.4am ET